Archives: InvestorWire

Knightscope (NASDAQ: KSCP), a leading innovator in robotics and artificial intelligence (“AI”) technologies focused on public safety, has deployed its K1 Hemisphere Autonomous Security Robots (“ASRs”) to two new clients: a church in Missouri and a hospital in Minnesota. The full-featured, compact devices are providing enhanced perimeter protection at these client properties, elevating safety for staff and visitors alike, reported Knightscope.

According to the announcement, KSCP’s K1 Hemisphere is an efficient, affordable entry point into leveraging Knightscope’s protective technologies. The platform, which can be mounted on many different surfaces, features three cameras that offer 210 degrees of eye-level, high-definition video; the solution also includes a strobe light, automatic license plate recognition, optional facial recognition, automated broadcast announcements, and an intercom that can run on either a wired or fully encrypted wireless network.

“Knightscope’s experience using artificial intelligence (‘AI) and machine learning to advance the future of physical security has grown significantly in accuracy and reliability since its first ASR deployment in May 2015,” said the company in the press release. “AI and analytics have helped clients accelerate the obsolescence of monitoring live video feeds by delivering real-time alerts when an anomaly is detected. As an example, ASRs can accurately detect people in places they should not be or at times of day they should not be there, identify known threats, read vehicle license plates and pinpoint the location of such detections, enabling faster forensic searches and response times to any threats.”

To view the full press release, visit https://ibn.fm/XzcbS

About Knightscope, Inc.

Knightscope builds cutting-edge technologies to improve public safety. The company’s long-term ambition is to make the United States of America the safest country in the world. For more information about the company, please visit www.Knightscope.com.

NOTE TO INVESTORS: The latest news and updates relating to KSCP are available in the company’s newsroom at https://ibn.fm/KSCP

About InvestorWire

InvestorWire (“IW”) is a specialized communications platform with a focus on advanced wire-grade press release syndication for private and public companies and the investment community. It is one of 60+ brands within the Dynamic Brand Portfolio @ IBN that delivers: (1) access to a vast network of wire solutions via InvestorWire to efficiently and effectively reach a myriad of target markets, demographics and diverse industries; (2) article and editorial syndication to 5,000+ outlets; (3) enhanced press release enhancement to ensure maximum impact; (4) social media distribution via IBN to millions of social media followers; and (5) a full array of tailored corporate communications solutions. With broad reach and a seasoned team of contributing journalists and writers, IW is uniquely positioned to best serve private and public companies that want to reach a wide audience of investors, influencers, consumers, journalists and the general public. By cutting through the overload of information in today’s market, IW brings its clients unparalleled recognition and brand awareness. IW is where breaking news, insightful content and actionable information converge.

For more information, please visit https://www.InvestorWire.com

Please see full terms of use and disclaimers on the InvestorWire website applicable to all content provided by IW, wherever published or re-published: https://www.InvestorWire.com/Disclaimer

InvestorWire
Los Angeles, CA
www.InvestorWire.com
310.299.1717 Office
[email protected]

InvestorWire is powered by IBN

Safety Shot (NASDAQ: SHOT), a pioneer in innovative well-being solutions, has appointed a new CEO. According to the company, Jarrett Boon, one of the original thought leaders and investors in LifeLock, will be taking over for Brian John, who is leaving to work with Elite Health Partners Inc., where he will focus on legacy Jupiter Wellness products. Boon was the cofounder and CEO of GBB Drink Lab, which developed Safety Shot, the company’s flagship product offering. As CEO, Boon will lead the launch and growth of the Safety Shot business. With more than three decades of experience in building, growing and selling businesses, Boon has gained invaluable expertise in in sales, marketing and strategic business development. “I thank Brian for the passion and commitment he has brought to Safety Shot and wish him well as he moves on to his next chapter with Elite Health Partners,” said Safety Shot CEO Jarrett Boon in the press release. “I am excited to take the business forward and even more excited about the tremendous potential that Safety Shot has to improve the health and well-being of millions of consumers in the growing $1.56 billion market. This is an amazing opportunity, and I will be dedicated to accelerating the growth of Safety Shot into a leading wellness beverage while increasing shareholder value.”

To view the full press release, visit https://ibn.fm/1ho8L

About Safety Shot

Safety Shot Inc., founded in 2018, is the first patented beverage that makes you feel better fast by reducing blood alcohol content and increasing mental clarity. Valued at $1.56 billion in 2020 and projected to grow at a CAGR of 14.6% through 2028, Safety Shot leverages scientifically proven ingredients to enhance metabolic pathways responsible for breaking down blood alcohol levels. The drink is purported to form a protective layer around the stomach, preventing residual alcohol absorption into the body. The formulation includes a tailored selection of all-natural vitamins, minerals, and nootropics, promoting faster alcohol breakdown and aiding in recovery and rehydration Safety Shot has been available for retail purchase since the first week of December 2023 at www.DrinkSafetyShot.com and www.Amazon.com . Additionally, the company plans to introduce business-to-business sales to distributors, retailers, restaurants, and bars in 2024. For more information about the company, visit www.SafetyShotHoldings.com.

NOTE TO INVESTORS: The latest news and updates relating to SHOT are available in the company’s newsroom at https://ibn.fm/SHOT

About InvestorWire

InvestorWire (“IW”) is a specialized communications platform with a focus on advanced wire-grade press release syndication for private and public companies and the investment community. It is one of 60+ brands within the Dynamic Brand Portfolio @ IBN that delivers: (1) access to a vast network of wire solutions via InvestorWire to efficiently and effectively reach a myriad of target markets, demographics and diverse industries; (2) article and editorial syndication to 5,000+ outlets; (3) enhanced press release enhancement to ensure maximum impact; (4) social media distribution via IBN to millions of social media followers; and (5) a full array of tailored corporate communications solutions. With broad reach and a seasoned team of contributing journalists and writers, IW is uniquely positioned to best serve private and public companies that want to reach a wide audience of investors, influencers, consumers, journalists and the general public. By cutting through the overload of information in today’s market, IW brings its clients unparalleled recognition and brand awareness. IW is where breaking news, insightful content and actionable information converge.

For more information, please visit https://www.InvestorWire.com

Please see full terms of use and disclaimers on the InvestorWire website applicable to all content provided by IW, wherever published or re-published: https://www.InvestorWire.com/Disclaimer

InvestorWire
Los Angeles, CA
www.InvestorWire.com
310.299.1717 Office
[email protected]

InvestorWire is powered by IBN

Advanced Gold Exploration (CSE: AUEX), has appointed Dr. Andrew Ramcharan, PhD, P.Eng., as president of the company; the appointment was effective beginning Feb. 15, 2024. The company noted that current president Jim Atkinson is resigning as president, although he remains as CEO and as a company director. Ramcharan brings a deep background in investor relations and corporate strategies to his new position, having completed more than 300 project evaluations globally on many commodities and proposed 40-plus investment strategies; he has also been involved in the completion of two major takeover transactions worth $800 million and $1.5 billion and has raised more than $1 billion in funding. The company announced that is has granted Ramcharan stock options to purchase an aggregate of 150,000 common shares in the capital of the company in connection to his new appointment. In addition, the announcement also noted that Advanced Gold Exploration has appointed MS Partners LLP is its new auditor; the appointment has been reviewed by the board of directors and filed on SEDAR+. “I am pleased to announce the appointment of Dr. Andrew Ramcharan as president of the company,” said Advanced Gold Exploration CEO Jim Atkinson in the press release.

“Dr. Ramcharan has over 20 years’ unique experience in the mining industry, which includes investor relations, project evaluation, operations, capital markets, consultancy and investment banking. Andrew’s vast experience and sound technical knowledge coupled with a financial side will be valuable. . . . He will assist the company in the identification, analyzing and due diligence in evaluating mining projects or companies for mergers and acquisitions and investments, and will assist in technical areas within the company. We anticipate that his extensive contacts and knowledge in the business will be invaluable to the continued success of our company.”

To view the full press release, visit https://ibn.fm/493eg

About Advanced Gold Exploration Inc.

Advanced Gold Exploration (Formerly Advance United Holdings Inc.) brings an entirely different approach to the mining industry. The company doesn’t mine; rather, it has acquired a portfolio of undervalued gold properties and is increasing its value through the application of modern technology. Advanced Gold Exploration has a growing pipeline of similar properties that it is looking to acquire and is exclusively involved in the acquisition and advancement of past projects, with no intent to bring them back into production or to mine them ourselves. The company’s expertise is in identifying and acquiring undervalued properties with significant historical work, which were uneconomic at the time, but that have economic value at today’s prices. The company funds the reworking historic data and applies modern technology to underwrite new qualified reports, document quantifiable resources and reserves to current standards, thereby recognizing the current value. The company’s purpose is to bring immediate and long-term value to its partners and shareholders while seeking to eliminate exploration risk, so that its projects can all advance in the shortest possible time frame. To learn more about the company, visit www.AdvancedGoldExploration.com.

About InvestorWire

InvestorWire (“IW”) is a specialized communications platform with a focus on advanced wire-grade press release syndication for private and public companies and the investment community. It is one of 60+ brands within the Dynamic Brand Portfolio @ IBN that delivers: (1) access to a vast network of wire solutions via InvestorWire to efficiently and effectively reach a myriad of target markets, demographics and diverse industries; (2) article and editorial syndication to 5,000+ outlets; (3) enhanced press release enhancement to ensure maximum impact; (4) social media distribution via IBN to millions of social media followers; and (5) a full array of tailored corporate communications solutions. With broad reach and a seasoned team of contributing journalists and writers, IW is uniquely positioned to best serve private and public companies that want to reach a wide audience of investors, influencers, consumers, journalists and the general public. By cutting through the overload of information in today’s market, IW brings its clients unparalleled recognition and brand awareness. IW is where breaking news, insightful content and actionable information converge.

For more information, please visit https://www.InvestorWire.com

Please see full terms of use and disclaimers on the InvestorWire website applicable to all content provided by IW, wherever published or re-published: https://www.InvestorWire.com/Disclaimer

InvestorWire
Los Angeles, CA
www.InvestorWire.com
310.299.1717 Office
[email protected]

InvestorWire is powered by IBN

DarioHealth (NASDAQ: DRIO), a leader in the global digital health market, will be participating in the 44th annual Cowen Healthcare Conference. The three-day event is slated for March 4–6, 2024, in Boston. During the conference, DarioHealth CEO Erez Raphael and president Rick Anderson will be featured in a fireside chat scheduled to begin at 10:30 a.m. on March 6. A replay of the chat will be available following the event. The company is focused on changing how people with chronic conditions manage their health by providing a user-centric, multichronic condition digital therapeutics platform and suite of solutions that deliver personalized interventions driven by data analytics and one-on-one coaching for diabetes, hypertension, weight management, musculoskeletal pain and behavioral health.

To view the fireside chat, visit https://ibn.fm/1jvKY

To view the full press release, visit https://ibn.fm/8kpkb

About DarioHealth Corp.

DarioHealth Corp. is a leading digital health company revolutionizing how people with chronic conditions manage their health through a user-centric, multichronic condition digital therapeutics platform. Dario’s platform and suite of solutions deliver personalized and dynamic interventions driven by data analytics and one-on-one coaching for diabetes, hypertension, weight management, musculoskeletal pain and behavioral health. The company’s user-centric platform offers people continuous and customized care for health, disrupting the traditional episodic approach to healthcare. This approach empowers people to holistically adapt their lifestyles for sustainable behavior change, driving exceptional user satisfaction, retention and results, and making the right thing to do the easy thing to do. Dario provides its highly user-rated solutions globally to health plans and other payors, self-insured employers and providers of care as well as directly to consumers. For more information about the company, please visit www.DarioHealth.com.

NOTE TO INVESTORS: The latest news and updates relating to DRIO are available in the company’s newsroom at http://ibn.fm/DRIO

About InvestorWire

InvestorWire (“IW”) is a specialized communications platform with a focus on advanced wire-grade press release syndication for private and public companies and the investment community. It is one of 60+ brands within the Dynamic Brand Portfolio @ IBN that delivers: (1) access to a vast network of wire solutions via InvestorWire to efficiently and effectively reach a myriad of target markets, demographics and diverse industries; (2) article and editorial syndication to 5,000+ outlets; (3) enhanced press release enhancement to ensure maximum impact; (4) social media distribution via IBN to millions of social media followers; and (5) a full array of tailored corporate communications solutions. With broad reach and a seasoned team of contributing journalists and writers, IW is uniquely positioned to best serve private and public companies that want to reach a wide audience of investors, influencers, consumers, journalists and the general public. By cutting through the overload of information in today’s market, IW brings its clients unparalleled recognition and brand awareness. IW is where breaking news, insightful content and actionable information converge.

For more information, please visit https://www.InvestorWire.com

Please see full terms of use and disclaimers on the InvestorWire website applicable to all content provided by IW, wherever published or re-published: https://www.InvestorWire.com/Disclaimer

InvestorWire
Los Angeles, CA
www.InvestorWire.com
310.299.1717 Office
[email protected]

InvestorWire is powered by IBN

Vistagen (NASDAQ: VTGN), a biopharmaceutical company pioneering neuroscience to deliver groundbreaking therapies for individuals affected by psychiatric and neurological disorders, today announced that company management will present and host one-on-one meetings at the TD Cowen 44th Annual Health Care Conference. The event is taking place from March 4 to 6, 2024, in Boston, Massachusetts. Vistagen CEO Shawn Singh will present a corporate overview on Wednesday, March 6, at 10:30 a.m. Eastern Time. A webcast will be accessible via the company’s website, through the “Events” page in the “Investors” section. Investors interested in scheduling a one-on-one meeting during the conference should contact their Cowen representative.

To view the full press release, visit https://ibn.fm/XuiNe

About Vistagen Therapeutics Inc.

Vistagen is a biopharmaceutical company pioneering neuroscience to deliver groundbreaking therapies for individuals affected by psychiatric and neurological disorders. Five of Vistagen’s clinical-stage neuroscience pipeline candidates belong to a new class of drugs known as pherines, which are investigational neuroactive nasal sprays with innovative proposed mechanisms of action that activate chemosensory neurons in the nasal passages to impact fundamental neural circuitry in the brain without the need for systemic absorption or binding to receptors in the brain. Vistagen’s sixth investigational candidate is an oral prodrug with potential to inhibit, but not block, NMDA receptor activity. Vistagen is passionate about delivering differentiated treatments that set new standards of care for people living with anxiety, depression and other neurological disorders. For more information, visit the company’s website at www.Vistagen.com.

NOTE TO INVESTORS: The latest news and updates relating to VTGN are available in the company’s newsroom at https://nnw.fm/VTGN

About InvestorWire

InvestorWire (“IW”) is a specialized communications platform with a focus on advanced wire-grade press release syndication for private and public companies and the investment community. It is one of 60+ brands within the Dynamic Brand Portfolio @ IBN that delivers: (1) access to a vast network of wire solutions via InvestorWire to efficiently and effectively reach a myriad of target markets, demographics and diverse industries; (2) article and editorial syndication to 5,000+ outlets; (3) enhanced press release enhancement to ensure maximum impact; (4) social media distribution via IBN to millions of social media followers; and (5) a full array of tailored corporate communications solutions. With broad reach and a seasoned team of contributing journalists and writers, IW is uniquely positioned to best serve private and public companies that want to reach a wide audience of investors, influencers, consumers, journalists and the general public. By cutting through the overload of information in today’s market, IW brings its clients unparalleled recognition and brand awareness. IW is where breaking news, insightful content and actionable information converge.

For more information, please visit https://www.InvestorWire.com

Please see full terms of use and disclaimers on the InvestorWire website applicable to all content provided by IW, wherever published or re-published: https://www.InvestorWire.com/Disclaimer

InvestorWire
Los Angeles, CA
www.InvestorWire.com
310.299.1717 Office
[email protected]

InvestorWire is powered by IBN

Silo Pharma (NASDAQ: SILO) is a developmental stage biopharmaceutical company focused on novel formulations and drug delivery systems for traditional therapeutics and psychedelic treatments. The company today announced positive results from its non-GLP small animal dose-ranging study of SPC-15, an intranasal prophylactic treatment for anxiety and post-traumatic stress disorder (“PTSD”). The purpose of the study was to identify the maximum tolerated intranasal dose of the drug pharmacokinetic and the therapeutically relevant dose range to be studied in clinical trials. Data analysis demonstrated rapid absorption of SPC-15 with good exposure over a 24-hour period, suggesting optimality of a once-per-day human intranasal dosing regimen. “Non-GLP and GLP toxicology and safety pharmacology studies are required steps before seeking approval for our first-in-human clinical-stage trials of SPC-15,” said Eric Weisblum, CEO of Silo. “We are currently on track to submit a pre-investigational New Drug Application (‘IND’) to the FDA by the end of the second quarter 2024. This is an exciting step forward for our company as we advance our lead therapeutic, SPC-15.”

To view the full press release, visit https://ibn.fm/2x7R7

About Silo Pharma Inc.

Silo Pharma is a developmental-stage biopharmaceutical company developing novel therapeutics that address underserved conditions including stress-induced psychiatric disorders, chronic pain conditions and central nervous system (“CNS”) diseases. Silo focuses on developing traditional therapies and psychedelic treatments in novel formulations and drug delivery systems. The company’s lead program, SPC-15, is an intranasal treatment targeting PTSD and stress-induced anxiety disorders. SP-26 is a time-release ketamine-loaded implant for fibromyalgia and chronic pain relief. Silo’s two preclinical programs are SPC-14, an intranasal compound for the treatment of Alzheimer’s disease, and SPU-16, a CNS-homing peptide targeting multiple sclerosis (“MS”). Silo’s research and development programs are conducted through collaborations with Columbia University and the University of Maryland, Baltimore. For more information about the company, visit www.SiloPharma.com.

NOTE TO INVESTORS: The latest news and updates relating to SILO are available in the company’s newsroom at https://ibn.fm/SILO

About InvestorWire

InvestorWire (“IW”) is a specialized communications platform with a focus on advanced wire-grade press release syndication for private and public companies and the investment community. It is one of 60+ brands within the Dynamic Brand Portfolio @ IBN that delivers: (1) access to a vast network of wire solutions via InvestorWire to efficiently and effectively reach a myriad of target markets, demographics and diverse industries; (2) article and editorial syndication to 5,000+ outlets; (3) enhanced press release enhancement to ensure maximum impact; (4) social media distribution via IBN to millions of social media followers; and (5) a full array of tailored corporate communications solutions. With broad reach and a seasoned team of contributing journalists and writers, IW is uniquely positioned to best serve private and public companies that want to reach a wide audience of investors, influencers, consumers, journalists and the general public. By cutting through the overload of information in today’s market, IW brings its clients unparalleled recognition and brand awareness. IW is where breaking news, insightful content and actionable information converge.

For more information, please visit https://www.InvestorWire.com

Please see full terms of use and disclaimers on the InvestorWire website applicable to all content provided by IW, wherever published or re-published: https://www.InvestorWire.com/Disclaimer

InvestorWire
Los Angeles, CA
www.InvestorWire.com
310.299.1717 Office
[email protected]

InvestorWire is powered by IBN

McEwen Mining (NYSE: MUX) (TSX: MUX), a gold and silver producer with operations in Nevada, Canada, Mexico and Argentina, is reporting on three results of its large exploration investment at the Stock Mine property, which is part of the Fox Complex located in the prolific Timmins gold district of Northern Ontario. According to the announcement, the three outcomes include the following: a 31% year-over-year increase of gold resources at Stock West and Stock Main (historic Stock Mine); a confirmation of good grading structures plunging to depth; and Stock East emerging as a potential new near-term source of future revenue. “Exploration drill core samples at the Stock Complex were typically submitted as 1/2 core,” said the company in the press release. “Analyses reported herein were either performed by the fire assay method at the accredited laboratory Pangea Laboratorio in Sinaloa, Mexico, owned and operated by an indirect subsidiary of the company, or by the photon assay method at the accredited laboratory MSA Labs in Timmins, Ontario, Canada.”

To view the full press release, visit https://ibn.fm/QHrWi

About McEwen Mining Inc.

McEwen Mining is a gold and silver producer with operations in Nevada, Canada, Mexico and Argentina. In addition, the company owns approximately 47.7% of McEwen Copper, which is developing the large, advanced-stage Los Azules copper project in Argentina. The company’s goal is to improve the productivity and life of its assets with the objective of increasing its share price and providing a yield. Rob McEwen, chair and chief owner, has a personal investment in the company of $220 million. His annual salary is $1. To learn more about the company, visit www.McEwenMining.com.

NOTE TO INVESTORS: The latest news and updates relating to MUX are available in the company’s newsroom at https://ibn.fm/MUX

About InvestorWire

InvestorWire (“IW”) is a specialized communications platform with a focus on advanced wire-grade press release syndication for private and public companies and the investment community. It is one of 60+ brands within the Dynamic Brand Portfolio @ IBN that delivers: (1) access to a vast network of wire solutions via InvestorWire to efficiently and effectively reach a myriad of target markets, demographics and diverse industries; (2) article and editorial syndication to 5,000+ outlets; (3) enhanced press release enhancement to ensure maximum impact; (4) social media distribution via IBN to millions of social media followers; and (5) a full array of tailored corporate communications solutions. With broad reach and a seasoned team of contributing journalists and writers, IW is uniquely positioned to best serve private and public companies that want to reach a wide audience of investors, influencers, consumers, journalists and the general public. By cutting through the overload of information in today’s market, IW brings its clients unparalleled recognition and brand awareness. IW is where breaking news, insightful content and actionable information converge.

For more information, please visit https://www.InvestorWire.com

Please see full terms of use and disclaimers on the InvestorWire website applicable to all content provided by IW, wherever published or re-published: https://www.InvestorWire.com/Disclaimer

InvestorWire
Los Angeles, CA
www.InvestorWire.com
310.299.1717 Office
[email protected]

InvestorWire is powered by IBN

The Alternative Products Expo is coming to Miami March 14-16, 2024. A leading organizer of CBD & Hemp products, the Alternative Products Expo offers niche manufacturers and service providers a common forum to network and showcase their products.

The Alternative Product category includes a broad spectrum of herbal products, mood enhancers, vape products, energy boosts, cannabis derivatives, and dietary supplements, to name a few. As Florida is a major hub of alternate lifestyles and trendsetting products, Miami emerges as a suitable venue for the…

Read More>>

To know more, please visit https://altproexpo.com/

About InvestorWire

InvestorWire (“IW”) is a specialized communications platform with a focus on advanced wire-grade press release syndication for private and public companies and the investment community. It is one of 60+ brands within the Dynamic Brand Portfolio @ IBN that delivers: (1) access to a vast network of wire solutions via InvestorWire to efficiently and effectively reach a myriad of target markets, demographics and diverse industries; (2) article and editorial syndication to 5,000+ outlets; (3) enhanced press release enhancement to ensure maximum impact; (4) social media distribution via IBN to millions of social media followers; and (5) a full array of tailored corporate communications solutions. With broad reach and a seasoned team of contributing journalists and writers, IW is uniquely positioned to best serve private and public companies that want to reach a wide audience of investors, influencers, consumers, journalists and the general public. By cutting through the overload of information in today’s market, IW brings its clients unparalleled recognition and brand awareness. IW is where breaking news, insightful content and actionable information converge.

For more information, please visit https://www.InvestorWire.com

Please see full terms of use and disclaimers on the InvestorWire website applicable to all content provided by IW, wherever published or re-published: https://www.InvestorWire.com/Disclaimer

InvestorWire
Los Angeles, CA
www.InvestorWire.com
310.299.1717 Office
[email protected]

InvestorWire is powered by IBN

• Early-stage lending fell 44% year-over-year in the first six months of 2023 following Silicon Valley Bank collapse
• Demand for venture debt remains strong for companies that aim to preserve control, stay autonomous, and maintain flexibility over capital structure
• Hosted by DealFlow Events, The Venture Debt Conference on March 6, 2024, in New York City features 30+ experts, interactive panel discussions, and opportunities to meet with the largest group of dealmakers in the lending business
• Emerging venture debt lenders bring expertise to startups and new companies navigating complex financial arrangements
• Attendance is free for qualified C-level executives representing a venture-backed or emerging growth company

The collapse of Silicon Valley Bank (SVB last year had a  significant impact on the venture debt market, resulting in a 44% year-over-year drop in early-stage lending during the first six months of 2023. Despite SVB’s failure, demand for venture debt remained strong. What was initially a major debt hole has since been filled by lending firms offering high-level insights and technological expertise.

Venture debt is favored by many startups and high-growth companies – especially those that want to preserve control and maintain autonomy without giving up equity. Venture debt can also provide startups with predictable repayment schedules and interest rates, enabling them to optimize…

Read More>>

Learn more about the Venture Debt Conference and review the full program agenda.

About InvestorWire

InvestorWire (“IW”) is a specialized communications platform with a focus on advanced wire-grade press release syndication for private and public companies and the investment community. It is one of 60+ brands within the Dynamic Brand Portfolio @ IBN that delivers: (1) access to a vast network of wire solutions via InvestorWire to efficiently and effectively reach a myriad of target markets, demographics and diverse industries; (2) article and editorial syndication to 5,000+ outlets; (3) enhanced press release enhancement to ensure maximum impact; (4) social media distribution via IBN to millions of social media followers; and (5) a full array of tailored corporate communications solutions. With broad reach and a seasoned team of contributing journalists and writers, IW is uniquely positioned to best serve private and public companies that want to reach a wide audience of investors, influencers, consumers, journalists and the general public. By cutting through the overload of information in today’s market, IW brings its clients unparalleled recognition and brand awareness. IW is where breaking news, insightful content and actionable information converge.

For more information, please visit https://www.InvestorWire.com

Please see full terms of use and disclaimers on the InvestorWire website applicable to all content provided by IW, wherever published or re-published: https://www.InvestorWire.com/Disclaimer

InvestorWire
Los Angeles, CA
www.InvestorWire.com
310.299.1717 Office
[email protected]

InvestorWire is powered by IBN

Tonix Pharmaceuticals (NASDAQ: TNXP), a biopharmaceutical company with marketed products and a pipeline of development candidates, has completed the clinical stage of its phase 1 single ascending dose escalation trial, designed to evaluate TNX-1500 (Fc-modified humanized anti-CD40L monoclonal antibody, or mAb) in healthy volunteers. According to the announcement, the company anticipates receiving topline results from the trial in Q3 2024 and is now planning a phase 2 trial focused on evaluating the drug for prevention of kidney transplant rejection.

In addition, Tonix Pharmaceuticals CEO Seth Lederman, MD, was featured in two releases from Proactive, a best-in-class media provider of 24/7 breaking news, commentary and analysis on hundreds of listed and pre-IPO companies around the globe. In the videos Lederman and Proactive host Steve Darling discuss two key news releases from Tonix: positive results from a phase 3 study on Tonmya, also known as TNX-102 SL, for the management of fibromyalgia, and the clearance of the Investigational New Drug application by the U.S. Food and Drug Administration for the company’s phase 2 investigator-initiated OASIS trial.

To view the videos, visit https://ibn.fm/yiFou and https://ibn.fm/66mmh.

To view the full press releases, visit https://ibn.fm/tjE3X, https://ibn.fm/XFUBN and https://ibn.fm/HktND.

About Tonix Pharmaceuticals Holding Corp.

Tonix is a biopharmaceutical company focused on developing, licensing and commercializing therapeutics to treat and prevent human disease and alleviate suffering. Tonix’s development portfolio is focused on central nervous system (“CNS”) disorders. Tonix’s priority is to submit a New Drug Application (“NDA”) to the U.S. Food and Drug Administration in the second half of 2024 for Tonmya, a product candidate for which two positive phase 3 studies have been completed for the management of fibromyalgia. TNX-102 SL is also being developed to treat acute stress reaction as well as fibromyalgia-type Long COVID. Tonix’s CNS portfolio includes TNX-1300 (cocaine esterase), a biologic designed to treat cocaine intoxication with Breakthrough Therapy designation. Tonix’s immunology development portfolio consists of biologics to address organ-transplant rejection, autoimmunity and cancer, including TNX-1500, which is a humanized monoclonal antibody targeting CD40-ligand (“CD40L” or “CD154”) being developed for the prevention of allograft rejection and for the treatment of autoimmune diseases. Tonix also has product candidates in development in the areas of rare disease and infectious disease. Tonix Medicines, the company’s commercial subsidiary, markets Zembrace(R) SymTouch(R) (sumatriptan injection) 3 mg and Tosymra(R) (sumatriptan nasal spray) 10 mg for the treatment of acute migraine with or without aura in adults. For more information about the company, please visit www.TonixPharma.com.

About InvestorWire

InvestorWire (“IW”) is a specialized communications platform with a focus on advanced wire-grade press release syndication for private and public companies and the investment community. It is one of 60+ brands within the Dynamic Brand Portfolio @ IBN that delivers: (1) access to a vast network of wire solutions via InvestorWire to efficiently and effectively reach a myriad of target markets, demographics and diverse industries; (2) article and editorial syndication to 5,000+ outlets; (3) enhanced press release enhancement to ensure maximum impact; (4) social media distribution via IBN to millions of social media followers; and (5) a full array of tailored corporate communications solutions. With broad reach and a seasoned team of contributing journalists and writers, IW is uniquely positioned to best serve private and public companies that want to reach a wide audience of investors, influencers, consumers, journalists and the general public. By cutting through the overload of information in today’s market, IW brings its clients unparalleled recognition and brand awareness. IW is where breaking news, insightful content and actionable information converge.

For more information, please visit https://www.InvestorWire.com

Please see full terms of use and disclaimers on the InvestorWire website applicable to all content provided by IW, wherever published or re-published: https://www.InvestorWire.com/Disclaimer

InvestorWire
Los Angeles, CA
www.InvestorWire.com
310.299.1717 Office
[email protected]

InvestorWire is powered by IBN

DealFlow Events, host of hundreds of conferences over the past two decades, has selected IBN as the official media partner for the upcoming Activist Investor Conference 2024. DealFlow Events is organizing and hosting the event, which is slated for March 21, 2024, in New York City. Focused on the industry’s most innovative and transformative ideas, the conference has been around for more than a decade and is designed to provide invaluable opportunities for professional education and networking as well as forging new business relationships. Information presented during the event is designed to support investors as they work on deepening their knowledge of governance issues and improving the fortunes of the companies in which they have invested. Conference attendees come from a wide array of sectors, including activist investors, rating platforms, hedge funds and public equity investors, corporate governance specialists, advisory firms, proxy solicitors and corporate board members. IBN is a multifaceted communications organization committed to connecting companies with the investment community through its dynamic portfolio of 60-plus brands.

As media sponsor, IBN will leverage its complete corporate communications platform to increase awareness of the conference and expand the visibility of invited speakers and presenters as well as event sponsors. “At DealFlow, we are excited to renew our collaboration with IBN for the Activist Investor Conference 2024 event,” said DealFlow Events managing director Charlie Napolitano in the press release. “IBN has consistently provided state-of-the-art communications services, optimized our outreach to relevant audiences, and offered highly-effective media coverage. We appreciate IBN’s ongoing support and look forward to a lasting partnership.”

To learn more about the conference, visit https://ibn.fm/SHrBn

To view the full press release, visit https://ibn.fm/pLYGn

About DealFlow Events

DealFlow Events is widely recognized as a symbol of quality. For more than two decades, DealFlow has created events that feature exclusive networking, education and business-development opportunities. In addition, DealFlow Events has produced more than 200 conferences, seminars and webcasts covering a variety of financial topics. These events are the signature programs in their respective markets, offering high-quality content and professional networking opportunities. To learn more about the company, please visit www.DealFlowEvents.com.

About InvestorWire

InvestorWire (“IW”) is a specialized communications platform with a focus on advanced wire-grade press release syndication for private and public companies and the investment community. It is one of 60+ brands within the Dynamic Brand Portfolio @ IBN that delivers: (1) access to a vast network of wire solutions via InvestorWire to efficiently and effectively reach a myriad of target markets, demographics and diverse industries; (2) article and editorial syndication to 5,000+ outlets; (3) enhanced press release enhancement to ensure maximum impact; (4) social media distribution via IBN to millions of social media followers; and (5) a full array of tailored corporate communications solutions. With broad reach and a seasoned team of contributing journalists and writers, IW is uniquely positioned to best serve private and public companies that want to reach a wide audience of investors, influencers, consumers, journalists and the general public. By cutting through the overload of information in today’s market, IW brings its clients unparalleled recognition and brand awareness. IW is where breaking news, insightful content and actionable information converge.

For more information, please visit https://www.InvestorWire.com

Please see full terms of use and disclaimers on the InvestorWire website applicable to all content provided by IW, wherever published or re-published: https://www.InvestorWire.com/Disclaimer

InvestorWire
Los Angeles, CA
www.InvestorWire.com
310.299.1717 Office
[email protected]

InvestorWire is powered by IBN

RB Capital Partners, a judgment creditor against Optec International Inc. (OTC: OPTI), today announced its engagement of Mark Basile and The Basile Law Firm P.C. to work with the courts to officially appoint a receiver to run Optec in the interim while a new company is merged into the public vehicle. RB Capital, the largest investor and legitimate shareholder of Optec International, was forced to bring a shareholder derivative action against Optec to secure the company’s judgment, oust Roger Pawson and to try to preserve Optec’s assets. According to the announcement, the next step in the process is to officially appoint a receiver in order for the new management to obtain control of Optec/OPTI, the public vehicle, and ultimately access to OTC Markets via OTCIQ. “We are working very diligently with all parties involved to get this matter resolved as fast as possible so Optec can begin the next chapter of the company’s story,” said Brett Rosen, managing partner of RB Capital Partners. “In order to promote transparency, RB Capital commits to making consistent updates about Optec via press releases and social media posts. We could have easily just walked away with our judgement, but Deborah and I stayed and took on the responsibility of Optec so we can make this right for all those who were wronged by the former CEO’s actions.”

To view the full press release, visit https://ibn.fm/MrRSE

About RB Capital Partners Inc.

RB Capital Partners is a private investment fund headquartered and incorporated in California. The main investment focus of RB Capital is on small and microcap publicly traded companies trading on the OTC Markets, Nasdaq and New York Stock Exchange. RB Capital predominantly makes debt investments and is known for paying off any harmful convertible debt, giving companies a real chance at success. RB Capital Partners does NOT manage any outside money, nor does it have any investors. It is run and funded solely by Brett Rosen and Deborah Rosen who each have a 50% ownership stake in the company.

About InvestorWire

InvestorWire (“IW”) is a specialized communications platform with a focus on advanced wire-grade press release syndication for private and public companies and the investment community. It is one of 60+ brands within the Dynamic Brand Portfolio @ IBN that delivers: (1) access to a vast network of wire solutions via InvestorWire to efficiently and effectively reach a myriad of target markets, demographics and diverse industries; (2) article and editorial syndication to 5,000+ outlets; (3) enhanced press release enhancement to ensure maximum impact; (4) social media distribution via IBN to millions of social media followers; and (5) a full array of tailored corporate communications solutions. With broad reach and a seasoned team of contributing journalists and writers, IW is uniquely positioned to best serve private and public companies that want to reach a wide audience of investors, influencers, consumers, journalists and the general public. By cutting through the overload of information in today’s market, IW brings its clients unparalleled recognition and brand awareness. IW is where breaking news, insightful content and actionable information converge.

For more information, please visit https://www.InvestorWire.com

Please see full terms of use and disclaimers on the InvestorWire website applicable to all content provided by IW, wherever published or re-published: https://www.InvestorWire.com/Disclaimer

InvestorWire
Los Angeles, CA
www.InvestorWire.com
310.299.1717 Office
[email protected]

InvestorWire is powered by IBN

CISO Global Inc. (NASDAQ: CISO), an industry leader as a managed cybersecurity and compliance provider (“MSSP”), has appointed a seasoned tech executive to its board of directors. The company announced that Brett Chugg has joined the board and provide strategic support and guidance as the company focuses on the next stage of growth underpinned by its software-first product platform strategy. Chugg brings a depth of experience to his board role, including his most recent service as senior managing director at Koch Disruptive Technologies, a venture and growth equity investment group at Koch Industries. Prior to joining Koch, Chugg served in a variety of positions, including as director on several high-growth company boards, such as Insightec, Vayyar, Valo Health, Shine Technologies and Cohere Communications. Chugg has a proven track record as an investor and leader in technology with global, multi-industry experience including hardware, software, manufacturing, healthcare and petrochemical markets.

“CISO Global is undergoing transformative growth,” said CISO Global CEO David Jemmett in the press release. “This is a pivotal time for Brett to join our company and further enable its continued evolution with his deep experience, strategic capabilities and highly sought after business acumen. He shares our vision of the critical role our talent and software-first solutions are playing in outpacing competitors with our leading managed security and compliance services.”

To view the full press release, visit https://ibn.fm/3DYqx

About CISO Global Inc.

CISO Global is based in Scottsdale, Arizona, and is a top 25 managed cybersecurity and compliance services provider that is delivering innovative solutions through its newly developed artificial intelligence (“AI”) and machine-learning (“ML”)-powered product portfolio. The company protects the most demanding businesses and government organizations against continuing and emerging security threats and ensures their compliance obligations are being met. For more information about the company, visit www.CISO.inc.

NOTE TO INVESTORS: The latest news and updates relating to CISO are available in the company’s newsroom at https://ibn.fm/CISO

About InvestorWire

InvestorWire (“IW”) is a specialized communications platform with a focus on advanced wire-grade press release syndication for private and public companies and the investment community. It is one of 60+ brands within the Dynamic Brand Portfolio @ IBN that delivers: (1) access to a vast network of wire solutions via InvestorWire to efficiently and effectively reach a myriad of target markets, demographics and diverse industries; (2) article and editorial syndication to 5,000+ outlets; (3) enhanced press release enhancement to ensure maximum impact; (4) social media distribution via IBN to millions of social media followers; and (5) a full array of tailored corporate communications solutions. With broad reach and a seasoned team of contributing journalists and writers, IW is uniquely positioned to best serve private and public companies that want to reach a wide audience of investors, influencers, consumers, journalists and the general public. By cutting through the overload of information in today’s market, IW brings its clients unparalleled recognition and brand awareness. IW is where breaking news, insightful content and actionable information converge.

For more information, please visit https://www.InvestorWire.com

Please see full terms of use and disclaimers on the InvestorWire website applicable to all content provided by IW, wherever published or re-published: https://www.InvestorWire.com/Disclaimer

InvestorWire
Los Angeles, CA
www.InvestorWire.com
310.299.1717 Office
[email protected]

InvestorWire is powered by IBN

Safety Shot (NASDAQ: SHOT) today announced its appointment of Danielle De Rosa as its new chief financial officer effective March 1, 2024. A multifaceted, analytical and results-driven professional, Rosa brings more than 25 years of experience in all aspects of financial services and operational functions including serving as a public company CFO. “With the national launch of our highly anticipated functional beverage, Safety Shot, our revenue and operations structure are changing rapidly. We’re bringing Danielle on board to benefit from her strategic and diligent approach to managing growth, cash flow, inventory, and operations,” said Safety Shot CEO Brian John. “She’s successfully managed growing teams and assets at public and private companies. We’re pleased to welcome her aboard.”

To view the full press release, visit https://ibn.fm/1cN0q

About Safety Shot Inc.

Safety Shot, a wellness and functional beverage company, is set to launch Safety Shot, the first patented wellness beverage on Earth that helps people feel better faster by reducing blood alcohol content, boosting clarity and overall mood. Safety Shot is available for retail purchase at www.DrinkSafetyShot.com and www.Amazon.com. The company plans to launch business-to-business sales of Safety Shot to distributors, retailers, restaurants, and bars in the first quarter of 2024. Safety Shot recently announced plans to spin off legacy assets from its Jupiter Wellness business to unlock value for shareholders.

About InvestorWire

InvestorWire (“IW”) is a specialized communications platform with a focus on advanced wire-grade press release syndication for private and public companies and the investment community. It is one of 60+ brands within the Dynamic Brand Portfolio @ IBN that delivers: (1) access to a vast network of wire solutions via InvestorWire to efficiently and effectively reach a myriad of target markets, demographics and diverse industries; (2) article and editorial syndication to 5,000+ outlets; (3) enhanced press release enhancement to ensure maximum impact; (4) social media distribution via IBN to millions of social media followers; and (5) a full array of tailored corporate communications solutions. With broad reach and a seasoned team of contributing journalists and writers, IW is uniquely positioned to best serve private and public companies that want to reach a wide audience of investors, influencers, consumers, journalists and the general public. By cutting through the overload of information in today’s market, IW brings its clients unparalleled recognition and brand awareness. IW is where breaking news, insightful content and actionable information converge.

For more information, please visit https://www.InvestorWire.com

Please see full terms of use and disclaimers on the InvestorWire website applicable to all content provided by IW, wherever published or re-published: https://www.InvestorWire.com/Disclaimer

InvestorWire
Los Angeles, CA
www.InvestorWire.com
310.299.1717 Office
[email protected]

InvestorWire is powered by IBN

Hillcrest (CSE: HEAT) (OTCQB: HLRTF) (FSE: 7HI), an innovative clean technology company redefining power conversion technologies, today announced the addition of Dan Mathieson as a strategic advisor to the company. Mathieson will work with Hillcrest’s executive team to deliver new business expansion opportunities both domestically and internationally. “Dan is a genuine innovator driven by a commitment to propel Canada forward,” said Hillcrest’s Chief Executive Officer Don Currie. “Over the past two decades, he’s successfully demonstrated his ability to drive progress and push boundaries to propel his community forward. During that time, he also cultivated a valuable network of like-minded leaders globally and will play a pivotal role in ensuring Hillcrest’s successful advancement. On behalf of the board and the entire Hillcrest team, we extend a warm welcome to Dan and eagerly anticipate our collaboration.”

To view the full press release, visit https://ibn.fm/cUqDQ

About Hillcrest Energy Technologies Ltd.

Hillcrest is a clean technology company focused on providing advanced power conversion technologies and digital control systems for next-generation powertrains and grid-connected renewable energy systems. From concept to commercialization, Hillcrest is investing in the development of energy solutions that will power a more sustainable and electrified future. Hillcrest is publicly traded on the CSE under the symbol HEAT, on the OTCQB Venture Market as HLRTF and on the Frankfurt Exchange as 7HI. For more information, please visit www.HillcrestEnergy.tech.

NOTE TO INVESTORS: The latest news and updates relating to HLRTF are available in the company’s newsroom at https://ibn.fm/HLRTF

About InvestorWire

InvestorWire (“IW”) is a specialized communications platform with a focus on advanced wire-grade press release syndication for private and public companies and the investment community. It is one of 60+ brands within the Dynamic Brand Portfolio @ IBN that delivers: (1) access to a vast network of wire solutions via InvestorWire to efficiently and effectively reach a myriad of target markets, demographics and diverse industries; (2) article and editorial syndication to 5,000+ outlets; (3) enhanced press release enhancement to ensure maximum impact; (4) social media distribution via IBN to millions of social media followers; and (5) a full array of tailored corporate communications solutions. With broad reach and a seasoned team of contributing journalists and writers, IW is uniquely positioned to best serve private and public companies that want to reach a wide audience of investors, influencers, consumers, journalists and the general public. By cutting through the overload of information in today’s market, IW brings its clients unparalleled recognition and brand awareness. IW is where breaking news, insightful content and actionable information converge.

For more information, please visit https://www.InvestorWire.com

Please see full terms of use and disclaimers on the InvestorWire website applicable to all content provided by IW, wherever published or re-published: https://www.InvestorWire.com/Disclaimer

InvestorWire
Los Angeles, CA
www.InvestorWire.com
310.299.1717 Office
[email protected]

InvestorWire is powered by IBN

Cybin (NYSE American: CYBN) (Cboe CA: CYBN), a clinical-stage biopharmaceutical company committed to revolutionizing mental healthcare by developing new and innovative psychedelic-based treatment options, will be spotlighted at next month’s 44th annual TD Cowen Health Care Conference. The three-day event is scheduled for March 4–6, 2024, in Boston. During the conference, Cybin CEO Doug Drysdale will be presenting. His presentation is slated to begin at 12:50 p.m. ET on March 4. Drysdale’s presentation will be available live on a webcast; a replay of his presentation will also be available following the live event on the company’s investor relations website. 

To view the presentation, visit https://ibn.fm/FCAus

To view the full press release, visit https://ibn.fm/pKif0

About Cybin Inc.

Cybin is a clinical-stage biopharmaceutical company on a mission to create safe and effective psychedelic-based therapeutics to address the large unmet need for new and innovative treatment options for people who suffer from mental-health conditions. Cybin’s goal of revolutionizing mental healthcare is supported by a network of world-class partners and internationally recognized scientists aimed at progressing proprietary drug-discovery platforms, innovative drug-delivery systems, and novel formulation approaches and treatment regimens. The company is currently developing CYB003, a proprietary deuterated psilocybin analog for the treatment of major depressive disorder, and CYB004, a proprietary deuterated DMT molecule for generalized anxiety disorder; the company also has a research pipeline of investigational psychedelic-based compounds. Headquartered in Canada and founded in 2019, Cybin is operational in Canada, the United States, the United Kingdom, the Netherlands and Ireland. For more information, visit the company’s website at www.Cybin.com.

NOTE TO INVESTORS: The latest news and updates relating to CYBN are available in the company’s newsroom at https://ibn.fm/CYBN

About InvestorWire

InvestorWire (“IW”) is a specialized communications platform with a focus on advanced wire-grade press release syndication for private and public companies and the investment community. It is one of 60+ brands within the Dynamic Brand Portfolio @ IBN that delivers: (1) access to a vast network of wire solutions via InvestorWire to efficiently and effectively reach a myriad of target markets, demographics and diverse industries; (2) article and editorial syndication to 5,000+ outlets; (3) enhanced press release enhancement to ensure maximum impact; (4) social media distribution via IBN to millions of social media followers; and (5) a full array of tailored corporate communications solutions. With broad reach and a seasoned team of contributing journalists and writers, IW is uniquely positioned to best serve private and public companies that want to reach a wide audience of investors, influencers, consumers, journalists and the general public. By cutting through the overload of information in today’s market, IW brings its clients unparalleled recognition and brand awareness. IW is where breaking news, insightful content and actionable information converge.

For more information, please visit https://www.InvestorWire.com

Please see full terms of use and disclaimers on the InvestorWire website applicable to all content provided by IW, wherever published or re-published: https://www.InvestorWire.com/Disclaimer

InvestorWire
Los Angeles, CA
www.InvestorWire.com
310.299.1717 Office
[email protected]

InvestorWire is powered by IBN

Tonix Pharmaceuticals (NASDAQ: TNXP), a biopharmaceutical company with marketed products and a pipeline of development candidates, is reporting positive results from its clinical pharmacokinetic (“PK”) bridging study of Tonmya(TM). The study evaluated the efficacy of Tonmya, also known as TNX-102 SL (cyclobenzaprine HCl sublingual tablets), in healthy adult male and female ethnic Japanese and Chinese volunteers. The report noted that Tonmya was generally well tolerated in the ethnic Japanese and Chinese healthy volunteers. Tonix holds issued patents for market exclusivity rights of Tonmya in Japan, China, Hong Kong and Taiwan.”

“This bridging study is an important first step as we begin evaluating the potential for approval and marketing Tonmya in Japan and China,” said Tonix Pharmaceuticals CEO Seth Lederman, MD, in the press release. “The results show a similar pharmacokinetic profile in ethnic Japanese and Chinese volunteers with a Caucasian comparator group. As a result, we believe that these data, with supporting results recently reported from the positive phase 3 RESILIENT study, are the only clinical data needed to support regulatory filings in Japan and China.”

To view the full press release, visit https://ibn.fm/FmAfl

About Tonix Pharmaceuticals Holding Corp.

Tonix is a biopharmaceutical company focused on developing, licensing and commercializing therapeutics to treat and prevent human disease and alleviate suffering. Tonix’s development portfolio is focused on central nervous system (“CNS”) disorders. Tonix’s priority is to submit a New Drug Application (“NDA”) to the U.S. Food and Drug Administration in the second half of 2024 for Tonmya, a product candidate for which two positive phase 3 studies have been completed for the management of fibromyalgia. TNX-102 SL is also being developed to treat acute stress reaction as well as fibromyalgia-type Long COVID. Tonix’s CNS portfolio includes TNX-1300 (cocaine esterase) a biologic designed to treat cocaine intoxication with Breakthrough Therapy designation. Tonix’s immunology development portfolio consists of biologics to address organ-transplant rejection, autoimmunity and cancer, including TNX-1500, which is a humanized monoclonal antibody targeting CD40-ligand (“CD40L” or “CD154”) being developed for the prevention of allograft rejection and for the treatment of autoimmune diseases. Tonix also has product candidates in development in the areas of rare disease and infectious disease. Tonix Medicines, the company’s commercial subsidiary, markets Zembrace(R) SymTouch(R) (sumatriptan injection) 3 mg and Tosymra(R) (sumatriptan nasal spray) 10 mg for the treatment of acute migraine with or without aura in adults. For more information about the company, please visit www.TonixPharma.com.

About InvestorWire

InvestorWire (“IW”) is a specialized communications platform with a focus on advanced wire-grade press release syndication for private and public companies and the investment community. It is one of 60+ brands within the Dynamic Brand Portfolio @ IBN that delivers: (1) access to a vast network of wire solutions via InvestorWire to efficiently and effectively reach a myriad of target markets, demographics and diverse industries; (2) article and editorial syndication to 5,000+ outlets; (3) enhanced press release enhancement to ensure maximum impact; (4) social media distribution via IBN to millions of social media followers; and (5) a full array of tailored corporate communications solutions. With broad reach and a seasoned team of contributing journalists and writers, IW is uniquely positioned to best serve private and public companies that want to reach a wide audience of investors, influencers, consumers, journalists and the general public. By cutting through the overload of information in today’s market, IW brings its clients unparalleled recognition and brand awareness. IW is where breaking news, insightful content and actionable information converge.

For more information, please visit https://www.InvestorWire.com

Please see full terms of use and disclaimers on the InvestorWire website applicable to all content provided by IW, wherever published or re-published: https://www.InvestorWire.com/Disclaimer

InvestorWire
Los Angeles, CA
www.InvestorWire.com
310.299.1717 Office
[email protected]

InvestorWire is powered by IBN

Vocodia Holdings Corp. (CBOE: VHAI, VHAI+A, VHAI+B), a software company that builds practical AI functions, recently announced the pricing of its underwritten initial public offering of 1,400,000 units, each consisting of one share of common stock of the company, par value $0.0001 (“Common Stock”), one Series A Warrant to purchase one share of Common Stock at $4.25 (the “Series A Warrant”), and one Series B Warrant to purchase one share of Common Stock at $8.50 (the “Series B Warrant”), at a price to the public of $4.25 per unit. Gross proceeds from the offering were expected to be approximately $5,950,000. In addition, Vocodia granted the underwriters a 45-day option to purchase up to 210,000 additional units at the public offering price, less the underwriting discount. The company intends to use the net proceeds for the acquisition of websites, technologies or other assets, building an improved switch, and for expanding its product offering from other digital channels, sales and marketing, working capital and other general corporate purposes. Alexander Capital, L.P. acted as sole book-running manager for the offering. Sichenzia Ross Ference Carmel LLP served as counsel to the company, and Sullivan & Worcester LLP served as counsel to the underwriters.

To view the full press release, visit https://ibn.fm/5XSBT

About Vocodia Holdings Corp.

Vocodia is an AI software company that builds practical AI functions and makes them easily obtainable for businesses on cloud-based platform solutions at low costs and scalable to multiagent vast enterprise solutions. Vocodia is a conversational AI software developer and provider that offers scalable enterprise-level AI sales and customer service solutions that allow for AI sales representatives to reduce human labor costs and responsibilities while increasing the reach and efficacy of human-led, purposeful, agenda driven and conversational communications. Vocodia deliver its patent pending conversational AI software in the form of Digital Intelligent Sales Agents (the “DISAs”), which are built with AI software programmed to sound and feel human and to perform business tasks that require humans to converse with one another effectively, and thus to provide the best representation for each of its customers’ businesses. For more information, please visit: www.Vocodia.com.

About InvestorWire

InvestorWire (“IW”) is a specialized communications platform with a focus on advanced wire-grade press release syndication for private and public companies and the investment community. It is one of 60+ brands within the Dynamic Brand Portfolio @ IBN that delivers: (1) access to a vast network of wire solutions via InvestorWire to efficiently and effectively reach a myriad of target markets, demographics and diverse industries; (2) article and editorial syndication to 5,000+ outlets; (3) enhanced press release enhancement to ensure maximum impact; (4) social media distribution via IBN to millions of social media followers; and (5) a full array of tailored corporate communications solutions. With broad reach and a seasoned team of contributing journalists and writers, IW is uniquely positioned to best serve private and public companies that want to reach a wide audience of investors, influencers, consumers, journalists and the general public. By cutting through the overload of information in today’s market, IW brings its clients unparalleled recognition and brand awareness. IW is where breaking news, insightful content and actionable information converge.

For more information, please visit https://www.InvestorWire.com

Please see full terms of use and disclaimers on the InvestorWire website applicable to all content provided by IW, wherever published or re-published: https://www.InvestorWire.com/Disclaimer

InvestorWire
Los Angeles, CA
www.InvestorWire.com
310.299.1717 Office
[email protected]

InvestorWire is powered by IBN

McEwen Mining (NYSE: MUX) (TSX: MUX), a gold and silver producer with operations in Nevada, Canada, Mexico and Argentina, and McEwen Copper Inc. have released assay results from the final unreleased drill holes of the 2022–2023 season. According to the report, the results validate previous drilling results and confirm the continuity of mineralization as well as extend the mineralization. Highlights from the report indicate the following: hole AZ23 205 MET returned 257 m of 0.76% Cu within the Enriched zone; hole AZ23 228 MET returned 446 m of 0.63% Cu in the Enriched zone, including 76 m of 0.92% Cu; and hole AZ23 230 MET returned 250 m of 0.68% Cu in the Enriched zone, including 192 m of 0.83% Cu. The company noted that the goal of the drilling campaign was to collect information needed as the project advances toward the completion of a feasibility study. Work will continue during the 2023–2024 field season toward this objective; that work will include resource, geotechnical, metallurgical, hydrogeological, exploration and condemnation drilling.

The report noted that the Los Azules project is fully funded with investments from both Nuton, a Rio Tinto venture, and Stellantis; McEwen Copper is seeking funding to support feasibility-level engineering and preconstruction work. “McEwen Copper’s Los Azules project is progressing at light speed towards completing a feasibility study by Q1 2025, and it has already delivered significant economic benefits to the neighboring communities,” said McEwen Copper vice president and general manager Michael Meding in the press release. “It is a very large copper resource, where recent exploration drilling suggests it definitely has room to grow.”

To view the full press release, visit https://ibn.fm/XF1YO

About McEwen Mining Inc.

McEwen Mining is a gold and silver producer with operations in Nevada, Canada, Mexico and Argentina. In addition, the company holds a 47.7% of McEwen Copper, which is developing the large, advanced-stage Los Azules copper project in Argentina. The company’s goal is to improve the productivity and life of its assets with the objective of increasing its share price and providing a yield. Rob McEwen, chair and chief owner, has a personal investment in the company of $220 million. His annual salary is $1. To learn more about the company, visit www.McEwenMining.com.

NOTE TO INVESTORS: The latest news and updates relating to MUX are available in the company’s newsroom at https://ibn.fm/MUX

About InvestorWire

InvestorWire (“IW”) is a specialized communications platform with a focus on advanced wire-grade press release syndication for private and public companies and the investment community. It is one of 60+ brands within the Dynamic Brand Portfolio @ IBN that delivers: (1) access to a vast network of wire solutions via InvestorWire to efficiently and effectively reach a myriad of target markets, demographics and diverse industries; (2) article and editorial syndication to 5,000+ outlets; (3) enhanced press release enhancement to ensure maximum impact; (4) social media distribution via IBN to millions of social media followers; and (5) a full array of tailored corporate communications solutions. With broad reach and a seasoned team of contributing journalists and writers, IW is uniquely positioned to best serve private and public companies that want to reach a wide audience of investors, influencers, consumers, journalists and the general public. By cutting through the overload of information in today’s market, IW brings its clients unparalleled recognition and brand awareness. IW is where breaking news, insightful content and actionable information converge.

For more information, please visit https://www.InvestorWire.com

Please see full terms of use and disclaimers on the InvestorWire website applicable to all content provided by IW, wherever published or re-published: https://www.InvestorWire.com/Disclaimer

InvestorWire
Los Angeles, CA
www.InvestorWire.com
310.299.1717 Office
[email protected]

InvestorWire is powered by IBN

Infobird (NASDAQ: IFBD), a software-as-a-service(“SaaS”) provider of innovative, AI-powered or artificial intelligence-enabled customer engagement solutions, today announced that it is amending the effective date for its reverse stock split. Due to an unanticipated delay in obtaining necessary regulatory clearances, the effective date was revised to Monday, March 4, 2024, where trading will begin at market open on a split-adjusted basis.

To view the full press release, visit https://ibn.fm/Mq6mL

About Infobird Co. Ltd.

Infobird is a software-as-a-service (“SaaS”) provider of innovative, AI-powered or artificial intelligence-enabled customer engagement solutions. For more information, visit Infobird’s website at www.Infobird.com.

NOTE TO INVESTORS: The latest news and updates relating to IFBD are available in the company’s newsroom at https://ibn.fm/IFBD

About InvestorWire

InvestorWire (“IW”) is a specialized communications platform with a focus on advanced wire-grade press release syndication for private and public companies and the investment community. It is one of 60+ brands within the Dynamic Brand Portfolio @ IBN that delivers: (1) access to a vast network of wire solutions via InvestorWire to efficiently and effectively reach a myriad of target markets, demographics and diverse industries; (2) article and editorial syndication to 5,000+ outlets; (3) enhanced press release enhancement to ensure maximum impact; (4) social media distribution via IBN to millions of social media followers; and (5) a full array of tailored corporate communications solutions. With broad reach and a seasoned team of contributing journalists and writers, IW is uniquely positioned to best serve private and public companies that want to reach a wide audience of investors, influencers, consumers, journalists and the general public. By cutting through the overload of information in today’s market, IW brings its clients unparalleled recognition and brand awareness. IW is where breaking news, insightful content and actionable information converge.

For more information, please visit https://www.InvestorWire.com

Please see full terms of use and disclaimers on the InvestorWire website applicable to all content provided by IW, wherever published or re-published: https://www.InvestorWire.com/Disclaimer

InvestorWire
Los Angeles, CA
www.InvestorWire.com
310.299.1717 Office
[email protected]

InvestorWire is powered by IBN

Knightscope (NASDAQ: KSCP), a leading innovator in robotics and artificial intelligence (“AI”) technologies focused on public safety, announced that its fifth-generation K5 autonomous security robot (“ASR”) is the newest member of the team at Margaritaville Resort Casino in Bossier City, Louisiana. According to the update, this marks the 5th and most recent deployment as part of a larger master agreement announced in September with the operator of integrated entertainment, sports content and casinos.

The announcement reads, “The Knightscope ASR is driven by proprietary AI software that enhances safety measures at the property while providing visitors with a unique, interactive guest experience with Margaritaville-branded graphics, a client-chosen voice for custom audio broadcast messaging, improved access to emergency services and plenty of opportunities for robot selfies.”

To view the full press release, visit https://ibn.fm/NTiTF

About Knightscope, Inc.

Knightscope builds cutting-edge technologies to improve public safety, and its long-term ambition is to make the United States of America the safest country in the world. For more information or to book a discovery call or demonstration, visit the company’s website at www.knightscope.com.

NOTE TO INVESTORS: The latest news and updates relating to Knightscope are available in the company’s newsroom at https://ibn.fm/KSCP

About InvestorWire

InvestorWire (“IW”) is a specialized communications platform with a focus on advanced wire-grade press release syndication for private and public companies and the investment community. It is one of 60+ brands within the Dynamic Brand Portfolio @ IBN that delivers: (1) access to a vast network of wire solutions via InvestorWire to efficiently and effectively reach a myriad of target markets, demographics and diverse industries; (2) article and editorial syndication to 5,000+ outlets; (3) enhanced press release enhancement to ensure maximum impact; (4) social media distribution via IBN to millions of social media followers; and (5) a full array of tailored corporate communications solutions. With broad reach and a seasoned team of contributing journalists and writers, IW is uniquely positioned to best serve private and public companies that want to reach a wide audience of investors, influencers, consumers, journalists and the general public. By cutting through the overload of information in today’s market, IW brings its clients unparalleled recognition and brand awareness. IW is where breaking news, insightful content and actionable information converge.

For more information, please visit https://www.InvestorWire.com

Please see full terms of use and disclaimers on the InvestorWire website applicable to all content provided by IW, wherever published or re-published: https://www.InvestorWire.com/Disclaimer

InvestorWire
Los Angeles, CA
www.InvestorWire.com
310.299.1717 Office
[email protected]

InvestorWire is powered by IBN

Pressure BioSciences (OTCQB: PBIO), a pioneer in the development and distribution of broadly enabling pressure-based instruments, consumables, and specialty process development and testing services across global industries, including health and wellness, nutraceuticals, food and beverage, cosmetics, biotherapeutics, and more, is releasing information on the growth of its recent acquisition: Uncle Bud’s Health & Wellness. According to the company, Amazon sales of the product have experienced a 60% increase over the previous month, with direct-to-consumer (“DTC”) sales Increasing by 16% from the previous month. In addition, the DTC customer base has increased by 13% and the company has seen “unprecedented” DTC subscription growth, with new subscriptions surging by 138% in the last month and website traffic increasing by 142%. The company noted that it anticipates the announcement of several high-profile celebrities as well as the launch of an extensive influencer campaign. The Uncle Bud’s line began in 2018 with a hemp-based pain relief product and has become a leader in the hemp seed oil, cannabidiol (“CBD”) and health & wellness sectors.

“We are thrilled to witness such dynamic growth in our DTC metrics, a testament to the trust and loyalty our customers have in Uncle Bud’s products, as well as anticipatory excitement for the promise of PBIO’s new nanoemulsion product enhancement capabilities,” said Uncle Bud marketing director Garrett Greller in the press release. “The significant upswing in new subscriptions, customers, revenue and website traffic are not just numbers to us; they represent real people exploring and definitively choosing better-for-you wellness and natural solutions for their everyday lives. Moreover, our forthcoming collaborations with high-profile celebrities and the launch of our influencer campaign will not only enhance brand visibility but will reinforce our deep-rooted engagement and adoption of cutting-edge science-driven improvements. They will also strengthen our mission to make Uncle Bud’s extraordinary wellness accessible to everyone. We are on an exciting path of growth and innovation, and these results are just the beginning of what promises to be a rewarding journey ahead for all PBIO stakeholders.”

To view the full press release, visit https://ibn.fm/YiuDt

About Pressure BioSciences Inc.

Pressure BioSciences is a global leader in providing innovative, broadly enabling, high-pressure-based solutions for a range of industries, including biotechnology, pharmaceutical, nutraceutical, cosmeceutical and agrochemical, as well as food and beverage manufacturing. PBIO’s patented enabling platform, Pressure Cycling Technology (“PCT”), utilizes alternating cycles of pressure to control biomolecular interactions (such as cell lysis and biomolecule extraction) safely and reproducibly. PCT-based products are used for biomarker and target discovery, drug design and development, biotherapeutics characterization and quality control, soil and plant biology, forensics and counterbioterrorism applications. The company’s patented BaroFold(TM) technology platform allows PBIO to enter the biopharma contract services and GMP manufacturing equipment sector. PBIO has also developed the scalable and high-efficiency pressure-based UltraShear Technology(TM) platform, which allows for the creation of stable nanoemulsions of otherwise immiscible fluids. It also allows for the preparation of higher quality, homogenized, extended shelf-life or room-temperature-stable, low-acid liquid foods that cannot be effectively preserved using existing nonthermal technologies. The company’s commitment to innovation and cutting-edge technology has established PBIO as a leader in the high-pressure industry, providing unique and effective solutions to its customers. For more information, visit the company website at www.PressureBioSciences.com.

NOTE TO INVESTORS: The latest news and updates relating to PBIO are available in the company’s newsroom at http://ibn.fm/PBIO

About InvestorWire

InvestorWire (“IW”) is a specialized communications platform with a focus on advanced wire-grade press release syndication for private and public companies and the investment community. It is one of 60+ brands within the Dynamic Brand Portfolio @ IBN that delivers: (1) access to a vast network of wire solutions via InvestorWire to efficiently and effectively reach a myriad of target markets, demographics and diverse industries; (2) article and editorial syndication to 5,000+ outlets; (3) enhanced press release enhancement to ensure maximum impact; (4) social media distribution via IBN to millions of social media followers; and (5) a full array of tailored corporate communications solutions. With broad reach and a seasoned team of contributing journalists and writers, IW is uniquely positioned to best serve private and public companies that want to reach a wide audience of investors, influencers, consumers, journalists and the general public. By cutting through the overload of information in today’s market, IW brings its clients unparalleled recognition and brand awareness. IW is where breaking news, insightful content and actionable information converge.

For more information, please visit https://www.InvestorWire.com

Please see full terms of use and disclaimers on the InvestorWire website applicable to all content provided by IW, wherever published or re-published: https://www.InvestorWire.com/Disclaimer

InvestorWire
Los Angeles, CA
www.InvestorWire.com
310.299.1717 Office
[email protected]

InvestorWire is powered by IBN

Flora (NASDAQ: FLGC), a cannabis focused consumer-packaged goods leader and pharmaceutical distributor serving all 50 states and 28 countries with 20,000+ points of distribution around the world, today issued an update to applaud the German parliament for voting in favor of legalizing cannabis for recreation use. After obtaining the first medical cannabis license in Germany, Flora’s wholly owned subsidiaries are responsible for selling the first gram of medical cannabis in the country and have been active there since 2017. “The decision marks a historic day for cannabis in Germany,” said Flora CEO Clifford Starke. “The legalization of recreational cannabis in Europe’s leading economy and the easing of access to medicinal cannabis will benefit consumers and patients tremendously. On behalf of Flora, we welcome Germany’s decision and look forward to playing an important role in the process.”

To view the full press release, visit https://ibn.fm/bHCgv

About Flora Growth Corp.

Flora is a cannabis-focused consumer-packaged goods leader and pharmaceutical distributor serving all 50 states and 28 countries with 20,000+ points of distribution around the world. For more information on Flora, visit www.FloraGrowth.com.

NOTE TO INVESTORS: The latest news and updates relating to FLGC are available in the company’s newsroom at https://ibn.fm/FLGC

About InvestorWire

InvestorWire (“IW”) is a specialized communications platform with a focus on advanced wire-grade press release syndication for private and public companies and the investment community. It is one of 60+ brands within the Dynamic Brand Portfolio @ IBN that delivers: (1) access to a vast network of wire solutions via InvestorWire to efficiently and effectively reach a myriad of target markets, demographics and diverse industries; (2) article and editorial syndication to 5,000+ outlets; (3) enhanced press release enhancement to ensure maximum impact; (4) social media distribution via IBN to millions of social media followers; and (5) a full array of tailored corporate communications solutions. With broad reach and a seasoned team of contributing journalists and writers, IW is uniquely positioned to best serve private and public companies that want to reach a wide audience of investors, influencers, consumers, journalists and the general public. By cutting through the overload of information in today’s market, IW brings its clients unparalleled recognition and brand awareness. IW is where breaking news, insightful content and actionable information converge.

For more information, please visit https://www.InvestorWire.com

Please see full terms of use and disclaimers on the InvestorWire website applicable to all content provided by IW, wherever published or re-published: https://www.InvestorWire.com/Disclaimer

InvestorWire
Los Angeles, CA
www.InvestorWire.com
310.299.1717 Office
[email protected]

InvestorWire is powered by IBN

Save Foods (NASDAQ: SVFD) (FSE: 80W), a pioneer agri-food tech company offering sustainable solutions for agriculture and plant based food, today announced the commencement of commercial activity in Brazil. According to the announcement, the company’s entry into the Brazilian market was facilitated by its local exclusive distributor after confirming that Save Foods’ solutions comply with local regulations. “As the country is put under pressure to comply with the Farm to Fork Strategy aligned with the European Green Deal, it has become increasingly crucial for suppliers of fresh fruit and vegetables to proactively adopt sustainable practices and stay ahead of evolving standards,” said Antonio Lunguinho, the CEO of Oxytrade Comercio and Ricardo Picard, the CEO of Endeavor Biologics . “We are thrilled to represent Save Foods in Brazil and combine our strengths with Save Foods’ innovative solutions. We are glad Save Foods’ products are cleared for distribution and we are looking forward to start our commitment to buying minimum quantities. We believe this partnership is poised to revolutionize the post-harvest treatment of fresh produce starting with limes and mangos, benefiting farmers, distributors and consumers alike.”

To view the full press release, visit https://ibn.fm/ZyfD6

About Save Foods Inc.

Save Foods is an innovative agri-food tech company that through its three operational arms delivers integrated solutions for improved safety, quality and sustainability every step of the way from field to fork. Save Foods Ltd., Save Foods’ majority owned Israeli subsidiary, focuses on post-harvest treatments in fruit and vegetables to control and prevent pathogen contamination, significantly reduce the use of hazardous chemicals, and prolong fresh produce’s shelf life. Nitrousink Ltd., Save Foods’ majority owned Israeli subsidiary, contributes to tackling greenhouse gas emissions, offering a pioneering solution to mitigate N2O (nitrous oxide) emissions, a potent greenhouse gas with 265 times the global warming impact of carbon dioxide. Nitrousink aims to promote agricultural practices that are both environmentally friendly and economically viable. Plantify Foods Inc. (PTFY), Save Foods’ minority owned Canadian subsidiary listed on the TSXV, offers a wide range of clean-label healthy food options that are nutritious, gluten free, non-allergenic, use whole natural ingredients, and are easy to prepare. For more information, visit the company’s website at https://savefoods.co.

NOTE TO INVESTORS: The latest news and updates relating to SVFD are available in the company’s newsroom at https://ibn.fm/SVFD         

About InvestorWire

InvestorWire (“IW”) is a specialized communications platform with a focus on advanced wire-grade press release syndication for private and public companies and the investment community. It is one of 60+ brands within the Dynamic Brand Portfolio @ IBN that delivers: (1) access to a vast network of wire solutions via InvestorWire to efficiently and effectively reach a myriad of target markets, demographics and diverse industries; (2) article and editorial syndication to 5,000+ outlets; (3) enhanced press release enhancement to ensure maximum impact; (4) social media distribution via IBN to millions of social media followers; and (5) a full array of tailored corporate communications solutions. With broad reach and a seasoned team of contributing journalists and writers, IW is uniquely positioned to best serve private and public companies that want to reach a wide audience of investors, influencers, consumers, journalists and the general public. By cutting through the overload of information in today’s market, IW brings its clients unparalleled recognition and brand awareness. IW is where breaking news, insightful content and actionable information converge.

For more information, please visit https://www.InvestorWire.com

Please see full terms of use and disclaimers on the InvestorWire website applicable to all content provided by IW, wherever published or re-published: https://www.InvestorWire.com/Disclaimer

InvestorWire
Los Angeles, CA
www.InvestorWire.com
310.299.1717 Office
[email protected]

InvestorWire is powered by IBN

• Activist investors target underperforming companies with an eye toward implementing agendas to maximize shareholder value
• Efforts by the SEC to limit activist interventions include proposals to shorten Schedule 13 filing deadlines, mandate amendments within a day of significant changes, and prevent shareholders from interfering with a company’s pro-ESG initiatives
• Activist investors tackle ongoing challenges by staying on top of emerging trends, adopting best practices, and forming strategic alliances
• DealFlow Events presents an unparalleled networking and learning opportunity: The Activist Investor Conference on March 21, 2024, in New York City
• Like all DealFlow events, this conference promises to deliver. The event features 20+ experts discussing topics covering value investing strategies, legal issues, corporate relations, and international opportunities

Activist investors remain a force to be reckoned with. They target companies perceived to be underperforming or inefficient and implement strategies to maximize shareholder value.

That’s why they’re also called…

Read more>>

As with all DealFlow Events, the Activist Investor Conference promises to deliver. Learn more and register.

About InvestorWire

InvestorWire (“IW”) is a specialized communications platform with a focus on advanced wire-grade press release syndication for private and public companies and the investment community. It is one of 60+ brands within the Dynamic Brand Portfolio @ IBN that delivers: (1) access to a vast network of wire solutions via InvestorWire to efficiently and effectively reach a myriad of target markets, demographics and diverse industries; (2) article and editorial syndication to 5,000+ outlets; (3) enhanced press release enhancement to ensure maximum impact; (4) social media distribution via IBN to millions of social media followers; and (5) a full array of tailored corporate communications solutions. With broad reach and a seasoned team of contributing journalists and writers, IW is uniquely positioned to best serve private and public companies that want to reach a wide audience of investors, influencers, consumers, journalists and the general public. By cutting through the overload of information in today’s market, IW brings its clients unparalleled recognition and brand awareness. IW is where breaking news, insightful content and actionable information converge.

For more information, please visit https://www.InvestorWire.com

Please see full terms of use and disclaimers on the InvestorWire website applicable to all content provided by IW, wherever published or re-published: https://www.InvestorWire.com/Disclaimer

InvestorWire
Los Angeles, CA
www.InvestorWire.com
310.299.1717 Office
[email protected]

InvestorWire is powered by IBN

180 Life Sciences (NASDAQ: ATNF), a clinical-stage biotechnology company, will conduct a reverse stock split of its outstanding shares of common stock. The ratio of the reverse stock split, which is slated to go into effect on Feb. 28 with market open, will be 1-for-19. According to the announcement, the reverse stock split, which was approved by stockholders at the company’s Feb. 16 Special Meeting of Stockholders, will reduce the number of the company’s outstanding common shares from approximately 11.3 million shares to approximately 0.6 million shares. “In connection with the reverse stock split, every 19 shares of the company’s common stock issued and outstanding as of the effective time will be automatically converted into one share of the company’s common stock,” said the company in the press release. “No change will be made to the trading symbol for the company’s shares of common stock or public warrants, ATNF and ATNFW, respectively, in connection with the reverse split. The reverse stock split is part of the company’s plan to regain compliance with the minimum bid price requirement of $1 per share required to maintain continued listing on the NASDAQ Capital Market, among other benefits.”

To view the full press release, visit https://ibn.fm/YsimJ

About 180 Life Sciences Corp.

180 Life Sciences is a clinical-stage biotechnology company focused on the development of therapeutics for unmet medical needs in chronic pain, inflammation and fibrosis by employing innovative research and, where appropriate, combination therapy. The company’s current primary focus is a novel program to treat several inflammatory disorders using anti-TNF, or tumor necrosis factor. For more information about the company, visit www.180LifeSciences.com.

NOTE TO INVESTORS: The latest news and updates relating to ATNF are available in the company’s newsroom at https://ibn.fm/ATNF

About InvestorWire

InvestorWire (“IW”) is a specialized communications platform with a focus on advanced wire-grade press release syndication for private and public companies and the investment community. It is one of 60+ brands within the Dynamic Brand Portfolio @ IBN that delivers: (1) access to a vast network of wire solutions via InvestorWire to efficiently and effectively reach a myriad of target markets, demographics and diverse industries; (2) article and editorial syndication to 5,000+ outlets; (3) enhanced press release enhancement to ensure maximum impact; (4) social media distribution via IBN to millions of social media followers; and (5) a full array of tailored corporate communications solutions. With broad reach and a seasoned team of contributing journalists and writers, IW is uniquely positioned to best serve private and public companies that want to reach a wide audience of investors, influencers, consumers, journalists and the general public. By cutting through the overload of information in today’s market, IW brings its clients unparalleled recognition and brand awareness. IW is where breaking news, insightful content and actionable information converge.

For more information, please visit https://www.InvestorWire.com

Please see full terms of use and disclaimers on the InvestorWire website applicable to all content provided by IW, wherever published or re-published: https://www.InvestorWire.com/Disclaimer

InvestorWire
Los Angeles, CA
www.InvestorWire.com
310.299.1717 Office
[email protected]

InvestorWire is powered by IBN

Energy Fuels (NYSE American: UUUU) (TSX: EFR), a leading U.S. producer of uranium, rare earth elements (“REE”) and vanadium, is reporting its financial results for the year ended Dec. 31, 2023. Highlights of the report include a record annual net income totaling almost $100 million, a balance sheet showing more than $200 million liquidity as well as no debt and an estimated $5 million of additional liquidity from inventory. In addition, the company reported that uranium drove the company’s revenue, with the sale of its Alta Mesa project funding investment in uranium and rare earth production. The report also showed the company is well-stocked to capture market opportunities. “In 2023, Energy Fuels joined an exclusive club,” said Energy Fuels president and CEO Mark Chalmers in the press release.

“With nearly $100 million in net income, we became one of the only profitable nonstate-owned uranium mining companies in the world. . . . Our nimble business plan enabled us to capture opportunities in the uranium market as prices surged beginning in late-2023. During 2023, we sold 560,000 pounds of uranium for about $60 per pound for total gross profits of $17.96 million and a 54% gross margin. However, uranium prices have risen significantly since then, and in Q1 2024, we intend to sell approximately 300,000 pounds of uranium under long-term contracts and on the spot market at an expected weighted average sales price of $84.38 per pound and at substantially higher gross margins. As long as market prices are strong, we will continue to selectively capitalize on spot market sales opportunities as we ramp up our production, in ways that are unique to our company, in 2024 and beyond, and with limited capital. . . . Energy Fuels is taking a unique and attractive path in the critical minerals business. Unlike other companies, who are reliant on only uranium, Energy Fuels is taking a broader view of the critical mineral industry and is producing the materials necessary to power the energy transition. Over time, our intent is to build a multiproduct, high-value commodity portfolio, centered on uranium, that earns long-term, sustainable and high-margin cashflows.”

To view the full press release, visit https://ibn.fm/UUEYj

About Energy Fuels Inc.

Energy Fuels is a leading U.S.-based critical minerals company. As the leading producer of uranium in the United States, Energy Fuels mines uranium and produces natural uranium concentrates that are sold to major nuclear utilities for the production of carbon-free nuclear energy. Energy Fuels recently began production of advanced rare earth element (“REE”) materials, including mixed REE carbonate, and plans to produce commercial quantities of separated REE oxides in the future. Energy Fuels also produces vanadium from certain of its projects, as market conditions warrant, and is evaluating the recovery of radionuclides needed for emerging cancer treatments. Its corporate offices are in Lakewood, Colorado, and substantially all assets and employees are in the United States. Energy Fuels holds two of America’s key uranium production centers: the White Mesa Mill in Utah and the Nichols Ranch in-situ recovery (“ISR”) project in Wyoming. The White Mesa Mill is the only conventional uranium mill operating in the country today, has a licensed capacity of more than 8 million pounds of U3O8per year, and has the ability to produce vanadium when market conditions warrant, as well as REE products, from various uranium-bearing ores. The Nichols Ranch ISR project is on standby and has a licensed capacity of 2 million pounds of U3O8per year. The company recently acquired the Bahia Project in Brazil, which is believed to have significant quantities of titanium (ilmenite and rutile), zirconium (zircon) and REE (monazite) minerals. In addition, Energy Fuels also has one of the largest NI 43-101-compliant uranium resource portfolios in the United States and several uranium and uranium/vanadium mining projects on standby and in various stages of permitting and development. For more information, visit the company’s website at www.EnergyFuels.com.

NOTE TO INVESTORS: The latest news and updates relating to UUUU are available in the company’s newsroom at http://ibn.fm/UUUU

About InvestorWire

InvestorWire (“IW”) is a specialized communications platform with a focus on advanced wire-grade press release syndication for private and public companies and the investment community. It is one of 60+ brands within the Dynamic Brand Portfolio @ IBN that delivers: (1) access to a vast network of wire solutions via InvestorWire to efficiently and effectively reach a myriad of target markets, demographics and diverse industries; (2) article and editorial syndication to 5,000+ outlets; (3) enhanced press release enhancement to ensure maximum impact; (4) social media distribution via IBN to millions of social media followers; and (5) a full array of tailored corporate communications solutions. With broad reach and a seasoned team of contributing journalists and writers, IW is uniquely positioned to best serve private and public companies that want to reach a wide audience of investors, influencers, consumers, journalists and the general public. By cutting through the overload of information in today’s market, IW brings its clients unparalleled recognition and brand awareness. IW is where breaking news, insightful content and actionable information converge.

For more information, please visit https://www.InvestorWire.com

Please see full terms of use and disclaimers on the InvestorWire website applicable to all content provided by IW, wherever published or re-published: https://www.InvestorWire.com/Disclaimer

InvestorWire
Los Angeles, CA
www.InvestorWire.com
310.299.1717 Office
[email protected]

InvestorWire is powered by IBN

Quant Strats invites thought leaders, c-suite representatives, and executives from all over the globe, for a flourishing debate and discussion on the key trends and changes in the industry, with a specific focus on real-life applications. The Quant Strats Conference, taking place March 12th, 2024, is the leading event for quantitative thought leaders, where you can network with a crowd of over 300 quant leaders to learn the latest market dynamics. Connect with over 50 speakers from reputed entities such as Goldman Sachs, Robeco, Point72, ADIA, and many more.

The Quant Strats summit provides a phenomenal platform for industry representatives to meet and network with a unique audience, gather informative data that gives them a competitive edge, as well as connect with leaders of great knowledge and connect. The event will host debates, presentations, and…

Read More>>

To know more, please visit https://ibn.fm/2e3QR

About InvestorWire

InvestorWire (“IW”) is a specialized communications platform with a focus on advanced wire-grade press release syndication for private and public companies and the investment community. It is one of 60+ brands within the Dynamic Brand Portfolio @ IBN that delivers: (1) access to a vast network of wire solutions via InvestorWire to efficiently and effectively reach a myriad of target markets, demographics and diverse industries; (2) article and editorial syndication to 5,000+ outlets; (3) enhanced press release enhancement to ensure maximum impact; (4) social media distribution via IBN to millions of social media followers; and (5) a full array of tailored corporate communications solutions. With broad reach and a seasoned team of contributing journalists and writers, IW is uniquely positioned to best serve private and public companies that want to reach a wide audience of investors, influencers, consumers, journalists and the general public. By cutting through the overload of information in today’s market, IW brings its clients unparalleled recognition and brand awareness. IW is where breaking news, insightful content and actionable information converge.

For more information, please visit https://www.InvestorWire.com

Please see full terms of use and disclaimers on the InvestorWire website applicable to all content provided by IW, wherever published or re-published: https://www.InvestorWire.com/Disclaimer

InvestorWire
Los Angeles, CA
www.InvestorWire.com
310.299.1717 Office
[email protected]

InvestorWire is powered by IBN

Tonix Pharmaceuticals (NASDAQ: TNXP), a fully integrated biopharmaceutical company focused on developing, licensing and commercializing therapeutics to treat and prevent human disease and alleviate suffering, is reporting positive study results for its sleep-quality targeted therapy. According to the report, the company’s product candidate Tonmya(R) reduced widespread pain in fibromyalgia reported by study participants. The company believes these results show potential for the drug to be the first in a new class of painkiller to be approved for use in fibromyalgia.

Also known as TNX-102 SL, Tonmya belongs to a new class of medicines for fibromyalgia.

The drug targets the characteristic sleep disturbance of fibromyalgia, which is called “nonrestorative sleep” and causes individuals to wake up feeling unrefreshed because their sleep fails to provide key restorative properties. The sublingual tablet is taken at bedtime and is designed to deliver the active ingredient into the brain during sleep and reduce its presence during wakefulness. Tonix plans to file for approval for the drug from the U.S. Food and Drug Administration (“FDA”) later this year. TN-102 SL is currently conditionally accepted by the FDA for the management of fibromyalgia, but as an investigational new medicine, it has not been accepted for any indication.

“If and when Tonmya is approved, it will offer a new first line treatment option for fibromyalgia patients,” said Tonix PharmaceuticalsCEO Seth Lederman, MD, in the press release. “Ultimately, we believe Tonmya will also be an option for patients who need pain relief but can’t tolerate or don’t respond to the currently marketed drugs for fibromyalgia. Because Tonmya targets sleep quality, we believe it’s a major step forward in both the treatment of fibromyalgia and in understanding the roles of nonrestorative sleep in causing or exacerbating fibromyalgia.”

To view the full press release, visit https://ibn.fm/DH2dJ

About Tonix Pharmaceuticals Holding Corp.

Tonix is a fully integrated biopharmaceutical company focused on developing, licensing and commercializing therapeutics to treat and prevent human disease and alleviate suffering. Tonix recently announced the U.S. Department of Defense (“DoD”), Defense Threat Reduction Agency (“DTRA”) awarded it a contract for up to $34 million over five years in an Other Transaction Agreement (“OTA”) to develop TNX-4200 small molecule broad-spectrum antiviral agents targeting CD45 for the prevention or treatment of infections to improve the medical readiness of military personnel in biological threat environments. Tonix owns and operates a state-of-the art, infectious-disease research facility in Frederick, Maryland. The company’s Good Manufacturing Practice (“GMP”)-capable advanced manufacturing facility in Dartmouth, Maine, was purpose built to manufacture TNX-801, and the GMP suites are ready to be reactivated in case of a national or international emergency. Tonix’s development portfolio is focused on central nervous system (“CNS”) disorders. Tonix’s priority is to submit a New Drug Application (“NDA”) to the FDA in the second half of 2024 for TNX-102 SL, a product candidate for which two statistically significant phase 3 studies have been completed for the management of fibromyalgia. The FDA has granted Fast Track designation to TNX-102 SL for the management of fibromyalgia. TNX-102 SL is also being developed to treat acute stress reaction. Tonix’s CNS portfolio includes TNX-1300 (cocaine esterase), a biologic designed to treat cocaine intoxication that has Breakthrough Therapy designation. Tonix’s immunology development portfolio consists of biologics to address organ-transplant rejection, autoimmunity and cancer, including TNX-1500, which is a humanized monoclonal antibody targeting CD40-ligand (“CD40L” or “CD154”) being developed for the prevention of allograft rejection and for the treatment of autoimmune diseases. Tonix also has product candidates in development in the areas of rare disease and infectious disease. Tonix Medicines, the company’s commercial subsidiary, markets Zembrace(R) SymTouch(R) (sumatriptan injection) 3 mg and Tosymra(R) (sumatriptan nasal spray) 10 mg for the treatment of acute migraine with or without aura in adults. For more information about the company, please visit www.TonixPharma.com.

About InvestorWire

InvestorWire (“IW”) is a specialized communications platform with a focus on advanced wire-grade press release syndication for private and public companies and the investment community. It is one of 60+ brands within the Dynamic Brand Portfolio @ IBN that delivers: (1) access to a vast network of wire solutions via InvestorWire to efficiently and effectively reach a myriad of target markets, demographics and diverse industries; (2) article and editorial syndication to 5,000+ outlets; (3) enhanced press release enhancement to ensure maximum impact; (4) social media distribution via IBN to millions of social media followers; and (5) a full array of tailored corporate communications solutions. With broad reach and a seasoned team of contributing journalists and writers, IW is uniquely positioned to best serve private and public companies that want to reach a wide audience of investors, influencers, consumers, journalists and the general public. By cutting through the overload of information in today’s market, IW brings its clients unparalleled recognition and brand awareness. IW is where breaking news, insightful content and actionable information converge.

For more information, please visit https://www.InvestorWire.com

Please see full terms of use and disclaimers on the InvestorWire website applicable to all content provided by IW, wherever published or re-published: https://www.InvestorWire.com/Disclaimer

InvestorWire
Los Angeles, CA
www.InvestorWire.com
310.299.1717 Office
[email protected]

InvestorWire is powered by IBN

IGC Pharma (NYSE American: IGC), a clinical-stage pharmaceutical company, is featured in a recent analyst coverage research report issued by Ascendiant Capital Markets LLC. The report included a “buy” recommendation with a $3 price target. The company noted that all reports prepared by analysts that spotlight IGC Pharma reflect the views of those analysts and are not necessarily those of IGC Pharma. “IGC is not responsible for the content, accuracy or timelines provided by analysts,” said the company in the press release. “By referring to these analysts or distributing their opinions, IGC does not in any way commit itself to the validity of such information, conclusions, or recommendations.”

To view the full analyst report, visit https://ibn.fm/pXMZC

To view the full press release, visit https://ibn.fm/JA9y0

About IGC Pharma

IGC Pharma is pursuing innovative solutions to fight Alzheimer’s disease and related challenges. The company’s portfolio comprises five assets, all with a singular mission: to transform the landscape of Alzheimer’s treatment. IGC-AD1 and LMP target neuroinflammation, Aβ plaques and neurofibrillary tangles. IGC-AD1 is currently in a phase 2b clinical trial for agitation in dementia due to Alzheimer’s. TGR-63 targets Aβ plaque to disrupt the progression of Alzheimer’s disease. IGC-M3 targets the inhibition of Aβ plaque aggregation with the potential to create a profound impact on early-stage Alzheimer’s. IGC-1C targets tau and neurofibrillary tangles as a forward-thinking approach to Alzheimer’s therapy. In parallel, IGC Pharma is at the forefront of generative AI development, with projects including clinical trials, early detection of Alzheimer’s and drug interactions with cannabinoids. For more information, visit the company’s website at www.IGCInc.us.

NOTE TO INVESTORS: The latest news and updates relating to IGC are available in the company’s newsroom at https://ibn.fm/IGC

About InvestorWire

InvestorWire (“IW”) is a specialized communications platform with a focus on advanced wire-grade press release syndication for private and public companies and the investment community. It is one of 60+ brands within the Dynamic Brand Portfolio @ IBN that delivers: (1) access to a vast network of wire solutions via InvestorWire to efficiently and effectively reach a myriad of target markets, demographics and diverse industries; (2) article and editorial syndication to 5,000+ outlets; (3) enhanced press release enhancement to ensure maximum impact; (4) social media distribution via IBN to millions of social media followers; and (5) a full array of tailored corporate communications solutions. With broad reach and a seasoned team of contributing journalists and writers, IW is uniquely positioned to best serve private and public companies that want to reach a wide audience of investors, influencers, consumers, journalists and the general public. By cutting through the overload of information in today’s market, IW brings its clients unparalleled recognition and brand awareness. IW is where breaking news, insightful content and actionable information converge.

For more information, please visit https://www.InvestorWire.com

Please see full terms of use and disclaimers on the InvestorWire website applicable to all content provided by IW, wherever published or re-published: https://www.InvestorWire.com/Disclaimer

InvestorWire
Los Angeles, CA
www.InvestorWire.com
310.299.1717 Office
[email protected]

InvestorWire is powered by IBN

Uber (NYSE: UBER) was featured in a recent analysis report that discussed the company’s bold strategy to ambitiously venture beyond ride sharing into the broader logistics and delivery sectors. According to the report, the strategy is working and handily places the company in a league of its own. “This move sets it starkly apart from Lyft, which continues to concentrate solely on…

To read the full report and view the infographic, please visit https://ibn.fm/QkT5x

About Uber Technologies Inc.

Uber’s mission is to create opportunity through movement. Uber started in 2010 to solve a simple problem: how to access a ride at the touch of a button? More than 44 billion trips later, the company is building products to get people closer to where they want to be. By changing how people, food and things move through cities, Uber is a platform that opens up the world to new possibilities.

About InvestorWire

InvestorWire (“IW”) is a specialized communications platform with a focus on advanced wire-grade press release syndication for private and public companies and the investment community. It is one of 60+ brands within the Dynamic Brand Portfolio @ IBN that delivers: (1) access to a vast network of wire solutions via InvestorWire to efficiently and effectively reach a myriad of target markets, demographics and diverse industries; (2) article and editorial syndication to 5,000+ outlets; (3) enhanced press release enhancement to ensure maximum impact; (4) social media distribution via IBN to millions of social media followers; and (5) a full array of tailored corporate communications solutions. With broad reach and a seasoned team of contributing journalists and writers, IW is uniquely positioned to best serve private and public companies that want to reach a wide audience of investors, influencers, consumers, journalists and the general public. By cutting through the overload of information in today’s market, IW brings its clients unparalleled recognition and brand awareness. IW is where breaking news, insightful content and actionable information converge.

For more information, please visit https://www.InvestorWire.com

Please see full terms of use and disclaimers on the InvestorWire website applicable to all content provided by IW, wherever published or re-published: https://www.InvestorWire.com/Disclaimer

InvestorWire
Los Angeles, CA
www.InvestorWire.com
310.299.1717 Office
[email protected]

InvestorWire is powered by IBN

American Express (NYSE: AXP) was featured in a recent analysis report that discussed why the company stands prominently in the league of competitors, excelling and capturing customer attention because of its specialization, clear mission, vivid vision, and superior offerings. “Amex has consistently attracted a consumer base that values status, perks and…

To read the full report and view the infographic, please visit https://ibn.fm/cDMeR

About American Express Company

American Express is a globally integrated payments company, providing customers with access to products, insights and experiences that enrich lives and build business success. For more information about the company, visit AmericanExpress.com.

About InvestorWire

InvestorWire (“IW”) is a specialized communications platform with a focus on advanced wire-grade press release syndication for private and public companies and the investment community. It is one of 60+ brands within the Dynamic Brand Portfolio @ IBN that delivers: (1) access to a vast network of wire solutions via InvestorWire to efficiently and effectively reach a myriad of target markets, demographics and diverse industries; (2) article and editorial syndication to 5,000+ outlets; (3) enhanced press release enhancement to ensure maximum impact; (4) social media distribution via IBN to millions of social media followers; and (5) a full array of tailored corporate communications solutions. With broad reach and a seasoned team of contributing journalists and writers, IW is uniquely positioned to best serve private and public companies that want to reach a wide audience of investors, influencers, consumers, journalists and the general public. By cutting through the overload of information in today’s market, IW brings its clients unparalleled recognition and brand awareness. IW is where breaking news, insightful content and actionable information converge.

For more information, please visit https://www.InvestorWire.com

Please see full terms of use and disclaimers on the InvestorWire website applicable to all content provided by IW, wherever published or re-published: https://www.InvestorWire.com/Disclaimer

InvestorWire
Los Angeles, CA
www.InvestorWire.com
310.299.1717 Office
[email protected]

InvestorWire is powered by IBN

Cboe Global Markets (Cboe: CBOE), the world’s leading derivatives and securities exchange network, has entered into a strategic collaborative initiative with MSCI Inc. (NYSE: MSCI). MSCI provides a critical decision support tools and services for the global investment community. The partnership is designed to expand the suite of Cboe-MSCI Index options and volatility indices and reflects a deepening relationship between the two companies, which have a longstanding tradition of working together, as they leverage their combined expertise to develop innovative solutions for investors. Specifically, Cboe will be offering three new options tied to MSCI’s international, developed, emerging and U.S. markets benchmark indices; those options are set to launch on March 18, 2024, pending approvals. In addition, Cboe will introduces two new volatility indices based on existing MSCI Index options and the proprietary VIX Index Methodology. The announcement noted that the new options will be based on the MSCI World Index, the MSCI ACWI Index and the MSCI USA Index. “In today’s rapidly evolving landscape, investors require sophisticated tools to navigate the markets with confidence,” said Cboe global head of derivatives Catherine Clay in the press release.

“Our ongoing collaboration with MSCI reflects our shared commitment to fostering innovation and providing solutions that empower investors to better manage risk and seize potential opportunities in the global marketplace. We are excited to expand our Cboe-MSCI toolkit with additional index options and volatility indices — an enhancement that will not only broaden our customers’ product choice, but also enrich the ways they interact with and analyze the global markets. Crucially, the three new index options, which cover developed and emerging markets, are expected to also give investors comprehensive access to gain a variety of different exposures around the globe.”

To view the full press release, visit https://ibn.fm/Ma884

About Cboe Global Markets Inc.

Cboe Global Markets, a leading provider of market infrastructure and tradable products, delivers cutting-edge trading, clearing and investment solutions to market participants around the world. The company is committed to operating a trusted, inclusive global marketplace as well as providing leading products, technology and data solutions that enable participants to define a sustainable financial future. Cboe provides trading solutions and products in multiple asset classes, including equities, derivatives, FX and digital assets, across North America, Europe and Asia Pacific. For more information, please visit www.Cboe.ca.

About InvestorWire

InvestorWire (“IW”) is a specialized communications platform with a focus on advanced wire-grade press release syndication for private and public companies and the investment community. It is one of 60+ brands within the Dynamic Brand Portfolio @ IBN that delivers: (1) access to a vast network of wire solutions via InvestorWire to efficiently and effectively reach a myriad of target markets, demographics and diverse industries; (2) article and editorial syndication to 5,000+ outlets; (3) enhanced press release enhancement to ensure maximum impact; (4) social media distribution via IBN to millions of social media followers; and (5) a full array of tailored corporate communications solutions. With broad reach and a seasoned team of contributing journalists and writers, IW is uniquely positioned to best serve private and public companies that want to reach a wide audience of investors, influencers, consumers, journalists and the general public. By cutting through the overload of information in today’s market, IW brings its clients unparalleled recognition and brand awareness. IW is where breaking news, insightful content and actionable information converge.

For more information, please visit https://www.InvestorWire.com

Please see full terms of use and disclaimers on the InvestorWire website applicable to all content provided by IW, wherever published or re-published: https://www.InvestorWire.com/Disclaimer

InvestorWire
Los Angeles, CA
www.InvestorWire.com
310.299.1717 Office
[email protected]

InvestorWire is powered by IBN

Save Foods (NASDAQ: SVFD), a pioneer agrifood tech company offering sustainable solutions for agriculture and plant-based food, and its majority-owned subsidiary NTwo Off Ltd., have filed an application for a U.S. patent. According to the announcement, the patent is aimed at revolutionizing wheat production and is related to NTwo Off’s focus on mitigating the environmental impact of agriculture, specifically the reduction of nitrous oxide (“N2O”) emissions in wheat farming. “The patented technology refers to methodologies of effectively mitigating nitrous oxide emissions during wheat cultivation,” said the company in the press release. “By implementing this innovative approach, NTwo Off hopes to reduce farmers’ environmental footprint while enhancing their sustainability of operations. NTwo Off has identified and isolated two naturally occurring bacteria species that can reduce N2O emissions under various environmental conditions from wheat roots. NTwo Off’s R&D team is currently testing its technology under greenhouse conditions with the aim of finding the optimal formula for reducing N2O emission in wheat crops. NTwo Off intends to continue its testing in micro field plots using different soils, dosages, and formulations for a variety of crops.

To view the full press release, visit https://ibn.fm/vhbNH

About Save Foods Inc.

Save Foods is an innovative agrifood tech company that through its operational arms — two majority-owned subsidiaries, Save Foods Ltd. and NTwo Off Ltd., and minority-owned subsidiary Plantify Foods Inc. — delivers integrated solutions for improved safety, quality and sustainability every step of the way from field to fork. Save Foods Ltd., Save Foods’ majority-owned Israeli subsidiary, focuses on post-harvest treatments in fruit and vegetables to control and prevent pathogen contamination, significantly reduce the use of hazardous chemicals and prolong fresh produce’s shelf life. NTwo Off, its other majority-owned Israeli subsidiary, contributes to tackle greenhouse gas emissions, offering a pioneering solution to mitigate nitrous oxide emissions, a potent greenhouse gas with 265 times the global warming impact of carbon dioxide. NTwo Off aims to promote agricultural practices that are both environmentally friendly and economically viable. Plantify Foods, Save Foods’ minority-owned Canadian subsidiary, offers a wide range of clean-label healthy food options that are nutritious, gluten free and nonallergenic; that use whole natural ingredients; and that are easy to prepare. For more information about the company, visit www.SaveFoods.co.

NOTE TO INVESTORS: The latest news and updates relating to SVFD are available in the company’s newsroom at https://ibn.fm/SVFD

About InvestorWire

InvestorWire (“IW”) is a specialized communications platform with a focus on advanced wire-grade press release syndication for private and public companies and the investment community. It is one of 60+ brands within the Dynamic Brand Portfolio @ IBN that delivers: (1) access to a vast network of wire solutions via InvestorWire to efficiently and effectively reach a myriad of target markets, demographics and diverse industries; (2) article and editorial syndication to 5,000+ outlets; (3) enhanced press release enhancement to ensure maximum impact; (4) social media distribution via IBN to millions of social media followers; and (5) a full array of tailored corporate communications solutions. With broad reach and a seasoned team of contributing journalists and writers, IW is uniquely positioned to best serve private and public companies that want to reach a wide audience of investors, influencers, consumers, journalists and the general public. By cutting through the overload of information in today’s market, IW brings its clients unparalleled recognition and brand awareness. IW is where breaking news, insightful content and actionable information converge.

For more information, please visit https://www.InvestorWire.com

Please see full terms of use and disclaimers on the InvestorWire website applicable to all content provided by IW, wherever published or re-published: https://www.InvestorWire.com/Disclaimer

InvestorWire
Los Angeles, CA
www.InvestorWire.com
310.299.1717 Office
[email protected]

InvestorWire is powered by IBN

McEwen Mining (NYSE: MUX) (TSX: MUX), a gold and silver producer with operations in Nevada, Canada, Mexico and Argentina, and McEwen Copper Inc. have released results from the recently completed phase 1 copper heap leaching metallurgical tests. The tests were conducted at SGS Chile Limitada in Santiago, Chile, with test results produced utilizing conventional bio-heap leaching technology. Final phase 1 results indicate an increase in the average recovery to 76% in an estimated 230 days of leaching over the planned 27-year life of the project. The report also showed average net acid consumption was reduced by 8.3% relative to the Preliminary Economic Assessment (“PEA”). The announcement noted that the potential impact of the 3.2% increase in average recovery and 8.3% reduction in net acid consumption could be illustrated by selectively adjusting the PEA Base Case financial model, which results in a life of mine copper cathode production increase of 172,000 tonnes and an after-tax NPV(8%) increase of approximately $262 million.

To view the full press release, visit https://ibn.fm/UxRiE

About McEwen Mining Inc.

McEwen Mining is a gold and silver producer with operations in Nevada, Canada, Mexico and Argentina. In addition, the company owns approximately 47.7% of McEwen Copper, which owns the large, advanced-stage Los Azules copper project in Argentina. The company’s goal is to improve the productivity and life of its assets with the objective of increasing its share price and providing a yield. Rob McEwen, chair and chief owner, has a personal investment in the company of US$220 million. His annual salary is US$1. To learn more about the company, visit www.McEwenMining.com.

NOTE TO INVESTORS: The latest news and updates relating to MUX are available in the company’s newsroom at https://ibn.fm/MUX

About InvestorWire

InvestorWire (“IW”) is a specialized communications platform with a focus on advanced wire-grade press release syndication for private and public companies and the investment community. It is one of 60+ brands within the Dynamic Brand Portfolio @ IBN that delivers: (1) access to a vast network of wire solutions via InvestorWire to efficiently and effectively reach a myriad of target markets, demographics and diverse industries; (2) article and editorial syndication to 5,000+ outlets; (3) enhanced press release enhancement to ensure maximum impact; (4) social media distribution via IBN to millions of social media followers; and (5) a full array of tailored corporate communications solutions. With broad reach and a seasoned team of contributing journalists and writers, IW is uniquely positioned to best serve private and public companies that want to reach a wide audience of investors, influencers, consumers, journalists and the general public. By cutting through the overload of information in today’s market, IW brings its clients unparalleled recognition and brand awareness. IW is where breaking news, insightful content and actionable information converge.

For more information, please visit https://www.InvestorWire.com

Please see full terms of use and disclaimers on the InvestorWire website applicable to all content provided by IW, wherever published or re-published: https://www.InvestorWire.com/Disclaimer

InvestorWire
Los Angeles, CA
www.InvestorWire.com
310.299.1717 Office
[email protected]

InvestorWire is powered by IBN

• Arizona-based SenesTech has developed a portfolio of rodent birth control products as a very effective alternative to deadly poisons often used to control rat populations
• SenesTech’s most recent product rollout is a soft bait formulation of its Birth Control for Rats(TM) branded Evolve(TM), in response to pest management businesses that prefer solid baits to SenesTech’s initial liquid products
• The company recently announced a partner agreement with grain management market distributor Poppe Enterprises to stock Evolve(TM) at outlets in states from North Dakota to Kansas and Colorado, following on the heels of a similar agricultural distribution agreement with a global irrigation solutions company

From New Orleans (https://ibn.fm/MyxuC) to Michigan (https://ibn.fm/nBfPB), eastward to Massachusetts (https://ibn.fm/1sMU1), and across the Atlantic to Europe (https://ibn.fm/6lMiL), concerns about confronting rats in the world’s cities continue to occupy news reports. But rats cause even more damage in agriculture.

Rodent pest control enterprise SenesTech (NASDAQ: SNES) is based in Arizona has begun to establish a global reach for its innovative Birth Control for Rats(TM) products, and the company is expanding its operations within agricultural sectors where rodent predation may otherwise have costly effects on…

Read More>>

NOTE TO INVESTORS: The latest news and updates relating to SNES are available in the company’s newsroom at https://ibn.fm/SNES

About InvestorWire

InvestorWire (“IW”) is a specialized communications platform with a focus on advanced wire-grade press release syndication for private and public companies and the investment community. It is one of 60+ brands within the Dynamic Brand Portfolio @ IBN that delivers: (1) access to a vast network of wire solutions via InvestorWire to efficiently and effectively reach a myriad of target markets, demographics and diverse industries; (2) article and editorial syndication to 5,000+ outlets; (3) enhanced press release enhancement to ensure maximum impact; (4) social media distribution via IBN to millions of social media followers; and (5) a full array of tailored corporate communications solutions. With broad reach and a seasoned team of contributing journalists and writers, IW is uniquely positioned to best serve private and public companies that want to reach a wide audience of investors, influencers, consumers, journalists and the general public. By cutting through the overload of information in today’s market, IW brings its clients unparalleled recognition and brand awareness. IW is where breaking news, insightful content and actionable information converge.

For more information, please visit https://www.InvestorWire.com

Please see full terms of use and disclaimers on the InvestorWire website applicable to all content provided by IW, wherever published or re-published: https://www.InvestorWire.com/Disclaimer

InvestorWire
Los Angeles, CA
www.InvestorWire.com
310.299.1717 Office
[email protected]

InvestorWire is powered by IBN

ECGI Holdings (OTC: ECGI), a diversified holding company, has launched a new initiative to strengthen its financial structure and enhance shareholder value. According to the announcement, the company has identified and initiated the reduction of more than $600,000 in liabilities from its balance sheet, reflecting ECGI’s commitment to operational efficiency and fiscal responsibility. Part of this strategic plan involves the cancelation of the second SRAX note, resulting in a direct reduction of $450,000. The company is committed to  maintaining the momentum of this financial optimization initiative as it focuses on setting the stage for greater financial flexibility and the potential for future growth opportunities. “The progress in cleaning up our balance sheet and reducing liabilities is expected to have a positive impact on our share structure,” the company stated in the press release.

“By alleviating the burden of these financial obligations, ECGI Holdings is better positioned to pursue strategic initiatives and capitalize on growth opportunities. This streamlined financial structure is anticipated to enhance investor confidence and attract additional investment, driving further value creation for our shareholders. As we move forward, ECGI Holdings remains focused on executing our strategic plan, pursuing growth opportunities and continuing to improve our financial structure. We are committed to transparent and timely communication with our investors and stakeholders as we make further progress.”

To view the full press release, visit https://ibn.fm/g70co

About ECGI Holdings Inc.

ECGI is a diversified holding company with a distinctive portfolio encompassing viticulture and luxury fashion. The company owns and manages a five-acre vineyard in Lake County, California, specializing in cultivating Petite Sirah, known for its bold and rich character and aligning with the growing demand for unique and high-quality wine experiences. In the fashion sector, ECGI has strategically invested in Pacific Saddlery, a premier manufacturer and retailer of luxury equestrian tack, apparel and accessories. This unique blend of wine and fashion investments reflects ECGI’s commitment to delivering sophistication and innovation across diverse markets, positioning the company as a distinctive player in the intersection of technology, viticulture and luxury lifestyle. For more information about the company, please visit [email protected].

About InvestorWire

InvestorWire (“IW”) is a specialized communications platform with a focus on advanced wire-grade press release syndication for private and public companies and the investment community. It is one of 60+ brands within the Dynamic Brand Portfolio @ IBN that delivers: (1) access to a vast network of wire solutions via InvestorWire to efficiently and effectively reach a myriad of target markets, demographics and diverse industries; (2) article and editorial syndication to 5,000+ outlets; (3) enhanced press release enhancement to ensure maximum impact; (4) social media distribution via IBN to millions of social media followers; and (5) a full array of tailored corporate communications solutions. With broad reach and a seasoned team of contributing journalists and writers, IW is uniquely positioned to best serve private and public companies that want to reach a wide audience of investors, influencers, consumers, journalists and the general public. By cutting through the overload of information in today’s market, IW brings its clients unparalleled recognition and brand awareness. IW is where breaking news, insightful content and actionable information converge.

For more information, please visit https://www.InvestorWire.com

Please see full terms of use and disclaimers on the InvestorWire website applicable to all content provided by IW, wherever published or re-published: https://www.InvestorWire.com/Disclaimer

InvestorWire
Los Angeles, CA
www.InvestorWire.com
310.299.1717 Office
[email protected]

InvestorWire is powered by IBN

Knightscope (NASDAQ: KSCP), a leading innovator in robotics and artificial intelligence (“AI”) technologies focused on public safety, today announced that one of the busiest international airports for travelers and cargo in the United States is upgrading its emergency communications with 22 new K1 Blue Light Emergency Phones (“E-Phones”). The E-Phones will be installed throughout a prime parking lot at a California airport.

The announcement reads, “California citizens and visitors depend upon telecommunication systems to seek help and obtain assistance during emergencies or times of crisis. Knightscope’s E-Phones boost safety by delivering enhanced wireless connectivity to critical services such as police, fire and EMS through a one-touch, ADA compliant device. Coordinated and efficient response is achieved with pinpoint accuracy since the exact location of each device is known, ensuring the well-being of those choosing to use the E-Phones instead of cellular devices when geographic familiarity is a challenge, cellphone batteries are dead or carrier coverage is limited.”

To view the full press release, visit https://ibn.fm/G5C37

About Knightscope, Inc.

Knightscope builds cutting-edge technologies to improve public safety. Knightscope’s long-term ambition is to make the United States of America the safest country in the world. For more information, visit the company’s website at www.knightscope.com.

NOTE TO INVESTORS: The latest news and updates relating to Knightscope are available in the company’s newsroom at https://ibn.fm/KSCP

About InvestorWire

InvestorWire (“IW”) is a specialized communications platform with a focus on advanced wire-grade press release syndication for private and public companies and the investment community. It is one of 60+ brands within the Dynamic Brand Portfolio @ IBN that delivers: (1) access to a vast network of wire solutions via InvestorWire to efficiently and effectively reach a myriad of target markets, demographics and diverse industries; (2) article and editorial syndication to 5,000+ outlets; (3) enhanced press release enhancement to ensure maximum impact; (4) social media distribution via IBN to millions of social media followers; and (5) a full array of tailored corporate communications solutions. With broad reach and a seasoned team of contributing journalists and writers, IW is uniquely positioned to best serve private and public companies that want to reach a wide audience of investors, influencers, consumers, journalists and the general public. By cutting through the overload of information in today’s market, IW brings its clients unparalleled recognition and brand awareness. IW is where breaking news, insightful content and actionable information converge.

For more information, please visit https://www.InvestorWire.com

Please see full terms of use and disclaimers on the InvestorWire website applicable to all content provided by IW, wherever published or re-published: https://www.InvestorWire.com/Disclaimer

InvestorWire
Los Angeles, CA
www.InvestorWire.com
310.299.1717 Office
[email protected]

InvestorWire is powered by IBN

Safety Shot (NASDAQ: SHOT) today announced that it has signed an agreement to license and sell its legacy Jupiter Wellness assets to Colorado-based Elite Health Partners Inc., a leading provider of world-class, innovative products and services that fulfill a broad range of consumer health and beauty needs globally. According to the announcement, Elite Health, currently a private company, plans to file a registration statement for an IPO by Q3 2024 and subsequently become publicly listed. The announcement further stated that upon its IPO, Elite Health intends to acquire the licensed Jupiter Wellness assets for a consideration of 40% of Elite Health’s outstanding shares that Safety Shot plans to dividend to its shareholders. Safety Shot’s Jupiter Wellness assets include a portfolio of over-the-counter commercialized products as well as product candidates in development for indications such as skin care, hair growth and women’s health.

“Elite Health, combined with our Jupiter Wellness portfolio, is set to become a wellness powerhouse that develops, manufactures, launches, markets and distributes a portfolio of high-quality products,” said Safety Shot CEO Brian John. “This deal with Elite Health is a great way for Safety Shot to monetize our assets, further freeing us up to focus solely on Safety Shot’s enormous opportunity in the functional beverage industry.”

To view the full press release, visit https://ibn.fm/otbsJ

About Safety Shot Inc.

Safety Shot, a wellness and functional beverage company, is set to launch Safety Shot, the first patented wellness beverage on Earth that helps people feel better faster by reducing blood alcohol content, boosting clarity and overall mood. Safety Shot is available for retail purchase at www.DrinkSafetyShot.com and www.Amazon.com. The company plans to launch business-to-business sales of Safety Shot to distributors, retailers, restaurants, and bars in the first quarter of 2024.

About InvestorWire

InvestorWire (“IW”) is a specialized communications platform with a focus on advanced wire-grade press release syndication for private and public companies and the investment community. It is one of 60+ brands within the Dynamic Brand Portfolio @ IBN that delivers: (1) access to a vast network of wire solutions via InvestorWire to efficiently and effectively reach a myriad of target markets, demographics and diverse industries; (2) article and editorial syndication to 5,000+ outlets; (3) enhanced press release enhancement to ensure maximum impact; (4) social media distribution via IBN to millions of social media followers; and (5) a full array of tailored corporate communications solutions. With broad reach and a seasoned team of contributing journalists and writers, IW is uniquely positioned to best serve private and public companies that want to reach a wide audience of investors, influencers, consumers, journalists and the general public. By cutting through the overload of information in today’s market, IW brings its clients unparalleled recognition and brand awareness. IW is where breaking news, insightful content and actionable information converge.

For more information, please visit https://www.InvestorWire.com

Please see full terms of use and disclaimers on the InvestorWire website applicable to all content provided by IW, wherever published or re-published: https://www.InvestorWire.com/Disclaimer

InvestorWire
Los Angeles, CA
www.InvestorWire.com
310.299.1717 Office
[email protected]

InvestorWire is powered by IBN

GolfLync has proven its success and is expanding to other markets!

In an era where the intersection of technology and sports continues to redefine engagement, GolfLync(TM) stands out as a beacon of innovation and growth. With a user base that has surged to over 100,000 members and a platform supporting over 850 of Virtual Golf Clubs(TM) (“VGCs”) across the nation, GolfLync’s trajectory in the digital sports networking space is noteworthy.

A Viral Sensation in the Golf Community

GolfLync’s journey began with a simple yet powerful mission: to connect golf enthusiasts through a dedicated social media platform. The app’s success, highlighted by a 3033% growth rate from April to the end of 2023, underscores a robust market fit and a burgeoning demand for specialized…

Read More>>

NOTE TO INVESTORS: The latest news and updates relating to GolfLync are available in the company’s newsroom at https://ibn.fm/GOLF

About InvestorWire

InvestorWire (“IW”) is a specialized communications platform with a focus on advanced wire-grade press release syndication for private and public companies and the investment community. It is one of 60+ brands within the Dynamic Brand Portfolio @ IBN that delivers: (1) access to a vast network of wire solutions via InvestorWire to efficiently and effectively reach a myriad of target markets, demographics and diverse industries; (2) article and editorial syndication to 5,000+ outlets; (3) enhanced press release enhancement to ensure maximum impact; (4) social media distribution via IBN to millions of social media followers; and (5) a full array of tailored corporate communications solutions. With broad reach and a seasoned team of contributing journalists and writers, IW is uniquely positioned to best serve private and public companies that want to reach a wide audience of investors, influencers, consumers, journalists and the general public. By cutting through the overload of information in today’s market, IW brings its clients unparalleled recognition and brand awareness. IW is where breaking news, insightful content and actionable information converge.

For more information, please visit https://www.InvestorWire.com

Please see full terms of use and disclaimers on the InvestorWire website applicable to all content provided by IW, wherever published or re-published: https://www.InvestorWire.com/Disclaimer

InvestorWire
Los Angeles, CA
www.InvestorWire.com
310.299.1717 Office
[email protected]

InvestorWire is powered by IBN

Pharmaceutical colleagues, academic institutions, HCPs, patients, advocacy groups, consumers, research sites and allied partners are invited to attend the 4th DEI For Pharma and Healthcare Summit organized by DGE, on March 25-26, 2024 in Tampa, FL.

The Dynamic Global Events (“DGE”) group is a Life Science leader in hosting B2B events, catering to the dynamic informational and networking needs of the…

Read More>>

To learn more, please visit https://ibn.fm/bzmJf.

About InvestorWire

InvestorWire (“IW”) is a specialized communications platform with a focus on advanced wire-grade press release syndication for private and public companies and the investment community. It is one of 60+ brands within the Dynamic Brand Portfolio @ IBN that delivers: (1) access to a vast network of wire solutions via InvestorWire to efficiently and effectively reach a myriad of target markets, demographics and diverse industries; (2) article and editorial syndication to 5,000+ outlets; (3) enhanced press release enhancement to ensure maximum impact; (4) social media distribution via IBN to millions of social media followers; and (5) a full array of tailored corporate communications solutions. With broad reach and a seasoned team of contributing journalists and writers, IW is uniquely positioned to best serve private and public companies that want to reach a wide audience of investors, influencers, consumers, journalists and the general public. By cutting through the overload of information in today’s market, IW brings its clients unparalleled recognition and brand awareness. IW is where breaking news, insightful content and actionable information converge.

For more information, please visit https://www.InvestorWire.com

Please see full terms of use and disclaimers on the InvestorWire website applicable to all content provided by IW, wherever published or re-published: https://www.InvestorWire.com/Disclaimer

InvestorWire
Los Angeles, CA
www.InvestorWire.com
310.299.1717 Office
[email protected]

InvestorWire is powered by IBN

Siyata Mobile (NASDAQ: SYTA, SYTAW), a global developer and vendor of Push-to-Talk over Cellular (“PoC”) handsets and accessories, has received a purchase order for 1,000 units of its UV350 all-in-one, in-vehicle fleet communication devices. The order was received from an international EMS provider. According to the announcement, the company anticipates fulfilling the order in the next few weeks, delivering the devices during the current Q1 2024. “Serving the first responder vertical is foundational to our business, and this order reinforces our prominent position within the space,” said Siyata Mobile CEO Marc Seelenfreund in the press release. “Our UV350 is essentially a smartphone that is specifically designed for fleet vehicles to optimize mobile communications while driving. We are pleased to add this international organization to our growing customer list and increase the geographic diversity of our revenue sources. Expansion of our dealer network, steady order flow and a growing pipeline of new, identified sales opportunities are the building blocks to achieving our number one goal in 2024 of aggressively ramping up sales and reaching profitability in the coming quarters.”

To view the full press release, visit https://ibn.fm/leA4E

About Siyata Mobile Inc.

Siyata Mobile is a business-to-business (“B2B”) global developer and vendor of next-generation, Push-to-Talk (“PTT”) over cellular (“POC”) handsets and accessories. The company’s portfolio of rugged PTT handsets and accessories enables first responders and enterprise workers to instantly communicate over a nationwide cellular network of choice, to increase situational awareness and save lives. Police, fire and ambulance organizations as well as schools, utilities, security companies, hospitals, waste-management companies, resorts and many other organizations use Siyata PTT handsets and accessories. In support of the company’s Push-to-Talk handsets and accessories, Siyata also offers enterprise-grade, in-vehicle solutions and cellular booster systems enabling its customers to communicate effectively when they are in their vehicles, and even in areas where the cellular signal is weak. Siyata sells its portfolio through leading North American cellular carriers, and through international cellular carriers and distributors. For more information about the company, visit www.SiyataMobile.com or www.UnidenCellular.com.

NOTE TO INVESTORS: The latest news and updates relating to SYTA are available in the company’s newsroom at http://ibn.fm/SYTA

About InvestorWire

InvestorWire (“IW”) is a specialized communications platform with a focus on advanced wire-grade press release syndication for private and public companies and the investment community. It is one of 60+ brands within the Dynamic Brand Portfolio @ IBN that delivers: (1) access to a vast network of wire solutions via InvestorWire to efficiently and effectively reach a myriad of target markets, demographics and diverse industries; (2) article and editorial syndication to 5,000+ outlets; (3) enhanced press release enhancement to ensure maximum impact; (4) social media distribution via IBN to millions of social media followers; and (5) a full array of tailored corporate communications solutions. With broad reach and a seasoned team of contributing journalists and writers, IW is uniquely positioned to best serve private and public companies that want to reach a wide audience of investors, influencers, consumers, journalists and the general public. By cutting through the overload of information in today’s market, IW brings its clients unparalleled recognition and brand awareness. IW is where breaking news, insightful content and actionable information converge.

For more information, please visit https://www.InvestorWire.com

Please see full terms of use and disclaimers on the InvestorWire website applicable to all content provided by IW, wherever published or re-published: https://www.InvestorWire.com/Disclaimer

InvestorWire
Los Angeles, CA
www.InvestorWire.com
310.299.1717 Office
[email protected]

InvestorWire is powered by IBN

Canada Nickel (TSX.V: CNC) (OTCQX: CNIKF) has announced the final set of assay results from its initial exploration program at the Mann Property. A joint venture with Noble Mineral Exploration Inc., the Mann Property is located 22 kilometers east of Crawford, 20 kilometers south of Cochrane, and 45 kilometers northeast of Timmins, covering Mann Township. It contains three large ultramafic bodies: Mann Northwest, Mann Central and Mann Southeast. The announcement summarized results from drill programs at Mann Northwest and Mann Central that were completed during the summer of 2023 and indicated plans for drilling at Mann Southeast during the summer of 2024. “Mann is an exceptionally large property with ultramafic targets extending beyond the township from Reaume through Mann and into Newmarket with a combined target strike length of over 25 kilometers. All fifteen initial holes at these first two targets successfully intersected large intervals of target mineralization. This area will be a focus of our exploration program in 2024. Further details on our 2024 exploration program will be provided at a conference call on Friday, Feb. 23,” said Mark Shelby, CEO of Canada Nickel.

To view the full press release, visit https://ibn.fm/2mQ3O

About Canada Nickel Company Inc.

Canada Nickel is advancing the next generation of nickel- sulphide projects to deliver nickel required to feed the high-growth electric vehicle and stainless steel markets. Canada Nickel has applied in multiple jurisdictions to trademark the terms NetZero Nickel(TM), NetZero Cobalt(TM) and NetZero Iron(TM) and is pursuing the development of processes to allow the production of net-zero carbon nickel, cobalt and iron products. Canada Nickel provides investors with leverage to nickel in low political risk jurisdictions. Canada Nickel is currently anchored by its 100% owned flagship Crawford Nickel-Cobalt Sulphide Project in the heart of the prolific Timmins-Cochrane mining camp. For more information, please visit www.CanadaNickel.com.

NOTE TO INVESTORS: The latest news and updates relating to CNIKF are available in the company’s newsroom at https://ibn.fm/CNIKF

About InvestorWire

InvestorWire (“IW”) is a specialized communications platform with a focus on advanced wire-grade press release syndication for private and public companies and the investment community. It is one of 60+ brands within the Dynamic Brand Portfolio @ IBN that delivers: (1) access to a vast network of wire solutions via InvestorWire to efficiently and effectively reach a myriad of target markets, demographics and diverse industries; (2) article and editorial syndication to 5,000+ outlets; (3) enhanced press release enhancement to ensure maximum impact; (4) social media distribution via IBN to millions of social media followers; and (5) a full array of tailored corporate communications solutions. With broad reach and a seasoned team of contributing journalists and writers, IW is uniquely positioned to best serve private and public companies that want to reach a wide audience of investors, influencers, consumers, journalists and the general public. By cutting through the overload of information in today’s market, IW brings its clients unparalleled recognition and brand awareness. IW is where breaking news, insightful content and actionable information converge.

For more information, please visit https://www.InvestorWire.com

Please see full terms of use and disclaimers on the InvestorWire website applicable to all content provided by IW, wherever published or re-published: https://www.InvestorWire.com/Disclaimer

InvestorWire
Los Angeles, CA
www.InvestorWire.com
310.299.1717 Office
[email protected]

InvestorWire is powered by IBN

Save Foods (NASDAQ: SVFD), a pioneer agrifood tech company offering sustainable solutions for agriculture and plant-based food, announced that a subsidiary is officially changing its name. According to the announcement, wholly owned subsidiary Nitrousink Ltd. was granted approval from Israel’s Registrar of Companies to change its name to NTWO (“NTWO”) OFF Ltd. “NTWO OFF has identified and isolated two naturally occurring bacteria species that can reduce N2O emissions from wheat roots under various environmental conditions,” the company stated in the press release. “The R&D team at NTWO OFF is currently testing its technology under greenhouse conditions with the objective of locating the optimal formula for reducing N2O emission in wheat crops. NTWO OFF intends to continue its testing in micro field plots using different soils, dosages and formulations for a variety of crops, including corn and rice.”

To view the full press release, visit https://ibn.fm/x33sI

About Save Foods Inc.

Save Foods is an innovative agrifood tech company that through its operational arms — two majority-owned subsidiaries, Save Foods Ltd. and NTWO OFF Ltd., and minority-owned subsidiary Plantify Foods Inc. — delivers integrated solutions for improved safety, quality and sustainability every step of the way from field to fork. Save Foods Ltd., Save Foods’ majority-owned Israeli subsidiary, focuses on post-harvest treatments in fruit and vegetables to control and prevent pathogen contamination, significantly reduce the use of hazardous chemicals and prolong fresh produce’s shelf life. NTWO OFF, its other majority-owned Israeli subsidiary, contributes to tackling greenhouse gas emissions, offering a pioneering solution to mitigate nitrous oxide emissions, a potent greenhouse gas with 265 times the global warming impact of carbon dioxide. NTWO OFF aims to promote agricultural practices that are both environmentally friendly and economically viable. Plantify Foods, Save Foods’ minority-owned Canadian subsidiary, offers a wide range of clean-label healthy food options that are nutritious, gluten free and nonallergenic; that use whole natural ingredients; and that are easy to prepare. For more information about the company, visit www.SaveFoods.co.

NOTE TO INVESTORS: The latest news and updates relating to SVFD are available in the company’s newsroom at https://ibn.fm/SVFD

About InvestorWire

InvestorWire (“IW”) is a specialized communications platform with a focus on advanced wire-grade press release syndication for private and public companies and the investment community. It is one of 60+ brands within the Dynamic Brand Portfolio @ IBN that delivers: (1) access to a vast network of wire solutions via InvestorWire to efficiently and effectively reach a myriad of target markets, demographics and diverse industries; (2) article and editorial syndication to 5,000+ outlets; (3) enhanced press release enhancement to ensure maximum impact; (4) social media distribution via IBN to millions of social media followers; and (5) a full array of tailored corporate communications solutions. With broad reach and a seasoned team of contributing journalists and writers, IW is uniquely positioned to best serve private and public companies that want to reach a wide audience of investors, influencers, consumers, journalists and the general public. By cutting through the overload of information in today’s market, IW brings its clients unparalleled recognition and brand awareness. IW is where breaking news, insightful content and actionable information converge.

For more information, please visit https://www.InvestorWire.com

Please see full terms of use and disclaimers on the InvestorWire website applicable to all content provided by IW, wherever published or re-published: https://www.InvestorWire.com/Disclaimer

InvestorWire
Los Angeles, CA
www.InvestorWire.com
310.299.1717 Office
[email protected]

InvestorWire is powered by IBN

Standard Lithium (TSX.V: SLI) (NYSE American: SLI) (FRA: S5L), a leading near-commercial, lithium-development company, will be represented at three major industry events in the next few weeks. According to the announcement, members of the senior leadership team will be participating in the BMO 33rd Global Metals, Mining and Critical Minerals Conference; the BofA Global Agriculture and Materials Conference 2024; and the 36th annual Roth Conference. Standard Lithium CEO Robert Mintak will be presenting at the BMO Global Metals, Mining and Critical Minerals event, which is scheduled for Feb. 26–28, 2024; Mintak’s presentation is scheduled to begin at 10:45 a.m. ET on Feb. 27. Mintak will also be participating at the BofA Global Agriculture and Materials Conference, which is slated for Feb. 27–29, 2024; he will be involved in a panel discussion focused on lithium, which will begin at 8:20 a.m. ET on Feb. 29. Finally, SLI company officials will be participating at the 36th annual Roth Conference, which is scheduled for March 17–19, 2024, in Dana Point, California.

To view the full press release, visit https://ibn.fm/DGoLu

About Standard Lithium Ltd.

Standard Lithium is a leading near-commercial lithium development company focused on the sustainable development of a portfolio of lithium-brine bearing properties in the United States. The company prioritizes brine projects characterized by high-grade resources, robust infrastructure, skilled labor and streamlined permitting. The company aims to achieve sustainable, commercial-scale lithium production via the application of a scalable and fully integrated direct lithium extraction (“DLE”) and purification process. The company’s signature projects, the Phase 1A Project and the South West Arkansas Project, are located on the Smackover Formation in southern Arkansas, a region with a longstanding and established brine-processing industry. The company has also identified a number of highly prospective lithium brine project areas in the Smackover Formation in east Texas and has begun an extensive brine-leasing program in the key project areas. In addition, the company has an interest in certain mineral leases located in the Mojave Desert in San Bernardino County, California. For more information about the company, please visit www.StandardLithium.com.

NOTE TO INVESTORS: The latest news and updates relating to SLI are available in the company’s newsroom at https://ibn.fm/SLI

About InvestorWire

InvestorWire (“IW”) is a specialized communications platform with a focus on advanced wire-grade press release syndication for private and public companies and the investment community. It is one of 60+ brands within the Dynamic Brand Portfolio @ IBN that delivers: (1) access to a vast network of wire solutions via InvestorWire to efficiently and effectively reach a myriad of target markets, demographics and diverse industries; (2) article and editorial syndication to 5,000+ outlets; (3) enhanced press release enhancement to ensure maximum impact; (4) social media distribution via IBN to millions of social media followers; and (5) a full array of tailored corporate communications solutions. With broad reach and a seasoned team of contributing journalists and writers, IW is uniquely positioned to best serve private and public companies that want to reach a wide audience of investors, influencers, consumers, journalists and the general public. By cutting through the overload of information in today’s market, IW brings its clients unparalleled recognition and brand awareness. IW is where breaking news, insightful content and actionable information converge.

For more information, please visit https://www.InvestorWire.com

Please see full terms of use and disclaimers on the InvestorWire website applicable to all content provided by IW, wherever published or re-published: https://www.InvestorWire.com/Disclaimer

InvestorWire
Los Angeles, CA
www.InvestorWire.com
310.299.1717 Office
[email protected]

InvestorWire is powered by IBN

Predictive Oncology (NASDAQ: POAI), a leader in artificial intelligence (“AI”)-driven drug discovery and biologics, will be represented at three upcoming conferences: the BIO CEO & Investor Conference, the 2024 NeauxCancer Oncology Conference and H.C. Wainwright’s first Artificial Intelligence Based Drug Discovery & Development virtual conference. According to the announcement, POAI CEO Raymond F. Vennare will be presenting at all three events and will also be available for one-on-one meetings. Held in New York City, the BIO CEO & Investor Conference is slated for Feb. 26–27, 2024; Vennare’s presentation on Predictive Oncology will begin at 9 a.m. EST on Feb. 27. The 2024 NeauxCancer Oncology Conference will convene in New Orleans on Feb. 29–March 2, 2024. Vennare will be participating in both a company presentation and a panel discussion; the presentation is scheduled for 2:30 p.m. EST on March 1, and the Precision Medicine panel discussion will be held on March 2 at 12 p.m. ETS. The one-day H.C. Wainwright Artificial Intelligence Based Drug Discovery & Development Virtual Conference will feature a fireside chat by Vennare, which is scheduled for March 7, 2024, at 2 p.m. EST.

To view the full press release, visit https://ibn.fm/hHdfA

About Predictive Oncology Inc.

Predictive Oncology is on the cutting edge of the rapidly growing use of artificial intelligence (“AI”) and machine learning to expedite early drug discovery and enable drug development for the benefit of cancer patients worldwide. The company’s scientifically validated AI platform, PEDAL, is able to predict with 92% accuracy if a tumor sample will respond to a certain drug compound, allowing for a more informed selection of drug/tumor type combinations for subsequent in-vitro testing. With the company’s vast biobank of more than 150,000 assay-capable heterogenous human tumor samples, Predictive Oncology offers its academic and industry partners one of the industry’s broadest AI-based, drug-discovery solutions, further complemented by its wholly owned Clinical Laboratory Improvement Amendments (“CLIA”) lab and GMP facilities. For more information about the company, please visit www.Predictive-Oncology.com.

NOTE TO INVESTORS: The latest news and updates relating to POAI are available in the company’s newsroom at http://ibn.fm/POAI

About InvestorWire

InvestorWire (“IW”) is a specialized communications platform with a focus on advanced wire-grade press release syndication for private and public companies and the investment community. It is one of 60+ brands within the Dynamic Brand Portfolio @ IBN that delivers: (1) access to a vast network of wire solutions via InvestorWire to efficiently and effectively reach a myriad of target markets, demographics and diverse industries; (2) article and editorial syndication to 5,000+ outlets; (3) enhanced press release enhancement to ensure maximum impact; (4) social media distribution via IBN to millions of social media followers; and (5) a full array of tailored corporate communications solutions. With broad reach and a seasoned team of contributing journalists and writers, IW is uniquely positioned to best serve private and public companies that want to reach a wide audience of investors, influencers, consumers, journalists and the general public. By cutting through the overload of information in today’s market, IW brings its clients unparalleled recognition and brand awareness. IW is where breaking news, insightful content and actionable information converge.

For more information, please visit https://www.InvestorWire.com

Please see full terms of use and disclaimers on the InvestorWire website applicable to all content provided by IW, wherever published or re-published: https://www.InvestorWire.com/Disclaimer

InvestorWire
Los Angeles, CA
www.InvestorWire.com
310.299.1717 Office
[email protected]

InvestorWire is powered by IBN

• Despite a high interest rate environment, Hamptons-based real estate has shown remarkable resilience over the past year
• Median home sales prices in the Hamptons rose by 1.7% in 2023
• Mountain Top has partnered with On Site Builder Construction, a long-standing and reputed Hamptons-based developer to construct and market turnkey residential properties within the exclusive seaside enclave

Against a backdrop of slowing economic growth, rising interest rates and weak consumer sentiment, it comes as no surprise that the U.S. housing market was largely on hold in 2023. Residential transactions were forecast to have fallen by 37 percent in 2023, with commercial real estate suffering an even steeper decline in transaction volumes (https://ibn.fm/22gvk). Nonetheless and against that rather lackluster backdrop, one geography did stand out. Despite seeing a decline in year over year transaction volumes, median home sales prices across The Hamptons displayed remarkable resilience, rising by just under 2 percent in 2023 (https://ibn.fm/FsUzK).

The Hamptons has long been renowned for its high-end real estate market; notably, it was this very segment of the market which showed the most resilience over the past year. Despite seeing a 26 percent decline in year over year sales of individual properties, homes priced between…

Read More>>

NOTE TO INVESTORS: The latest news and updates relating to MTPP are available in the company’s newsroom at https://ibn.fm/MTPP

About InvestorWire

InvestorWire (“IW”) is a specialized communications platform with a focus on advanced wire-grade press release syndication for private and public companies and the investment community. It is one of 60+ brands within the Dynamic Brand Portfolio @ IBN that delivers: (1) access to a vast network of wire solutions via InvestorWire to efficiently and effectively reach a myriad of target markets, demographics and diverse industries; (2) article and editorial syndication to 5,000+ outlets; (3) enhanced press release enhancement to ensure maximum impact; (4) social media distribution via IBN to millions of social media followers; and (5) a full array of tailored corporate communications solutions. With broad reach and a seasoned team of contributing journalists and writers, IW is uniquely positioned to best serve private and public companies that want to reach a wide audience of investors, influencers, consumers, journalists and the general public. By cutting through the overload of information in today’s market, IW brings its clients unparalleled recognition and brand awareness. IW is where breaking news, insightful content and actionable information converge.

For more information, please visit https://www.InvestorWire.com

Please see full terms of use and disclaimers on the InvestorWire website applicable to all content provided by IW, wherever published or re-published: https://www.InvestorWire.com/Disclaimer

InvestorWire
Los Angeles, CA
www.InvestorWire.com
310.299.1717 Office
[email protected]

InvestorWire is powered by IBN

• The Venture Debt Conference is set for March 6, 2024, at the Edison Ballroom in Manhattan
• Now in its second year, this is the largest forum dedicated to non-dilutive financing strategies for emerging growth companies
• The conference also explores various forms of financing available to start-ups, including term loans, revenue-based financing, receivables financing and equipment financing, among others

Venture debt has rapidly grabbed attention as an attractive complement to venture capital funding for fast-growing start-ups. A catch-all term for loans designed to meet the unique needs of venture-backed start-ups in the innovation economy, venture debt has gained increasing popularity as a financing option for founders seeking to extend their runway, lower the cost of capital and most importantly, to thrive.

Venture debt can provide companies with an increased funding runway without the same level of dilution as an equity raise; better still, it is capital that founders can often employ to accelerate growth, achieve…

Read More>>

For additional details about the Venture Debt Conference, including registration, visit: www.VentureDebtConference.com.

About InvestorWire

InvestorWire (“IW”) is a specialized communications platform with a focus on advanced wire-grade press release syndication for private and public companies and the investment community. It is one of 60+ brands within the Dynamic Brand Portfolio @ IBN that delivers: (1) access to a vast network of wire solutions via InvestorWire to efficiently and effectively reach a myriad of target markets, demographics and diverse industries; (2) article and editorial syndication to 5,000+ outlets; (3) enhanced press release enhancement to ensure maximum impact; (4) social media distribution via IBN to millions of social media followers; and (5) a full array of tailored corporate communications solutions. With broad reach and a seasoned team of contributing journalists and writers, IW is uniquely positioned to best serve private and public companies that want to reach a wide audience of investors, influencers, consumers, journalists and the general public. By cutting through the overload of information in today’s market, IW brings its clients unparalleled recognition and brand awareness. IW is where breaking news, insightful content and actionable information converge.

For more information, please visit https://www.InvestorWire.com

Please see full terms of use and disclaimers on the InvestorWire website applicable to all content provided by IW, wherever published or re-published: https://www.InvestorWire.com/Disclaimer

InvestorWire
Los Angeles, CA
www.InvestorWire.com
310.299.1717 Office
[email protected]

InvestorWire is powered by IBN

Save Foods (NASDAQ: SVFD), a pioneer in sustainable solutions for agriculture and plant-based foods, has announced the newest member of its scientific advisory board. According to the announcement, Galit Kenigsberg, a member of Tel Aviv University’s Climate Center and CEO of the Sustainability Economic Development Corp., will head up sustainability operations on the board and will assist in achieving the company’s goal of joining the worldwide effort to achieve global net-zero goals. Founder of the Israeli Eco-Arena, Kenigsberg is a key leader at Nibbana-Group and has proven experience in climate crisis management in the business sector. The company is confident that her extensive expertise as a carbon trader and green-business-development specialist will strengthen and support its approach to sustainability and commitment to innovation and sustainability. “In the fight against climate change, there is a critical window of opportunity to decrease greenhouse gas emissions,” said Save Foods scientific advisory board member Galit Kenigsberg in the press release. “I am thrilled to collaborate with Save Foods and, specifically, its subsidiary Nitrousink. Moreover, I believe that Save Foods’ other subsidiaries, Save Foods Ltd. and Plantify Foods Inc., are also well-positioned to contribute substantially to these efforts by tackling the use of hazardous pesticides.”

To view the full press release, visit https://ibn.fm/kcw0G

About Save Foods Inc.

Save Foods is an innovative agrifood tech company that through its operational arms — two majority-owned subsidiaries, Save Foods Ltd. and Nitrousink Ltd., and minority-owned subsidiary Plantify Foods Inc. — delivers integrated solutions for improved safety, quality and sustainability every step of the way from field to fork. Save Foods Ltd., Save Foods’ majority-owned Israeli subsidiary, focuses on post-harvest treatments in fruit and vegetables to control and prevent pathogen contamination, significantly reduce the use of hazardous chemicals and prolong fresh produce’s shelf life. Nitrousink Ltd., another majority-owned Israeli subsidiary, contributes to tackling greenhouse gas emissions, offering a pioneering solution to mitigate nitrous oxide emissions, a potent greenhouse gas with 265 times the global warming impact of carbon dioxide. Nitrousink aims to promote agricultural practices that are both environmentally friendly and economically viable. Plantify Foods, Save Foods’ minority-owned Canadian subsidiary, offers a wide range of clean-label healthy food options that are nutritious, gluten free and nonallergenic; that use whole natural ingredients; and that are easy to prepare. For more information about the company, visit www.SaveFoods.co.

NOTE TO INVESTORS: The latest news and updates relating to SVFD are available in the company’s newsroom at https://ibn.fm/SVFD

About InvestorWire

InvestorWire (“IW”) is a specialized communications platform with a focus on advanced wire-grade press release syndication for private and public companies and the investment community. It is one of 60+ brands within the Dynamic Brand Portfolio @ IBN that delivers: (1) access to a vast network of wire solutions via InvestorWire to efficiently and effectively reach a myriad of target markets, demographics and diverse industries; (2) article and editorial syndication to 5,000+ outlets; (3) enhanced press release enhancement to ensure maximum impact; (4) social media distribution via IBN to millions of social media followers; and (5) a full array of tailored corporate communications solutions. With broad reach and a seasoned team of contributing journalists and writers, IW is uniquely positioned to best serve private and public companies that want to reach a wide audience of investors, influencers, consumers, journalists and the general public. By cutting through the overload of information in today’s market, IW brings its clients unparalleled recognition and brand awareness. IW is where breaking news, insightful content and actionable information converge.

For more information, please visit https://www.InvestorWire.com

Please see full terms of use and disclaimers on the InvestorWire website applicable to all content provided by IW, wherever published or re-published: https://www.InvestorWire.com/Disclaimer

InvestorWire
Los Angeles, CA
www.InvestorWire.com
310.299.1717 Office
[email protected]

InvestorWire is powered by IBN

Processa (NASDAQ: PCSA), a clinical-stage pharmaceutical company focused on developing the next generation of chemotherapeutic drugs to improve the efficacy and safety for patients suffering from cancer, today announced that its CEO George Ng will present a corporate update at the 2024 BIO CEO & Investor Conference. The event is slated to take place on Feb. 26 – 27, 2024, at the Marriott Marquis in New York City with Ng’s presentation scheduled to begin at 10 a.m. ET on Feb. 26. Interested parties should visit https://ibn.fm/lCCty to register for the conference.

To view the full press release, visit https://ibn.fm/3f0mD

About Processa Pharmaceuticals Inc.

Processa is a clinical stage pharmaceutical company focused on developing the Next Generation Chemotherapy (“NGC”) drugs to improve the safety and efficacy of cancer treatment. By combining Processa’s novel oncology pipeline with proven cancer-killing active molecules and Processa’s Regulatory Science Approach as well as experience in defining Optimal Dosage Regimens for FDA approvals, Processa not only will be providing better therapy options to cancer patients but also increasing the probability of FDA approval for its Next Generation Chemotherapy (“NGC”) drugs following an efficient path to approval. The company’s approach to drug development is based on more than 30 years of experience and uses its proven approach, including the determination of the Optimal Dosage Regimen using the principles of the FDA’s Project Optimus Oncology initiative. Processa’s NGC drugs are modifications of existing FDA-approved oncology drugs resulting in an alteration of the metabolism and/or distribution of these FDA-approved drugs while maintaining the existing mechanisms of killing the cancer cells. The advantages of Processa’s NGCs are expected to include fewer patients experiencing side effects that lead to dose discontinuation, more significant cancer response and a greater number of patients – over 250,000 patients treated each year for each drug — who will benefit from each NGC drug. Currently under development are three next generation chemotherapy oncology treatments: Next Generation Capecitabine (“PCS6422” and capecitabine to treat breast, metastatic colorectal, gastrointestinal, pancreatic, and other cancers), Next Generation Gemcitabine (“PCS3117” to treat pancreatic, lung, ovarian, breast, and other cancers), and Next Generation Irinotecan (“PCS11T” to treat lung, colorectal, gastrointestinal, pancreatic, and other cancers). For more information, visit the company’s website at www.ProcessaPharma.com.

NOTE TO INVESTORS: The latest news and updates relating to PCSA are available in the company’s newsroom at https://ibn.fm/PCSA

About InvestorWire

InvestorWire (“IW”) is a specialized communications platform with a focus on advanced wire-grade press release syndication for private and public companies and the investment community. It is one of 60+ brands within the Dynamic Brand Portfolio @ IBN that delivers: (1) access to a vast network of wire solutions via InvestorWire to efficiently and effectively reach a myriad of target markets, demographics and diverse industries; (2) article and editorial syndication to 5,000+ outlets; (3) enhanced press release enhancement to ensure maximum impact; (4) social media distribution via IBN to millions of social media followers; and (5) a full array of tailored corporate communications solutions. With broad reach and a seasoned team of contributing journalists and writers, IW is uniquely positioned to best serve private and public companies that want to reach a wide audience of investors, influencers, consumers, journalists and the general public. By cutting through the overload of information in today’s market, IW brings its clients unparalleled recognition and brand awareness. IW is where breaking news, insightful content and actionable information converge.

For more information, please visit https://www.InvestorWire.com

Please see full terms of use and disclaimers on the InvestorWire website applicable to all content provided by IW, wherever published or re-published: https://www.InvestorWire.com/Disclaimer

InvestorWire
Los Angeles, CA
www.InvestorWire.com
310.299.1717 Office
[email protected]

InvestorWire is powered by IBN

DarioHealth (NASDAQ: DRIO), a leader in the global digital health market, has acquired Twill Inc., a leader in digital-led care. According to the announcement, the acquisition will allow the company to “create one of the most comprehensive digital offerings in the market for chronic conditions, spanning a wide spectrum of health and well-being needs from emotional health to the costliest chronic conditions.” The company reported that the transaction creates immediate scale, with existing Twill customers including three of the top eight national health plans as well as several Fortune 100 employers and major pharmaceutical companies. The company projected that the acquisition will deliver several key results, including nearly doubling its pro forma revenues, accelerating market penetration and driving greater sales opportunities. In addition to the acquisition, the company also announced a $22.4 million private placement of convertible preferred stock, priced at the market under NASDAQ rules, with participation from investors from both companies. “The Twill acquisition is an incredible opportunity to bring together our complementary solutions and create an unrivaled platform for the next generation of consumer-centric digital health,” said DarioHealth CEO Erez Raphael in the press release.

“The addition of Twill instantly boosts revenue and margins, leveraging a robust SaaS-like model to fuel expected rapid growth and accelerating profitability. We are confident in our ability to integrate Twill and its employees and operations, as we have a track record of integrating previously acquired businesses. It’s rare to find not just alignment, but shared passion igniting a collaboration. That’s exactly what we’ve discovered in Twill. Their dedication to consumer empowerment through technology mirrors our own, making this union not just a strategic move but a powerful convergence of values and goals. This unwavering belief resonated with both companies’ shareholders, leading to shareholders from both companies participating in the financing. It’s an injection of not just capital, but confidence in the future we’re building together. With this strengthened foundation, we’re poised to aggressively pursue our growth plan, fueled by a shared vision and the passion of investors and executives alike.”

To view the full press release, visit https://ibn.fm/g9VLn

About DarioHealth Corp.

DarioHealth Corp. is a leading digital health company revolutionizing how people with chronic conditions manage their health through a user-centric, multichronic condition digital therapeutics platform. Dario’s platform and suite of solutions deliver personalized and dynamic interventions driven by data analytics and one-on-one coaching for diabetes, hypertension, weight management, musculoskeletal pain and behavioral health. The company’s user-centric platform offers people continuous and customized care for health, disrupting the traditional episodic approach to healthcare. This approach empowers people to holistically adapt their lifestyles for sustainable behavior change, driving exceptional user satisfaction, retention and results, and making the right thing to do the easy thing to do. Dario provides its highly user-rated solutions globally to health plans and other payors, self-insured employers and providers of care as well as directly to consumers. For more information about the company, please visit www.DarioHealth.com.

NOTE TO INVESTORS: The latest news and updates relating to DRIO are available in the company’s newsroom at http://ibn.fm/DRIO

About InvestorWire

InvestorWire (“IW”) is a specialized communications platform with a focus on advanced wire-grade press release syndication for private and public companies and the investment community. It is one of 60+ brands within the Dynamic Brand Portfolio @ IBN that delivers: (1) access to a vast network of wire solutions via InvestorWire to efficiently and effectively reach a myriad of target markets, demographics and diverse industries; (2) article and editorial syndication to 5,000+ outlets; (3) enhanced press release enhancement to ensure maximum impact; (4) social media distribution via IBN to millions of social media followers; and (5) a full array of tailored corporate communications solutions. With broad reach and a seasoned team of contributing journalists and writers, IW is uniquely positioned to best serve private and public companies that want to reach a wide audience of investors, influencers, consumers, journalists and the general public. By cutting through the overload of information in today’s market, IW brings its clients unparalleled recognition and brand awareness. IW is where breaking news, insightful content and actionable information converge.

For more information, please visit https://www.InvestorWire.com

Please see full terms of use and disclaimers on the InvestorWire website applicable to all content provided by IW, wherever published or re-published: https://www.InvestorWire.com/Disclaimer

InvestorWire
Los Angeles, CA
www.InvestorWire.com
310.299.1717 Office
[email protected]

InvestorWire is powered by IBN

• Arizona-based SenesTech Inc., is dramatically improving pest management technicians’ toolbox with its patent-pending Evolve(R) soft bait birth control product for rodents
• SenesTech’s Evolve(R) product joins the liquid ContraPest(TM) product in providing a non-lethal solutions to reducing rodent populations
• The company’s CEO and CFO recently appeared virtually at the Lytham Partners 2024 Investor Select Conference, participating in a fireside chat interview and meeting one-on-one with potential investors
• SenesTech also recently announced increased distribution of its product in partnership with Poppe Enterprises LLC, — a company that serves the grain management market in Nebraska, South Dakota, North Dakota, Kansas, Wyoming, Iowa, and Colorado

The chief officers of enterprising rodent control company SenesTech (NASDAQ: SNES) participated in a fireside chat interview detailing the company’s operations and also met with potential investors one-on-one at this month’s virtual Lytham Partners 2024 Investor Select Conference.

CEO Joel Fruendt and CFO Tom Chesterman enjoyed the opportunity to discuss the breakout success of its non-lethal Evolve(TM) Soft Bait product following on the heels of successful implementation of its original liquid bait formulation ContraPest(R), which, like Evolve(TM), is designed to reduce…

Read More>>

NOTE TO INVESTORS: The latest news and updates relating to SNES are available in the company’s newsroom at https://ibn.fm/SNES

About InvestorWire

InvestorWire (“IW”) is a specialized communications platform with a focus on advanced wire-grade press release syndication for private and public companies and the investment community. It is one of 60+ brands within the Dynamic Brand Portfolio @ IBN that delivers: (1) access to a vast network of wire solutions via InvestorWire to efficiently and effectively reach a myriad of target markets, demographics and diverse industries; (2) article and editorial syndication to 5,000+ outlets; (3) enhanced press release enhancement to ensure maximum impact; (4) social media distribution via IBN to millions of social media followers; and (5) a full array of tailored corporate communications solutions. With broad reach and a seasoned team of contributing journalists and writers, IW is uniquely positioned to best serve private and public companies that want to reach a wide audience of investors, influencers, consumers, journalists and the general public. By cutting through the overload of information in today’s market, IW brings its clients unparalleled recognition and brand awareness. IW is where breaking news, insightful content and actionable information converge.

For more information, please visit https://www.InvestorWire.com

Please see full terms of use and disclaimers on the InvestorWire website applicable to all content provided by IW, wherever published or re-published: https://www.InvestorWire.com/Disclaimer

InvestorWire
Los Angeles, CA
www.InvestorWire.com
310.299.1717 Office
[email protected]

InvestorWire is powered by IBN

Infobird (NASDAQ: IFBD), a software-as-a-service provider of innovative AI-powered, or artificial-intelligence-enabled, customer engagement solutions, will be effecting a planned 1-for-8 shared consolidation of its ordinary shares. The share consolidation was approved at the company’s extraordinary general meetings of the shareholders, which was held on Feb. 20, 2024, in Hong Kong. Other items that were approved at the meeting include a capital reduction and share capital reorganization. According to the announcement, the company’s ordinary shares will begin trading on a post-share consolidation basis with market open on Feb. 27, 2024. The move was approved as the company is focused on regaining compliance with NASDAQ market requirements. When the share consolidation takes effect, every eight ordinary shares of a par value of $0.5 each will be consolidated into one ordinary share of a par value of $4 each. The announcement also noted that the capital reduction will become effective when the Grand Court of the Cayman Islands grants a court order approving the move. “After the capital reduction and reorganization, our ordinary shares will have the same voting rights and rights to dividends and distributions and will be identical in all other respects to our ordinary shares now authorized,” the company stated in the press release. “The share consolidation and the capital reduction and reorganization was approved by the company’s board of directors on Jan. 10, 2024, and its shareholders on Feb. 20, 2024.”

To view the full press release, visit https://ibn.fm/UqXVe

About Infobird Software Co. Ltd.

Infobird is a software-as-a-service (“SaaS”) provider of innovative artificial intelligence (“AI”)-powered or AI-enabled customer-engagement solutions. For more information about the company, visit www.Infobird.com.

NOTE TO INVESTORS: The latest news and updates relating to IFBD are available in the company’s newsroom at https://ibn.fm/IFBD

About InvestorWire

InvestorWire (“IW”) is a specialized communications platform with a focus on advanced wire-grade press release syndication for private and public companies and the investment community. It is one of 60+ brands within the Dynamic Brand Portfolio @ IBN that delivers: (1) access to a vast network of wire solutions via InvestorWire to efficiently and effectively reach a myriad of target markets, demographics and diverse industries; (2) article and editorial syndication to 5,000+ outlets; (3) enhanced press release enhancement to ensure maximum impact; (4) social media distribution via IBN to millions of social media followers; and (5) a full array of tailored corporate communications solutions. With broad reach and a seasoned team of contributing journalists and writers, IW is uniquely positioned to best serve private and public companies that want to reach a wide audience of investors, influencers, consumers, journalists and the general public. By cutting through the overload of information in today’s market, IW brings its clients unparalleled recognition and brand awareness. IW is where breaking news, insightful content and actionable information converge.

For more information, please visit https://www.InvestorWire.com

Please see full terms of use and disclaimers on the InvestorWire website applicable to all content provided by IW, wherever published or re-published: https://www.InvestorWire.com/Disclaimer

InvestorWire
Los Angeles, CA
www.InvestorWire.com
310.299.1717 Office
[email protected]

InvestorWire is powered by IBN

Knightscope (NASDAQ: KSCP), a leading innovator in robotics and artificial intelligence (“AI”) technologies focused on public safety, is appointing new members of its board of directors. According to the announcement, the board will be comprised of Knightscope chair, president and CEO William Santana Li with the addition of three new board members: William G. Billings, Robert A. Mocny and Melvin W. Torrie. The new members succeed departing board members Patricia Howell, Linda Keene Solomon and Patricia L. Watkins.

A finance executive who joined GlobalFoundries (“GF”) in 2021 as its vice president of finance and chief accounting officer, Billings is responsible for overseeing GlobalFoundries global finance and accounting operations; he is also focused on enhancing the company’s financial organization at the functional, cultural and strategic levels. He has worked at Airbnb, where he led global operations, and World Fuel Services, where he served as a vice president and global controller.

Mocny brings more than 30 years of experience to his new role as a KSCP board member. He served as an inspector with the Immigration and Naturalization Service (“INS”) before moving to the Department of Homeland Security (“DHS”) where he reached the senior executive service level. Mocny served as deputy director and director of the United States Visitor and Immigrant Status Indicator Technology program, where he oversaw the implementation of the world’s largest biometrics program in response to the September 11 terrorist attacks; he also served as chief technology officer at the Federal Protective Service.

A professor at Utah State University and an expert in NASA Space Shuttle payloads, Torrie has extensive experience in autonomous vehicle development, which ultimately led to the spinout of Autonomous Solutions Inc. (“ASI”), a company focused on making driverless vehicles a reality in industries such as agriculture, mining, construction and logistics. Torrie served as ASI CEO and chair, and has been instrumental in piloting robotic development partnerships with some of the largest vehicle manufacturers in the world, including John Deere, Case, New Holland, Ford, Chrysler, Komatsu, Doosan and Toyota.

“Our departing directors have my deepest gratitude for their years of service on our board,” said Knightscope chair, president and CEO William Santana Li in the press release. “With our new directors, our board perfectly aligns with Knightscope’s position as a technology leader in public safety with a skill mix comprised of financial acumen, autonomous technology and deep expertise in the federal sector. I’m excited about Knightscope’s future and this new chapter aligned with our roadmap to profitable growth.”

To view the full press release, visit https://ibn.fm/TdiqT

About Knightscope, Inc.

Knightscope builds cutting-edge technologies to improve public safety. The company’s long-term ambition is to make the United States of America the safest country in the world. For more information about the company, please visit www.Knightscope.com.

NOTE TO INVESTORS: The latest news and updates relating to KSCP are available in the company’s newsroom at https://ibn.fm/KSCP

About InvestorWire

InvestorWire (“IW”) is a specialized communications platform with a focus on advanced wire-grade press release syndication for private and public companies and the investment community. It is one of 60+ brands within the Dynamic Brand Portfolio @ IBN that delivers: (1) access to a vast network of wire solutions via InvestorWire to efficiently and effectively reach a myriad of target markets, demographics and diverse industries; (2) article and editorial syndication to 5,000+ outlets; (3) enhanced press release enhancement to ensure maximum impact; (4) social media distribution via IBN to millions of social media followers; and (5) a full array of tailored corporate communications solutions. With broad reach and a seasoned team of contributing journalists and writers, IW is uniquely positioned to best serve private and public companies that want to reach a wide audience of investors, influencers, consumers, journalists and the general public. By cutting through the overload of information in today’s market, IW brings its clients unparalleled recognition and brand awareness. IW is where breaking news, insightful content and actionable information converge.

For more information, please visit https://www.InvestorWire.com

Please see full terms of use and disclaimers on the InvestorWire website applicable to all content provided by IW, wherever published or re-published: https://www.InvestorWire.com/Disclaimer

InvestorWire
Los Angeles, CA
www.InvestorWire.com
310.299.1717 Office
[email protected]

InvestorWire is powered by IBN

Vstock Transfer, a leading SEC-registered stock transfer firm known for its expertise in servicing private companies, IPOs and issuers listed on NYSE American, NASDAQ and OTC Markets, is sponsoring the 36th annual ROTH Conference. The conference is slated for March 17–19, 2024, in Dana Point, California. According to the announcement, the ROTH Conference has established a reputation for creating exclusive events that connect investors with private and public companies from diverse growth sectors, including consumer, technology and media, sustainability and industrial growth, agtech, energy, metals and mining, healthcare, services and insurance. The gathering includes both one-on-one and small-group meetings along with company presentations, analyst-selected fireside chats and industry panels; the event is also an ideal opportunity for networking, entertainment and athletic charity events. As a sponsor, Vstock Transfer will have an opportunity to showcasing its comprehensive range of services. “We are excited to sponsor the 36th annual ROTH Conference,” said VStock Transfer managing director Lisa Loew in the press release. “This event offers a unique chance for us to engage directly with the capital markets community and contribute to meaningful conversations around growth and innovation in the financial sector.”

To view the full press release, visit https://ibn.fm/eSbWs

About Vstock Transfer

Vstock Transfer is an SEC-registered stock transfer firm serving private companies, IPOs and issuers listed on NYSE American, NASDAQ and OTC markets. Vstock Transfer is owned and managed by attorneys and a team of professionals who have spent their careers working with issuers on all aspects of initial public offerings, follow-on public offerings, private placements, Reg A, proxy solicitations, DTC eligibility, SPACs, reverse mergers and stock transfers. For more information about the company, please visit www.VstockTransfer.com.

About InvestorWire

InvestorWire (“IW”) is a specialized communications platform with a focus on advanced wire-grade press release syndication for private and public companies and the investment community. It is one of 60+ brands within the Dynamic Brand Portfolio @ IBN that delivers: (1) access to a vast network of wire solutions via InvestorWire to efficiently and effectively reach a myriad of target markets, demographics and diverse industries; (2) article and editorial syndication to 5,000+ outlets; (3) enhanced press release enhancement to ensure maximum impact; (4) social media distribution via IBN to millions of social media followers; and (5) a full array of tailored corporate communications solutions. With broad reach and a seasoned team of contributing journalists and writers, IW is uniquely positioned to best serve private and public companies that want to reach a wide audience of investors, influencers, consumers, journalists and the general public. By cutting through the overload of information in today’s market, IW brings its clients unparalleled recognition and brand awareness. IW is where breaking news, insightful content and actionable information converge.

For more information, please visit https://www.InvestorWire.com

Please see full terms of use and disclaimers on the InvestorWire website applicable to all content provided by IW, wherever published or re-published: https://www.InvestorWire.com/Disclaimer

InvestorWire
Los Angeles, CA
www.InvestorWire.com
310.299.1717 Office
[email protected]

InvestorWire is powered by IBN

Mountain Top Properties (OTC: MTPP), a diversified real estate holding company, secured debt capital commitments covering 70% of the acquisition and 100% of the construction costs for its Hamptons development projects. “MTPP recently partnered with On-Site Builder Construction Co. Inc. to acquire and develop projects in the Hamptons… Through its subsidiary Mountain Top Capital Fund I, MTPP aims to raise $75 million to renovate and remarket properties in the Hamptons, using $10 million to explore additional opportunities in the area. The estimated target return for each investment is 20-30% with an anticipated timeline of 15-18 months for each transaction. MTPP has additionally filed a Regulation A offering to raise up to $10 million through the issuance of common stock… Mountain Top Properties diversifies its portfolio through investments in property technology (‘PropTech’) and acquiring mixed-use real estate in the tri-state area,” a recent article reads. “This company is really focused on two main sectors, which are real estate/real property development and property technology,” said MTPP CEO Beau Kelley. “We see that the property technology side of things is really a massive, growing opportunity to be able to expedite finance and payment methods and shipping routes, and so many things we can help out from a logistics standpoint.”

To view the full article, visit https://ibn.fm/OKZiF

About Mountain Top Properties Inc.

Mountain Top Properties is a diversified real estate holding company that acquires, sells and operates assets through its wholly owned subsidiaries and limited partnerships. The company specializes in property management, property technology (“PropTech”) and real estate redevelopment. Mountain Top Properties was incorporated in 1990 and is based in Liverpool, New York, with offices in Sag Harbor, New York. For more information, visit the company’s website at www.Mountain-Top-Properties.com.

NOTE TO INVESTORS: The latest news and updates relating to MTPP are available in the company’s newsroom at https://ibn.fm/MTPP

About InvestorWire

InvestorWire (“IW”) is a specialized communications platform with a focus on advanced wire-grade press release syndication for private and public companies and the investment community. It is one of 60+ brands within the Dynamic Brand Portfolio @ IBN that delivers: (1) access to a vast network of wire solutions via InvestorWire to efficiently and effectively reach a myriad of target markets, demographics and diverse industries; (2) article and editorial syndication to 5,000+ outlets; (3) enhanced press release enhancement to ensure maximum impact; (4) social media distribution via IBN to millions of social media followers; and (5) a full array of tailored corporate communications solutions. With broad reach and a seasoned team of contributing journalists and writers, IW is uniquely positioned to best serve private and public companies that want to reach a wide audience of investors, influencers, consumers, journalists and the general public. By cutting through the overload of information in today’s market, IW brings its clients unparalleled recognition and brand awareness. IW is where breaking news, insightful content and actionable information converge.

For more information, please visit https://www.InvestorWire.com

Please see full terms of use and disclaimers on the InvestorWire website applicable to all content provided by IW, wherever published or re-published: https://www.InvestorWire.com/Disclaimer

InvestorWire
Los Angeles, CA
www.InvestorWire.com
310.299.1717 Office
[email protected]

Golden Matrix Group (NASDAQ: GMGI), a developer, licensor and global operator of online gaming and eCommerce platforms, systems and gaming content, today announced that its CEO Brian Goodman will be hosted by JRC Stock Talk, a leading platform for insightful investor discussions. Goodman will participate in an exclusive Q&A session, slated to take place at 4:30 PM EST on Tuesday, Feb. 20, 2024, on X (formerly Twitter) Spaces, X’s platform for audio chats. The event will provide investors a unique opportunity to gain valuable insights into Golden Matrix Group’s growth trajectory and positioning as one of the world’s leading iGaming groups, offering casino, sportsbook and competition products. The announcement provides details for interested parties to join the Live Q&A Session.

To view the full press release, visit https://ibn.fm/OsfEB

About Golden Matrix Group Inc.

Golden Matrix Group, based in Las Vegas, Nevada, is an established business-to-business (“B2B”) and business-to-consumer (“B2C”) gaming technology company operating across multiple international markets. The B2B division of Golden Matrix develops and licenses proprietary gaming platforms for its extensive list of clients and RKings, its B2C division, operates a high-volume eCommerce site enabling end users to enter paid-for competitions on its proprietary platform in authorized markets. The company also owns and operates MEXPLAY, a regulated online casino in Mexico. The company’s sophisticated software automatically declines any gaming or redemption requests from within the United States, in strict compliance with current U.S. law.

NOTE TO INVESTORS: The latest news and updates relating to GMGI are available in the company’s newsroom at https://ibn.fm/GMGI

About InvestorWire

InvestorWire (“IW”) is a specialized communications platform with a focus on advanced wire-grade press release syndication for private and public companies and the investment community. It is one of 60+ brands within the Dynamic Brand Portfolio @ IBN that delivers: (1) access to a vast network of wire solutions via InvestorWire to efficiently and effectively reach a myriad of target markets, demographics and diverse industries; (2) article and editorial syndication to 5,000+ outlets; (3) enhanced press release enhancement to ensure maximum impact; (4) social media distribution via IBN to millions of social media followers; and (5) a full array of tailored corporate communications solutions. With broad reach and a seasoned team of contributing journalists and writers, IW is uniquely positioned to best serve private and public companies that want to reach a wide audience of investors, influencers, consumers, journalists and the general public. By cutting through the overload of information in today’s market, IW brings its clients unparalleled recognition and brand awareness. IW is where breaking news, insightful content and actionable information converge.

For more information, please visit https://www.InvestorWire.com

Please see full terms of use and disclaimers on the InvestorWire website applicable to all content provided by IW, wherever published or re-published: https://www.InvestorWire.com/Disclaimer

InvestorWire
Los Angeles, CA
www.InvestorWire.com
310.299.1717 Office
[email protected]

InvestorWire is powered by IBN

Cboe Canada is welcoming back the Canadian Imperial Bank of Commerce (“CIBC”) for the listing of seven new Canadian Depositary Receipts (“CDRs”). According to the announcement, with these additional listings, CIBC has expanded its existing CDR line-up to 54 blue-chip U.S. public companies. CDRs, which were launched in 2021 and are available at a fraction of the price per share of the underlying stock, offer Canadian investors easier access to cross-border investing. The seven new CDRs now trading on Cboe Canada include BlackRock CDR (BLK: AQL), Constellation Brands CDR (STZ: AQL), Deere CDR (DEER: AQL), lululemon CDR (LULU: AQL), Palo Alto Networks CDR (PANW: AQL), ServiceNow CDR (NOWS: AQL) and Thermo Fisher CDR (TMO: AQL). The new tickers join other popular U.S. stocks already trading as CDRs on Cboe Canada.

“CDRs are a made-in-Canada success story demonstrating clear and continued investor interest as a result of the success of the existing lineup,” said Cboe Canada chief revenue officer Erik Sloane in the press release. “Through CDRs, investors gain easy access to some of the largest companies in the world. We are incredibly excited to continue the innovation and collaboration with CIBC as we work to meet the demands of Canadian investors.” 

To view the full press release, visit https://ibn.fm/j5e5K

About Cboe Canada

Cboe Canada is home to more than 260 unique listings, including Canadian Depositary Receipts (“CDRs”), ETFs from Canada’s largest ETF issuers and some of the most innovative Canadian and international growth companies. In Canada, Cboe consistently facilitates more than 20% of all volume traded in Canadian ETFs and more than 15% of all volume traded in Canadian-listed companies. Cboe Canada is Canada’s Tier 1 stock exchange for the purpose-driven innovation economy, providing a best-in-class listing experience for issuers that are shaping the economies of tomorrow. Fully operational since 2015, Cboe Canada lists investment products and companies seeking an internationally recognized stock exchange that enables investor trust, quality liquidity and broad awareness including unfettered access to market data. Cboe Canada is part of the Cboe Global Markets network, leveraging deep international expertise, industry-leading market intelligence and technology, and unparalleled service to deliver what stakeholders and the world need now and for the future. For more information, please visit www.Cboe.ca.

About InvestorWire

InvestorWire (“IW”) is a specialized communications platform with a focus on advanced wire-grade press release syndication for private and public companies and the investment community. It is one of 60+ brands within the Dynamic Brand Portfolio @ IBN that delivers: (1) access to a vast network of wire solutions via InvestorWire to efficiently and effectively reach a myriad of target markets, demographics and diverse industries; (2) article and editorial syndication to 5,000+ outlets; (3) enhanced press release enhancement to ensure maximum impact; (4) social media distribution via IBN to millions of social media followers; and (5) a full array of tailored corporate communications solutions. With broad reach and a seasoned team of contributing journalists and writers, IW is uniquely positioned to best serve private and public companies that want to reach a wide audience of investors, influencers, consumers, journalists and the general public. By cutting through the overload of information in today’s market, IW brings its clients unparalleled recognition and brand awareness. IW is where breaking news, insightful content and actionable information converge.

For more information, please visit https://www.InvestorWire.com

Please see full terms of use and disclaimers on the InvestorWire website applicable to all content provided by IW, wherever published or re-published: https://www.InvestorWire.com/Disclaimer

InvestorWire
Los Angeles, CA
www.InvestorWire.com
310.299.1717 Office
[email protected]

InvestorWire is powered by IBN

Canada Nickel (TSX.V: CNC) (OTCQX: CNIKF), a company that is advancing the next generation of nickel-sulphide projects, is reporting on the successful completion of its initial infill drilling at its wholly owned Bannockburn Property “B” Zone. The company also noted that its 2024 summer drill program will complete the drill program in preparation for an initial resource later this year. In addition, the company has scheduled a webcast and conference call to discuss its 2024 exploration program. The call is slated for Feb. 23, 2024, at 11 a.m. ET. Those interested can dial 416-764-8688 (local Toronto participants) or 1-888-390-0546 (toll free, North America). “The five Canada Nickel holes drilled to infill the ‘B’ Zone successfully intersected multihundred meter intervals of 0.27–0.29% nickel and, more importantly, each contained higher grade intervals of 0.3% nickel or better,” said Canada Nickel CEO Mark Selby in the press release. “The Bannockburn ‘B’ Zone has now been tested for its total 1.1-kilometer strike length with multiple intervals in excess of 0.3% nickel from both previous and current drilling. Bannockburn is highly complementary to our southern cluster of properties at Sothman, Midlothian, Van Hise and Powell.”

To view the webcast, visit https://ibn.fm/AhMyO

To view the full release, visit https://ibn.fm/wsr4R

About Canada Nickel Company Inc.

Canada Nickel is advancing the next generation of nickel-sulphide projects to deliver nickel required to feed the high-growth electric vehicle and stainless-steel markets. Canada Nickel has applied in multiple jurisdictions to trademark the terms NetZero Nickel(TM), NetZero Cobalt(TM) and NetZero Iron(TM), and is pursuing the development of processes to allow the production of net-zero carbon nickel, cobalt and iron products. Canada Nickel provides investors with leverage to nickel in low political-risk jurisdictions. Canada Nickel is currently anchored by its 100% owned flagship Crawford Nickel-Cobalt Sulphide Project in the heart of the prolific Timmins-Cochrane mining camp. For more information about the company, visit www.CanadaNickel.com.

NOTE TO INVESTORS: The latest news and updates relating to CNIKF are available in the company’s newsroom at https://ibn.fm/CNIKF

About InvestorWire

InvestorWire (“IW”) is a specialized communications platform with a focus on advanced wire-grade press release syndication for private and public companies and the investment community. It is one of 60+ brands within the Dynamic Brand Portfolio @ IBN that delivers: (1) access to a vast network of wire solutions via InvestorWire to efficiently and effectively reach a myriad of target markets, demographics and diverse industries; (2) article and editorial syndication to 5,000+ outlets; (3) enhanced press release enhancement to ensure maximum impact; (4) social media distribution via IBN to millions of social media followers; and (5) a full array of tailored corporate communications solutions. With broad reach and a seasoned team of contributing journalists and writers, IW is uniquely positioned to best serve private and public companies that want to reach a wide audience of investors, influencers, consumers, journalists and the general public. By cutting through the overload of information in today’s market, IW brings its clients unparalleled recognition and brand awareness. IW is where breaking news, insightful content and actionable information converge.

For more information, please visit https://www.InvestorWire.com

Please see full terms of use and disclaimers on the InvestorWire website applicable to all content provided by IW, wherever published or re-published: https://www.InvestorWire.com/Disclaimer

InvestorWire
Los Angeles, CA
www.InvestorWire.com
310.299.1717 Office
[email protected]

InvestorWire is powered by IBN

CISO Global Inc. (NASDAQ: CISO), an industry leader as a managed cybersecurity and compliance provider (“MSSP”), has received an independent valuation of its initial IP Solutions Portfolio by a global leader in valuation, corporate finance and restructuring. According to the announcement, the valuation includes four IP solutions, which reflect the company’s push into delivering software-first solutions. The solutions include the company’s Skanda7 Breach Assessment Tool, CISO Edge Cloud Security Platform, CHECKLIGHT(R) Endpoint Security Monitoring and DISC VPN. Each of the solutions are powered by artificial intelligence (“AI”), neural nets and the latest generation of algorithms.

Skanda7 Breach Assessment Tool is a next-generation analysis tool that looks beyond vulnerabilities found by most other technology to deliver continuous security assessments. CISO Edge Cloud Security Platform is a cloud-first security solution focused on protecting users from untrusted, malicious online threats. CHECKLIGHT Endpoint Security Monitoring is a powerful security monitoring software that detects possible threats to networks and provides advance alerts. DISC VPN is a token exchange-protected remote access solution that replaces traditional VPN connections with enhanced security and access verification.

“This valuation is representative of our commitment to our clients, is unparalleled, and we continue to innovate by delivering high value, software-first solutions based on AI, ML and advanced algorithms,” said CISO Global CEO David Jemmett in the press release. “By leveraging the latest technology advances coupled with our threat intel team, we are providing unique and actionable intelligence to our clients. These solutions are now being deployed and are strengthening the security posture of our clients. CISO Global will continue to disrupt the status quo by delivering new IP already in development.”

To view the full press release, visit https://ibn.fm/n4Dk6

About CISO Global Inc.

CISO Global is based in Scottsdale, Arizona, and is a top 25 managed cybersecurity and compliance services provider that is delivering innovative solutions through its newly developed artificial intelligence (“AI”) and machine-learning (“ML”)-powered product portfolio. The company protects the most demanding businesses and government organizations against continuing and emerging security threats and ensures their compliance obligations are being met.mFor more information about the company, visit www.CISO.inc.

NOTE TO INVESTORS: The latest news and updates relating to CISO are available in the company’s newsroom at https://ibn.fm/CISO

About InvestorWire

InvestorWire (“IW”) is a specialized communications platform with a focus on advanced wire-grade press release syndication for private and public companies and the investment community. It is one of 60+ brands within the Dynamic Brand Portfolio @ IBN that delivers: (1) access to a vast network of wire solutions via InvestorWire to efficiently and effectively reach a myriad of target markets, demographics and diverse industries; (2) article and editorial syndication to 5,000+ outlets; (3) enhanced press release enhancement to ensure maximum impact; (4) social media distribution via IBN to millions of social media followers; and (5) a full array of tailored corporate communications solutions. With broad reach and a seasoned team of contributing journalists and writers, IW is uniquely positioned to best serve private and public companies that want to reach a wide audience of investors, influencers, consumers, journalists and the general public. By cutting through the overload of information in today’s market, IW brings its clients unparalleled recognition and brand awareness. IW is where breaking news, insightful content and actionable information converge.

For more information, please visit https://www.InvestorWire.com

Please see full terms of use and disclaimers on the InvestorWire website applicable to all content provided by IW, wherever published or re-published: https://www.InvestorWire.com/Disclaimer

InvestorWire
Los Angeles, CA
www.InvestorWire.com
310.299.1717 Office
[email protected]

InvestorWire is powered by IBN

Lottery.com (NASDAQ: LTRY, LTRYW), a leading online lottery services provider, has announced that the legal action alleging proxy misstatements filed in federal court by Woodford Eurasia Assets Ltd against Lottery.com and the individual members of the company’s board of directors has been voluntarily dismissed without prejudice by Woodford. The notice of voluntary dismissal was filed by Woodford in the United States District Court for the District of Delaware on Feb. 14, 2024, in Case No. 23-1317-GBW. “We are pleased to put this matter behind us. This resolution allows us to focus on our mission to offer innovative solutions in the lottery industry and to transform the sports media and entertainment arena with sports.com. We can now get back to focusing on providing value for our customers and stakeholders,” said Matthew McGahan, chairman of Lottery.com and Sports.com. “We remain committed to operating with the highest standards of integrity and look forward to continuing our work in revolutionizing the lottery and sports media experience worldwide. I would like to express my gratitude to our legal advisors, my fellow board directors and all those who have supported the company through this process.”

To view the full press release, visit https://ibn.fm/Wq0ET

About Lottery.com Inc.

Lottery.com is a leading technology company that is transforming how, where and when lottery is played. Its engaging mobile and online platforms enable players and commercial partners located in the United States and internationally to remotely purchase legally sanctioned lottery games. Fans and subscribers look to Lottery.com for compelling, real-time results on more than 800 lottery games from more than 40 countries. Additionally, through WinTogether.org, Lottery.com is fundamentally changing how non-profit donors are incentivized to action by gamifying charitable giving. In all that it does, Lottery.com’s mission remains the same: an uncompromising passion to innovate, grow a new demographic of enthusiasts, deliver responsible and trusted solutions, and promote community and philanthropic initiatives. For more information about the company, visit www.Lottery.com.

NOTE TO INVESTORS: The latest news and updates relating to LTRY are available in the company’s newsroom at https://ibn.fm/LTRY

About InvestorWire

InvestorWire (“IW”) is a specialized communications platform with a focus on advanced wire-grade press release syndication for private and public companies and the investment community. It is one of 60+ brands within the Dynamic Brand Portfolio @ IBN that delivers: (1) access to a vast network of wire solutions via InvestorWire to efficiently and effectively reach a myriad of target markets, demographics and diverse industries; (2) article and editorial syndication to 5,000+ outlets; (3) enhanced press release enhancement to ensure maximum impact; (4) social media distribution via IBN to millions of social media followers; and (5) a full array of tailored corporate communications solutions. With broad reach and a seasoned team of contributing journalists and writers, IW is uniquely positioned to best serve private and public companies that want to reach a wide audience of investors, influencers, consumers, journalists and the general public. By cutting through the overload of information in today’s market, IW brings its clients unparalleled recognition and brand awareness. IW is where breaking news, insightful content and actionable information converge.

For more information, please visit https://www.InvestorWire.com

Please see full terms of use and disclaimers on the InvestorWire website applicable to all content provided by IW, wherever published or re-published: https://www.InvestorWire.com/Disclaimer

InvestorWire
Los Angeles, CA
www.InvestorWire.com
310.299.1717 Office
[email protected]

InvestorWire is powered by IBN

• The Activist Investor Conference will take place on March 21, 2024, at 237 Park Avenue, one of Manhattan’s premiere meeting venues
• The 14th annual edition of the conference features investors, corporate board members and governance experts, advisory firms, proxy solicitors and finance professionals who will delve into the latest trends within shareholder activism
• This year’s conference features a number of keynote presentations by experts in the field, including Patrice Bonfiglio, Sean Donohue, and Jon Feldman

Shareholder activism emerged in the 1970s and 1980s as a tool to drive the process of price formation, improve corporate governance and defend minority shareholder interests. Today, in a market environment characterized by a surge in the number of passive investors and a reduction in the diversity of research and market participants, the importance of shareholder activism may be greater than ever.

Corporate engagement and shareholder activism has become increasingly crucial within the context of…

Read More>>

For additional details about the Activist Investor Conference, including registration, visit: https://www.activistinvestorconference.com.

About InvestorWire

InvestorWire (“IW”) is a specialized communications platform with a focus on advanced wire-grade press release syndication for private and public companies and the investment community. It is one of 60+ brands within the Dynamic Brand Portfolio @ IBN that delivers: (1) access to a vast network of wire solutions via InvestorWire to efficiently and effectively reach a myriad of target markets, demographics and diverse industries; (2) article and editorial syndication to 5,000+ outlets; (3) enhanced press release enhancement to ensure maximum impact; (4) social media distribution via IBN to millions of social media followers; and (5) a full array of tailored corporate communications solutions. With broad reach and a seasoned team of contributing journalists and writers, IW is uniquely positioned to best serve private and public companies that want to reach a wide audience of investors, influencers, consumers, journalists and the general public. By cutting through the overload of information in today’s market, IW brings its clients unparalleled recognition and brand awareness. IW is where breaking news, insightful content and actionable information converge.

For more information, please visit https://www.InvestorWire.com

Please see full terms of use and disclaimers on the InvestorWire website applicable to all content provided by IW, wherever published or re-published: https://www.InvestorWire.com/Disclaimer

InvestorWire
Los Angeles, CA
www.InvestorWire.com
310.299.1717 Office
[email protected]

InvestorWire is powered by IBN

Lucy Scientific Discovery (NASDAQ: LSDI), a company dedicated to advancing the understanding and applications of psychotropic medicines, improving mental-health outcomes, and enhancing well-being for individuals worldwide announces will affect a one-for-ten reverse split of its common shares. According to the announcement, LSDI is hoping the reverse split will help the company regain compliance with NASDAQ’s $1 minimum bid price requirement. The reverse share will become effective on Feb. 26, 2024, with shares expected to begin trading on the split-adjusted basis on the NASDAQ Stock Exchange. “On the effective date, every 10 issued and outstanding shares of the company’s common stock will be converted automatically into one share of the company’s common stock without any change in the par value per share,” stated Lucy Scientific Discovering in the press release.

To view the full press release, visit https://ibn.fm/CKzqI

About Lucy Scientific Discovery Inc.

Lucy Scientific Discovery is a NASDAQ-listed company with holdings and operations in a variety of psychotropic businesses. Lucy Scientific Discovery is dedicated to advancing the understanding and applications of psychotropic medicines, improving mental-health outcomes and enhancing well-being for individuals worldwide. For more information, visit the company’s website at www.LucyScientific.com.

NOTE TO INVESTORS: The latest news and updates relating to LSDI are available in the company’s newsroom at https://ibn.fm/LSDI

About InvestorWire

InvestorWire (“IW”) is a specialized communications platform with a focus on advanced wire-grade press release syndication for private and public companies and the investment community. It is one of 60+ brands within the Dynamic Brand Portfolio @ IBN that delivers: (1) access to a vast network of wire solutions via InvestorWire to efficiently and effectively reach a myriad of target markets, demographics and diverse industries; (2) article and editorial syndication to 5,000+ outlets; (3) enhanced press release enhancement to ensure maximum impact; (4) social media distribution via IBN to millions of social media followers; and (5) a full array of tailored corporate communications solutions. With broad reach and a seasoned team of contributing journalists and writers, IW is uniquely positioned to best serve private and public companies that want to reach a wide audience of investors, influencers, consumers, journalists and the general public. By cutting through the overload of information in today’s market, IW brings its clients unparalleled recognition and brand awareness. IW is where breaking news, insightful content and actionable information converge.

For more information, please visit https://www.InvestorWire.com

Please see full terms of use and disclaimers on the InvestorWire website applicable to all content provided by IW, wherever published or re-published: https://www.InvestorWire.com/Disclaimer

InvestorWire
Los Angeles, CA
www.InvestorWire.com
310.299.1717 Office
[email protected]

InvestorWire is powered by IBN

IGC Pharma (NYSE American: IGC), a clinical-stage pharmaceutical company, is reporting financial results and business updates for the third fiscal quarter of 2024, the period ended Dec. 31, 2023. Highlights of the report include the company receiving a patent from the European Patent Office covering a method for treating pain in humans and a patent from the Divisional Direction of Patents, Mexico, for a treatment of Alzheimer’s disease; in addition, the company entered an agreement with the University of Los Andes to research and study initiatives in artificial intelligence and machine learning. Financial numbers of note include approximately $204 thousand in revenue for the quarter, a 38% decrease compared to the three months ended Dec. 31, 2022, and an estimated $1.05 million in revenues generated for the nine months ended Dec. 31, 2023, an increase of 40% compares to the same period in 2022; selling, general and administrative expenses for the period reached approximately $2.2 million; research and development expenses came in at approximately $903 thousand; and net loss for the three-month period was an estimated $5.5 million, or $0.09 per share, compared to some $2.2 million, or $0.04 per share, for three months ended Dec. 31, 2022.

The report indicated current cash and cash equivalents is sufficient to support operations beyond the 12 months following the date the consolidated financial statements and footnotes were issued. “We are proud to share that our company is making progress with our lead asset, IGC-AD1, which is currently in a phase 2b trial for the treatment of agitation in dementia due to Alzheimer’s,” said IGC Pharma CEO Ram Mukunda in the press release. “We are working hard to obtain interim results in 2024. We estimate that in North America and Europe about 11 million Alzheimer’s patients have neuropsychiatric symptoms including agitation. With modest pricing and conservative market penetration IGC-AD1 can potentially be a blockbuster drug.”

To view the full press release, visit https://ibn.fm/XNQpz

About IGC Pharma

IGC Pharma is pursuing innovative solutions to fight Alzheimer’s disease and related challenges. The company’s portfolio comprises five assets, all with a singular mission: to transform the landscape of Alzheimer’s treatment. IGC-AD1 and LMP target neuroinflammation, Aβ plaques and neurofibrillary tangles. IGC-AD1 is currently in a phase 2b clinical trial for agitation in dementia due to Alzheimer’s. TGR-63 targets Aβ plaque to disrupt the progression of Alzheimer’s disease. IGC-M3 targets the inhibition of Aβ plaque aggregation with the potential to create a profound impact on early-stage Alzheimer’s. IGC-1C targets tau and neurofibrillary tangles as a forward-thinking approach to Alzheimer’s therapy. In parallel, IGC Pharma is at the forefront of generative AI development, with projects including clinical trials, early detection of Alzheimer’s and drug interactions with cannabinoids. For more information, visit the company’s website at www.IGCInc.us.

NOTE TO INVESTORS: The latest news and updates relating to IGC are available in the company’s newsroom at https://ibn.fm/IGC

About InvestorWire

InvestorWire (“IW”) is a specialized communications platform with a focus on advanced wire-grade press release syndication for private and public companies and the investment community. It is one of 60+ brands within the Dynamic Brand Portfolio @ IBN that delivers: (1) access to a vast network of wire solutions via InvestorWire to efficiently and effectively reach a myriad of target markets, demographics and diverse industries; (2) article and editorial syndication to 5,000+ outlets; (3) enhanced press release enhancement to ensure maximum impact; (4) social media distribution via IBN to millions of social media followers; and (5) a full array of tailored corporate communications solutions. With broad reach and a seasoned team of contributing journalists and writers, IW is uniquely positioned to best serve private and public companies that want to reach a wide audience of investors, influencers, consumers, journalists and the general public. By cutting through the overload of information in today’s market, IW brings its clients unparalleled recognition and brand awareness. IW is where breaking news, insightful content and actionable information converge.

For more information, please visit https://www.InvestorWire.com

Please see full terms of use and disclaimers on the InvestorWire website applicable to all content provided by IW, wherever published or re-published: https://www.InvestorWire.com/Disclaimer

InvestorWire
Los Angeles, CA
www.InvestorWire.com
310.299.1717 Office
[email protected]

InvestorWire is powered by IBN

Tonix Pharmaceuticals Holding (NASDAQ: TNXP), a biopharmaceutical company with marketed products and a pipeline of development candidates, today announced participation at the 2024 BIO CEO & Investor Conference. According to the announcement, Tonix’s President and CEO, Seth Lederman, M.D., will present at the event, with his presentation scheduled for February 26, 2024, at 1:30 p.m. ET in New York City.

To view the full press release, visit https://ibn.fm/p9Sx1

About Tonix Pharmaceuticals Holding Corp.

Tonix is a biopharmaceutical company focused on commercializing, developing, discovering and licensing therapeutics to treat and prevent human disease and alleviate suffering. Tonix’s development portfolio is focused on central nervous system disorders. Tonix’s priority is to submit a New Drug Application (“NDA”) to the FDA for Tonmya, which has completed two positive Phase 3 studies for the management of fibromyalgia. Tonix intends to meet with the FDA in the first half of 2024 and submit an NDA for the approval of Tonmya for the management of fibromyalgia in the second half of 2024. TNX-102 SL is being developed to treat fibromyalgia-type Long COVID, a chronic post-acute COVID-19 condition, and topline results from a proof-of-concept study were reported in the third quarter of 2023. TNX-1300 (cocaine esterase) is a biologic designed to treat cocaine intoxication and has been granted Breakthrough Therapy designation by the FDA. A Phase 2 study of TNX-1300 is expected to be initiated in the first quarter of 2024. Tonix’s rare disease development portfolio includes TNX-2900 (intranasal potentiated oxytocin) for the treatment of Prader-Willi syndrome (“PWS”). TNX-2900 has been granted Orphan Drug designation by the FDA and an investigational new drug (“IND”) application has been cleared to support a Phase 2 study in PWS patients. Tonix’s immunology development portfolio includes biologics to address organ transplant rejection, autoimmunity and cancer, including TNX-1500, which is a humanized monoclonal antibody targeting CD40-ligand (“CD40L” or “CD154”) being developed for the prevention of allograft rejection and for the treatment of autoimmune diseases. A Phase 1 study of TNX-801 was initiated in the third quarter of 2023. Tonix’s infectious disease pipeline includes TNX-801, a vaccine in development to prevent smallpox and mpox. TNX-801 also serves as the live virus vaccine platform or recombinant pox vaccine platform for other infectious diseases, including TNX-1800, in development as a vaccine to protect against COVID-19. During the fourth quarter of 2023, TNX-1800 was selected by the U.S. National Institutes of Health (“NIH”), National Institute of Allergy and Infectious Diseases (“NIAID”) Project NexGen for inclusion in Phase 1 clinical trials. The infectious disease development portfolio includes TNX-3900 and TNX-4000, which are classes of broad-spectrum small molecule oral antivirals. Tonix Medicines, the company’s commercial subsidiary, markets Zembrace(R) SymTouch(R) (sumatriptan injection) 3 mg and Tosymra(R) (sumatriptan nasal spray) 10 mg under a transition services agreement with Upsher-Smith Laboratories, LLC from whom the products were acquired on June 30, 2023. Zembrace SymTouch and Tosymra are each indicated for the treatment of acute migraine with or without aura in adults. For more information about Tonix, visit www.tonixpharma.com.

About InvestorWire

InvestorWire (“IW”) is a specialized communications platform with a focus on advanced wire-grade press release syndication for private and public companies and the investment community. It is one of 60+ brands within the Dynamic Brand Portfolio @ IBN that delivers: (1) access to a vast network of wire solutions via InvestorWire to efficiently and effectively reach a myriad of target markets, demographics and diverse industries; (2) article and editorial syndication to 5,000+ outlets; (3) enhanced press release enhancement to ensure maximum impact; (4) social media distribution via IBN to millions of social media followers; and (5) a full array of tailored corporate communications solutions. With broad reach and a seasoned team of contributing journalists and writers, IW is uniquely positioned to best serve private and public companies that want to reach a wide audience of investors, influencers, consumers, journalists and the general public. By cutting through the overload of information in today’s market, IW brings its clients unparalleled recognition and brand awareness. IW is where breaking news, insightful content and actionable information converge.

For more information, please visit https://www.InvestorWire.com

Please see full terms of use and disclaimers on the InvestorWire website applicable to all content provided by IW, wherever published or re-published: https://www.InvestorWire.com/Disclaimer

InvestorWire
Los Angeles, CA
www.InvestorWire.com
310.299.1717 Office
[email protected]

InvestorWire is powered by IBN

SenesTech (NASDAQ: SNES), the leader in fertility control to manage animal-pest populations, will be reporting its financial results for its fourth quarter and fiscal year 2023, or the period ended Dec. 31, 2023. The company has scheduled the release of the report for after market close on Feb. 21, 2024. In addition to releasing the report, the company has scheduled a teleconference for that same date to review the report; the call will begin at 5 p.m. ET. Those interested in participating in the call can dial (844) 308-3351 or (412) 317-5407. A replay of the teleconference will be available for seven days following the event; those interested in viewing the replay can dial (877) 344-7529 or (412) 317-0088, using replay access code 3232725.

To view the live webcast, visit https://ibn.fm/EI3H4

To view the full press release, visit https://ibn.fm/1WmVL

About SenesTech Inc.

SenesTech is committed to improving the health of the world by humanely managing animal-pest populations through fertility control. SenesTech is an expert in fertility control to manage animal pest populations. The company invented ContraPest, the only U.S. EPA-registered contraceptive for male and female rats, and Evolve, an EPA-designated minimum-risk contraceptive currently offered for rats. ContraPest and Evolve fit seamlessly into all integrated pest-management programs, significantly improving the overall goal of effective pest management. The company strives for clean cities, efficient businesses and happy households by providing a product designed to be humane, effective and sustainable. For more information about the company, please visit www.SenesTech.com.

NOTE TO INVESTORS: The latest news and updates relating to SNES are available in the company’s newsroom at https://ibn.fm/SNES

About InvestorWire

InvestorWire (“IW”) is a specialized communications platform with a focus on advanced wire-grade press release syndication for private and public companies and the investment community. It is one of 60+ brands within the Dynamic Brand Portfolio @ IBN that delivers: (1) access to a vast network of wire solutions via InvestorWire to efficiently and effectively reach a myriad of target markets, demographics and diverse industries; (2) article and editorial syndication to 5,000+ outlets; (3) enhanced press release enhancement to ensure maximum impact; (4) social media distribution via IBN to millions of social media followers; and (5) a full array of tailored corporate communications solutions. With broad reach and a seasoned team of contributing journalists and writers, IW is uniquely positioned to best serve private and public companies that want to reach a wide audience of investors, influencers, consumers, journalists and the general public. By cutting through the overload of information in today’s market, IW brings its clients unparalleled recognition and brand awareness. IW is where breaking news, insightful content and actionable information converge.

For more information, please visit https://www.InvestorWire.com

Please see full terms of use and disclaimers on the InvestorWire website applicable to all content provided by IW, wherever published or re-published: https://www.InvestorWire.com/Disclaimer

InvestorWire
Los Angeles, CA
www.InvestorWire.com
310.299.1717 Office
[email protected]

InvestorWire is powered by IBN

Battery Mineral Resources (TSX.V: BMR) (OTCQB: BTRMF) (“BMR”), a company providing shareholders exposure to the global megatrend of electrification while being focused on growth through cash flow, exploration and acquisitions in favorable mining jurisdictions, has closed the third and final tranche of a previously announced private placement of senior unsecured convertible debentures. The company raised gross proceeds of US$1,000,000 (C$1,349,300) from the third tranche, bringing the aggregate raised under the offering to US$4,285,000 (C$5,881,091). Battery Mineral Resources had raised gross proceeds of US$1,370,000 (C$1,871,557) from the first tranche of the offering, which closed on Oct. 19, 2023, and gross proceeds of US$1,915,000 (C$2,660,234) from the second tranche, which closed on Nov. 3, 2023. According to the announcement, the company intends to apply the proceeds from the debentures toward working capital and the restart of copper concentrate production at its Punitaqui copper project in Chile.

To view the full press release, visit https://ibn.fm/zv3Tz

About Battery Mineral Resources Corp.

Battery Mineral Resources is a battery minerals company providing shareholders exposure to the global megatrend of electrification while being focused on growth through cash flow, exploration and acquisitions in favorable mining jurisdictions. Battery Mineral’s mission is the discovery, acquisition and development of battery metals (namely cobalt, lithium, graphite and copper) in North America, South America and South Korea, and to become a premier and responsible supplier of battery minerals to the electrification marketplace. BMR is currently pursuing a near-term resumption of operations of the Punitaqui Mining Complex, a past copper-gold-silver producer in the Coquimbo region of Chile. BMR is the largest mineral claim holder in the historic Gowganda Cobalt-Silver Camp in Ontario, Canada, and continues to pursue a focused program to build on the recently announced, +1-million-pound high-grade cobalt resource at McAra. In addition, Battery Mineral owns 100% of ESI Energy Services Inc. (including ESI’s wholly owned USA operating subsidiary, Ozzie’s, Inc.), a profitable mainline pipeline and renewable energy equipment rental and sales company with operations in Alberta, Canada, and Arizona, USA. Battery Mineral Resources is based in Canada and its shares are listed on the TSX Venture Exchange under the symbol BMR and on the OTCQB under the symbol BTRMF. Further information about BMR and its projects can be found at www.BMRCorp.com.

NOTE TO INVESTORS: The latest news and updates relating to BTRMF are available in the company’s newsroom at https://ibn.fm/BTRMF

About InvestorWire

InvestorWire (“IW”) is a specialized communications platform with a focus on advanced wire-grade press release syndication for private and public companies and the investment community. It is one of 60+ brands within the Dynamic Brand Portfolio @ IBN that delivers: (1) access to a vast network of wire solutions via InvestorWire to efficiently and effectively reach a myriad of target markets, demographics and diverse industries; (2) article and editorial syndication to 5,000+ outlets; (3) enhanced press release enhancement to ensure maximum impact; (4) social media distribution via IBN to millions of social media followers; and (5) a full array of tailored corporate communications solutions. With broad reach and a seasoned team of contributing journalists and writers, IW is uniquely positioned to best serve private and public companies that want to reach a wide audience of investors, influencers, consumers, journalists and the general public. By cutting through the overload of information in today’s market, IW brings its clients unparalleled recognition and brand awareness. IW is where breaking news, insightful content and actionable information converge.

For more information, please visit https://www.InvestorWire.com

Please see full terms of use and disclaimers on the InvestorWire website applicable to all content provided by IW, wherever published or re-published: https://www.InvestorWire.com/Disclaimer

InvestorWire
Los Angeles, CA
www.InvestorWire.com
310.299.1717 Office
[email protected]

InvestorWire is powered by IBN

Infobird (NASDAQ: IFBD), a software-as-a-service provider of AI-powered customer engagement solutions in China, is announcing that its management team has decided not to carry out any financing activities in the next three months. The company has raised some operating funds in previous financing activities that will help Infobird expand its business. The decision follows consultations with previous investors and is intended to better protect the interests of the company’s small and medium shareholders, Infobird said in the announcement. Infobird’s management team expressed its appreciation for potential investors’ continued attention and interest in the company.

To view the full press release, visit https://ibn.fm/7sYm3

About Infobird Co. Ltd.

Infobird, headquartered in Hong Kong, is a software-as-a-service provider of innovative AI-powered, or artificial intelligence-enabled, customer engagement solutions. For more information, visit Infobird’s website at www.Infobird.com.

NOTE TO INVESTORS: The latest news and updates relating to IFBD are available in the company’s newsroom at https://ibn.fm/IFBD

About InvestorWire

InvestorWire (“IW”) is a specialized communications platform with a focus on advanced wire-grade press release syndication for private and public companies and the investment community. It is one of 60+ brands within the Dynamic Brand Portfolio @ IBN that delivers: (1) access to a vast network of wire solutions via InvestorWire to efficiently and effectively reach a myriad of target markets, demographics and diverse industries; (2) article and editorial syndication to 5,000+ outlets; (3) enhanced press release enhancement to ensure maximum impact; (4) social media distribution via IBN to millions of social media followers; and (5) a full array of tailored corporate communications solutions. With broad reach and a seasoned team of contributing journalists and writers, IW is uniquely positioned to best serve private and public companies that want to reach a wide audience of investors, influencers, consumers, journalists and the general public. By cutting through the overload of information in today’s market, IW brings its clients unparalleled recognition and brand awareness. IW is where breaking news, insightful content and actionable information converge.

For more information, please visit https://www.InvestorWire.com

Please see full terms of use and disclaimers on the InvestorWire website applicable to all content provided by IW, wherever published or re-published: https://www.InvestorWire.com/Disclaimer

InvestorWire
Los Angeles, CA
www.InvestorWire.com
310.299.1717 Office
[email protected]

InvestorWire is powered by IBN

Lottery.com (NASDAQ: LTRY), a leading online lottery services provider, has acquired S&MI Ltd., or SportLocker. According to the announcement, with the stock-based acquisition complete, SportLocker will be rebranded as Sports.com and will immediately launch as a premier platform for sports fans worldwide. The company noted that the transition marks “a pivotal leap in Sports.com’s evolution as the next-gen digital sports entertainment space.” The new platform will feature innovative community-driven aspects along with expansive content and technology. The company plans to roll out Sports.com in the United States and Europe first, along with concentrated efforts in the Middle East. Ultimately, the strategy includes a global expansion targeting high-energy sports such as soccer, motor racing, football, baseball, basketball, MMA, boxing, cricket, golf, field and ice hockey, and tennis. This global direction underscores Sports.com’s commitment to driving growth in higher-value territories and underserved markets. The announcement noted that a core strategy behind the acquisition of SportLocker and subsequent rebranding includes leveraging already-established partnerships with mobile network operators (“MNOs”) to offer localized branded sports content services.

“This acquisition is of great strategic importance to our group, and we are delighted to unveil Sports.com to the world with a revolutionary vision that will transform how fans engage with sports,” said Lottery.com chair and CEO Matthew McGahan in the press release. “By integrating SportLocker’s robust MNO partnerships, localized content services and community-focused features with enhanced content and technology, we are creating a dynamic ecosystem where fans can not only consume sports but also connect and create in ways never before offered to the mass of sports fans worldwide. We are positioning Sports.com to offer sports fans an unparalleled year-round experience. The introduction of our media platform is just a glimpse of how we intend to bring fans closer to the sports they love.”

To view the full press release, visit https://ibn.fm/NOLQZ

About Lottery.com Inc.

Lottery.com is a leading technology company that is transforming how, where and when lotteries are played. Its engaging mobile and online platforms enable players and commercial partners located throughout the United States and other countries to remotely purchase legally sanctioned lottery games. Fans and subscribers look to Lottery.com for compelling, real-time results on more than 800 lottery games from more than 40 countries. Additionally, through WinTogether.org, Lottery.com is fundamentally changing how nonprofit donors are incentivized to action by gamifying charitable giving. In all that it does, Lottery.com’s mission remains the same: an uncompromising passion to innovate, grow a new demographic of enthusiasts, deliver responsible and trusted solutions, and promote community and philanthropic initiatives. To learn more about the company, visit www.Lottery.com.

NOTE TO INVESTORS: The latest news and updates relating to Lottery are available in the company’s newsroom at https://ibn.fm/Lottery

About InvestorWire

InvestorWire (“IW”) is a specialized communications platform with a focus on advanced wire-grade press release syndication for private and public companies and the investment community. It is one of 60+ brands within the Dynamic Brand Portfolio @ IBN that delivers: (1) access to a vast network of wire solutions via InvestorWire to efficiently and effectively reach a myriad of target markets, demographics and diverse industries; (2) article and editorial syndication to 5,000+ outlets; (3) enhanced press release enhancement to ensure maximum impact; (4) social media distribution via IBN to millions of social media followers; and (5) a full array of tailored corporate communications solutions. With broad reach and a seasoned team of contributing journalists and writers, IW is uniquely positioned to best serve private and public companies that want to reach a wide audience of investors, influencers, consumers, journalists and the general public. By cutting through the overload of information in today’s market, IW brings its clients unparalleled recognition and brand awareness. IW is where breaking news, insightful content and actionable information converge.

For more information, please visit https://www.InvestorWire.com

Please see full terms of use and disclaimers on the InvestorWire website applicable to all content provided by IW, wherever published or re-published: https://www.InvestorWire.com/Disclaimer

InvestorWire
Los Angeles, CA
www.InvestorWire.com
310.299.1717 Office
[email protected]

InvestorWire is powered by IBN

Datasea (NASDAQ: DTSS) is a Nevada incorporated digital technology corporation engaged in innovative business segments for intelligent acoustics and 5G multimodal communication technology in China. The company has announced that on Feb. 2, 2024, Guozhong Times (Beijing) Technology Ltd., a subsidiary of the Chinese operating company contractually controlled by Datasea, has entered into a cooperation agreement with Hangzhou Chongda Technology Co., Ltd. (“Chongda”) to increase the sales of 5G multimodal communication services in China. “We are pleased to enter into this new collaboration as it will help to identify potential customers that need our 5G multimodal communication delivery services and enable us to quickly roll out our unique platform to new customers,” said Datasea CEO Zhixin Liu. “We believe that Datasea can capitalize on more opportunities of this nature to generate revenue and it is in line with our mission to become a leading provider of digital technology solutions as well as our unwavering commitment to the 5G multimodal communication market in China. At the same time, the company is negotiating with major potential clients of 5G multimodal communication services and expects to reach more agreements.”

To view the full press release, visit https://ibn.fm/o3rFE

About Datasea Inc.

Datasea is a leading provider of products, services and solutions for enterprise and retail customers in innovative industries, intelligent acoustics and 5G multimodal communication, especially focusing on ultrasonic, infrasound and directional sound technology. The company’s advanced R&D technology serves as the core infrastructure and backbone for its products. Its 5G multimodal communication segment operates on a cloud platform based on AI. Datasea leverages cutting-edge technologies in intelligent acoustics, utilizing ultrasonic sterilization to combat viruses and prevent human infections, and is also developing innovations in directional sound and medical ultrasonic cosmetology. In July 2023, Datasea established a wholly owned subsidiary, Datasea Acoustics LLC, in Delaware, in a strategic move to mark its global presence. This underlies Datasea’s commitment to intelligent acoustics and its intent to offer leading edge acoustic solutions to the U.S. market. For additional information about the company, visit www.DataseaInc.com.

About InvestorWire

InvestorWire (“IW”) is a specialized communications platform with a focus on advanced wire-grade press release syndication for private and public companies and the investment community. It is one of 60+ brands within the Dynamic Brand Portfolio @ IBN that delivers: (1) access to a vast network of wire solutions via InvestorWire to efficiently and effectively reach a myriad of target markets, demographics and diverse industries; (2) article and editorial syndication to 5,000+ outlets; (3) enhanced press release enhancement to ensure maximum impact; (4) social media distribution via IBN to millions of social media followers; and (5) a full array of tailored corporate communications solutions. With broad reach and a seasoned team of contributing journalists and writers, IW is uniquely positioned to best serve private and public companies that want to reach a wide audience of investors, influencers, consumers, journalists and the general public. By cutting through the overload of information in today’s market, IW brings its clients unparalleled recognition and brand awareness. IW is where breaking news, insightful content and actionable information converge.

For more information, please visit https://www.InvestorWire.com

Please see full terms of use and disclaimers on the InvestorWire website applicable to all content provided by IW, wherever published or re-published: https://www.InvestorWire.com/Disclaimer

InvestorWire
Los Angeles, CA
www.InvestorWire.com
310.299.1717 Office
[email protected]

InvestorWire is powered by IBN

Pressure BioSciences (OTCQB: PBIO), a leading innovator in high-pressure nanotechnology and a pioneer in the development of novel, broadly enabling, pressure-based instruments and nanoemulsion products and services for the health and wellness, food and beverage, pharmaceutical, and other industries, has achieved a significant milestone in its accelerating growth journey. The company has consolidated its Boston-area operations, uniting all of its personnel into a single Boston location. The new facility includes product manufacturing suites, an advanced R&D laboratory, state-of-the-art equipment manufacturing, formulation services and a demo lab designed to showcase PBIO’s cutting-edge UltraShear technology platform, allowing stakeholders to witness the platform’s potential firsthand. According to the announcement, consolidating R&D with all other departments of the company will streamline and achieve new production efficiencies as well as reduce costs and foster innovation by creating a collaborative work environment. “We are very excited about the opportunities this consolidation and expansion presents,” said Pressure BioSciences director of business development Ken Micciche in the press release. “The move reinforces our commitment to accelerating development and production capabilities, delivering exceptional products and services, advancing the field of high-pressure nanotechnology, fostering collaborations with academic and industry partners, and supporting our expected explosive growth in the direct-to-consumer area, led by our newly acquired subsidiary company Uncle Bud’s Health & Wellness.”

To view the full press release, visit https://ibn.fm/vT2t3

About Pressure BioSciences Inc.

Pressure BioSciences is a global leader in providing innovative, broadly enabling, high-pressure-based solutions for a range of industries, including biotechnology, pharmaceutical, nutraceutical, cosmeceutical and agrochemical, as well as food and beverage manufacturing. PBIO’s patented enabling platform, Pressure Cycling Technology (“PCT”), utilizes alternating cycles of pressure to control biomolecular interactions (such as cell lysis and biomolecule extraction) safely and reproducibly. PCT-based products are used for biomarker and target discovery, drug design and development, biotherapeutics characterization and quality control, soil and plant biology, forensics and counterbioterrorism applications. The company’s patented BaroFold(TM) technology platform allows PBIO to enter the biopharma contract services and GMP manufacturing equipment sector. PBIO has also developed the scalable and high-efficiency pressure-based UltraShear Technology(TM) platform, which allows for the creation of stable nanoemulsions of otherwise immiscible fluids. It also allows for the preparation of higher quality, homogenized, extended shelf-life or room-temperature-stable, low-acid liquid foods that cannot be effectively preserved using existing nonthermal technologies. The company’s commitment to innovation and cutting-edge technology has established PBIO as a leader in the high-pressure industry, providing unique and effective solutions to its customers. For more information, visit the company website at www.PressureBioSciences.com.

NOTE TO INVESTORS: The latest news and updates relating to PBIO are available in the company’s newsroom at http://ibn.fm/PBIO

About InvestorWire

InvestorWire (“IW”) is a specialized communications platform with a focus on advanced wire-grade press release syndication for private and public companies and the investment community. It is one of 60+ brands within the Dynamic Brand Portfolio @ IBN that delivers: (1) access to a vast network of wire solutions via InvestorWire to efficiently and effectively reach a myriad of target markets, demographics and diverse industries; (2) article and editorial syndication to 5,000+ outlets; (3) enhanced press release enhancement to ensure maximum impact; (4) social media distribution via IBN to millions of social media followers; and (5) a full array of tailored corporate communications solutions. With broad reach and a seasoned team of contributing journalists and writers, IW is uniquely positioned to best serve private and public companies that want to reach a wide audience of investors, influencers, consumers, journalists and the general public. By cutting through the overload of information in today’s market, IW brings its clients unparalleled recognition and brand awareness. IW is where breaking news, insightful content and actionable information converge.

For more information, please visit https://www.InvestorWire.com

Please see full terms of use and disclaimers on the InvestorWire website applicable to all content provided by IW, wherever published or re-published: https://www.InvestorWire.com/Disclaimer

InvestorWire
Los Angeles, CA
www.InvestorWire.com
310.299.1717 Office
[email protected]

InvestorWire is powered by IBN

Vstock Transfer, a premier stock-transfer agent serving nearly 1,000 issuers, is expanding its services designed specifically for initial public offerings (I”POs”) and existing public companies. Vstock’s expanded offerings include shareholder meeting services, virtual meeting administration, proxy tabulation, document web hosting, inspector of election services, and notice and access material distribution. The new offerings reflect the company’s mission, which is to serve as a robust resource for companies and shareholders with a comprehensive suite of services designed to streamline processes, ensure compliance and foster confidence at every stage of the capital markets journey. The announcement noted the company’s introduction of a a comprehensive, compliant and user-friendly IR widget investor solution that supports better communication with current and potential investors through corporate websites. The platform streamlines a variety of financial data, including stock price, volume, dividends, earnings reports and press releases, in real-time or with minimal delay.

“Even after 12 years, we are still innovating and rolling out new technology,” said Vstock Transfer CEO Yoel Goldfeder in the press release. “Our team is dedicated to supporting management teams and shareholders throughout the entire meeting process, from planning and execution to participation and post-meeting follow-up.”

To view the full press release, visit https://ibn.fm/UcjbS

About Vstock Transfer

Vstock Transfer is an SEC-registered stock transfer firm serving private companies, IPOs and issuers listed on NYSE American, NASDAQ and OTC markets. Vstock Transfer is owned and managed by attorneys and a team of professionals who have spent their careers working with issuers on all aspects of initial public offerings, follow-on public offerings, private placements, Reg A, proxy solicitations, DTC eligibility, SPACs, reverse mergers and stock transfers. For more information about the company, please visit www.VStockTransfer.com.

About InvestorWire

InvestorWire (“IW”) is a specialized communications platform with a focus on advanced wire-grade press release syndication for private and public companies and the investment community. It is one of 60+ brands within the Dynamic Brand Portfolio @ IBN that delivers: (1) access to a vast network of wire solutions via InvestorWire to efficiently and effectively reach a myriad of target markets, demographics and diverse industries; (2) article and editorial syndication to 5,000+ outlets; (3) enhanced press release enhancement to ensure maximum impact; (4) social media distribution via IBN to millions of social media followers; and (5) a full array of tailored corporate communications solutions. With broad reach and a seasoned team of contributing journalists and writers, IW is uniquely positioned to best serve private and public companies that want to reach a wide audience of investors, influencers, consumers, journalists and the general public. By cutting through the overload of information in today’s market, IW brings its clients unparalleled recognition and brand awareness. IW is where breaking news, insightful content and actionable information converge.

For more information, please visit https://www.InvestorWire.com

Please see full terms of use and disclaimers on the InvestorWire website applicable to all content provided by IW, wherever published or re-published: https://www.InvestorWire.com/Disclaimer

InvestorWire
Los Angeles, CA
www.InvestorWire.com
310.299.1717 Office
[email protected]

InvestorWire is powered by IBN

SenesTech (NASDAQ: SNES), the leader in fertility control to manage animal pest populations, today announced its entry into a distribution agreement with Q-chem, a pest control product supplier in the Netherlands. SenesTech has developed and is commercializing a proprietary technology for managing animal pest populations, primarily rat populations, through fertility control. “Q-chem is a perfect partner for SenesTech as we begin our expansion into Europe, and Evolve(TM) fits into their portfolio perfectly,” said Joel Fruendt, SenesTech’s president and CEO. “They have a stated focus on new, environmentally friendly and sustainable products for pest control, and they distribute pest control products in the Netherlands and specifically non-biocidal products throughout Europe.”

To view the full press release, visit https://ibn.fm/aZdFI

About SenesTech Inc.

SenesTech is committed to improving the health of the world by humanely managing animal pest populations through fertility control. The company is an expert in fertility control to manage animal pest populations. It invented ContraPest(R), the only U.S. EPA-registered contraceptive for male and female rats, and Evolve(TM), an EPA-designated minimum risk contraceptive currently offered for rats. ContraPest and Evolve fit seamlessly into all integrated pest management programs, significantly improving the overall goal of effective pest management. SenesTech strives for clean cities, efficient businesses and happy households – with a product designed to be humane, effective and sustainable. For more information about the company, visit www.SenesTech.com.

NOTE TO INVESTORS: The latest news and updates relating to SNES are available in the company’s newsroom at https://ibn.fm/SNES

About InvestorWire

InvestorWire (“IW”) is a specialized communications platform with a focus on advanced wire-grade press release syndication for private and public companies and the investment community. It is one of 60+ brands within the Dynamic Brand Portfolio @ IBN that delivers: (1) access to a vast network of wire solutions via InvestorWire to efficiently and effectively reach a myriad of target markets, demographics and diverse industries; (2) article and editorial syndication to 5,000+ outlets; (3) enhanced press release enhancement to ensure maximum impact; (4) social media distribution via IBN to millions of social media followers; and (5) a full array of tailored corporate communications solutions. With broad reach and a seasoned team of contributing journalists and writers, IW is uniquely positioned to best serve private and public companies that want to reach a wide audience of investors, influencers, consumers, journalists and the general public. By cutting through the overload of information in today’s market, IW brings its clients unparalleled recognition and brand awareness. IW is where breaking news, insightful content and actionable information converge.

For more information, please visit https://www.InvestorWire.com

Please see full terms of use and disclaimers on the InvestorWire website applicable to all content provided by IW, wherever published or re-published: https://www.InvestorWire.com/Disclaimer

InvestorWire
Los Angeles, CA
www.InvestorWire.com
310.299.1717 Office
[email protected]

InvestorWire is powered by IBN

Knightscope (NASDAQ: KSCP), a leading innovator in robotics and artificial intelligence (“AI”) technologies focused on public safety, has deployed two more of its K5 Autonomous Security Robots (“ASRs”). The robots feature KSCP’s proprietary AI software, which provides for enhanced safety measures. The robots were sent to patrol a Washington casino and a security-services company; the security-services company recently became a reseller in the Knightscope Authorized Partner (“KAP”) program.

“The robot’s commanding size along with its conspicuous lighting, strobe lights, broadcast messages and patrol sounds, effectively deter illicit activities, while its sensors gather evidentiary-quality video and publicly available data to aid investigations,” said the company in the press release. “The robots also provide a unique guest experience with branded graphics, a client-chosen voice for custom audio broadcast messaging and improved access to emergency services.”

Knightscope’s KAP program is offered to a limited number of established resellers that are focused on serving U.S. customer facilities. According to the company, approved KAPs can identify end users best suited for Knightscope’s technologies and generate contracts quickly.

To view the full press release, visit https://ibn.fm/RP2bY

About Knightscope, Inc.

Knightscope builds cutting-edge technologies to improve public safety. The company’s long-term ambition is to make the United States of America the safest country in the world. For more information about the company, please visit www.Knightscope.com.

NOTE TO INVESTORS: The latest news and updates relating to KSCP are available in the company’s newsroom at https://ibn.fm/KSCP

About InvestorWire

InvestorWire (“IW”) is a specialized communications platform with a focus on advanced wire-grade press release syndication for private and public companies and the investment community. It is one of 60+ brands within the Dynamic Brand Portfolio @ IBN that delivers: (1) access to a vast network of wire solutions via InvestorWire to efficiently and effectively reach a myriad of target markets, demographics and diverse industries; (2) article and editorial syndication to 5,000+ outlets; (3) enhanced press release enhancement to ensure maximum impact; (4) social media distribution via IBN to millions of social media followers; and (5) a full array of tailored corporate communications solutions. With broad reach and a seasoned team of contributing journalists and writers, IW is uniquely positioned to best serve private and public companies that want to reach a wide audience of investors, influencers, consumers, journalists and the general public. By cutting through the overload of information in today’s market, IW brings its clients unparalleled recognition and brand awareness. IW is where breaking news, insightful content and actionable information converge.

For more information, please visit https://www.InvestorWire.com

Please see full terms of use and disclaimers on the InvestorWire website applicable to all content provided by IW, wherever published or re-published: https://www.InvestorWire.com/Disclaimer

InvestorWire
Los Angeles, CA
www.InvestorWire.com
310.299.1717 Office
[email protected]

InvestorWire is powered by IBN

Safety Shot (NASDAQ: SHOT), a wellness and functional beverage company, has a new brand ambassador. The company announced that American professional skateboarder and businessperson Danny Way has joined Safety Shot. In his new brand ambassador role, Way will work to increase awareness of the world’s first patented wellness beverage designed to help people feel better faster by reducing blood alcohol content while also boosting clarity and overall mood. Way stated that “having survived and thrived through some serious hardship early in my life and injuries during my skateboarding career, believe me, I know about recovery.” He noted that he is a full supporter of Safety Shot’s mission and will be “sharing my love for it with anyone who wants to get sharper and energized.” At age 15, Way became the youngest person to win a pro vert skateboarding contest at the World Skateboard Association Pro Vert Contest; he then went on to become an award-winning professional skateboarder. Safety Shot is the first-ever patented wellness beverage that reduces blood alcohol content in as little as 30 minutes. According to the company, the game-changing beverage helps process alcohol more efficiently, helps the body maintain hydration and improves the overall feeling of well-being through nootropics and vitamins. “As a record-breaking experimentalist skateboarder and businessperson, Danny exemplifies Safety Shot’s thirst for life and resilience,” said Safety Shot CRO Josh Wagner in the press release. “We welcome him to our growing band of brand ambassadors who span a broad cultural swath with global reach and impact.”

To view the full press release, visit https://ibn.fm/KUshg

About Safety Shot

Safety Shot, a wellness and functional beverage company, is set to launch Safety Shot, the first patented beverage on Earth that helps people feel better faster by reducing blood alcohol content and boosting clarity and overall mood. Safety Shot is available for purchase online at DrinkSafetyShot.com and Amazon. The company plans to launch business-to-business sales of Safety Shot to distributors, retailers, restaurants and bars in the first quarter of 2024. For more information about the company, visit www.SafetyShotHoldings.com.

NOTE TO INVESTORS: The latest news and updates relating to SHOT are available in the company’s newsroom at https://ibn.fm/SHOT

About InvestorWire

InvestorWire (“IW”) is a specialized communications platform with a focus on advanced wire-grade press release syndication for private and public companies and the investment community. It is one of 60+ brands within the Dynamic Brand Portfolio @ IBN that delivers: (1) access to a vast network of wire solutions via InvestorWire to efficiently and effectively reach a myriad of target markets, demographics and diverse industries; (2) article and editorial syndication to 5,000+ outlets; (3) enhanced press release enhancement to ensure maximum impact; (4) social media distribution via IBN to millions of social media followers; and (5) a full array of tailored corporate communications solutions. With broad reach and a seasoned team of contributing journalists and writers, IW is uniquely positioned to best serve private and public companies that want to reach a wide audience of investors, influencers, consumers, journalists and the general public. By cutting through the overload of information in today’s market, IW brings its clients unparalleled recognition and brand awareness. IW is where breaking news, insightful content and actionable information converge.

For more information, please visit https://www.InvestorWire.com

Please see full terms of use and disclaimers on the InvestorWire website applicable to all content provided by IW, wherever published or re-published: https://www.InvestorWire.com/Disclaimer

InvestorWire
Los Angeles, CA
www.InvestorWire.com
310.299.1717 Office
[email protected]

InvestorWire is powered by IBN

Vivos Therapeutics (NASDAQ: VVOS) is a leading medical device and technology company specializing in the development and commercialization of highly effective proprietary treatments for sleep related breathing disorders (including all severities of obstructive sleep apnea (“OSA”)). The company today announced its entry into a definitive agreement for the immediate exercise of an outstanding common stock purchase warrant held by an institutional investor to purchase an aggregate of 980,393 shares of common stock for gross proceeds to Vivos of approximately $4.0 million. As part of the transaction, the investor agreed to exercise the existing warrant (originally issued in November 2023 with an exercise price of $3.83 per share) at a revised exercise price of $4.02 per share. The resale of the shares of common stock issuable upon exercise of the warrant were registered per an effective registration statement on Form S-1. In consideration for the immediate exercise of the existing warrant for cash, Vivos agreed to issue to the investor two new unregistered warrants, each to purchase 735,296 shares of common stock (or an aggregate of 1,470,592 shares) at an exercise price of $5.05 per share. The new warrants will be exercisable immediately upon issuance. Such warrants are identical, with exception of one warrant having a term of five years and the second a term of eighteen months. A.G.P./Alliance Global Partners is acting as the exclusive financial advisor in connection with the offering.

To view the full press release, visit https://ibn.fm/1voaI

About Vivos Therapeutics Inc.

Vivos Therapeutics is a medical technology company focused on developing and commercializing innovative diagnostic and treatment methods for patients suffering from breathing and sleep issues arising from certain dentofacial abnormalities such as obstructive sleep apnea (“OSA”) and snoring in adults. The Vivos Method represents the first clinically effective nonsurgical, noninvasive, nonpharmaceutical and cost-effective solution for treating mild-to-severe OSA. It has proven effective in approximately 40,000 patients treated worldwide by more than 1,800 trained dentists. The Vivos Method includes treatment regimens that employ the proprietary CARE appliance therapy and other modalities that alter the size, shape and position of the soft tissues that comprise a patient’s upper airway and/or palate. The Vivos Method opens airway space and may significantly reduce symptoms and conditions associated with mild-to-severe OSA, such as lowering Apnea Hypopnea Index scores. Vivos also markets and distributes SleepImage diagnostic technology under its VivoScore program for home sleep testing in adults and children. The Vivos Integrated Practice (“VIP”) program offers dentists training and other value-added services in connection with using The Vivos Method. For more information, visit www.Vivos.com.

NOTE TO INVESTORS: The latest news and updates relating to VVOS are available in the company’s newsroom at http://ibn.fm/VVOS

About InvestorWire

InvestorWire (“IW”) is a specialized communications platform with a focus on advanced wire-grade press release syndication for private and public companies and the investment community. It is one of 60+ brands within the Dynamic Brand Portfolio @ IBN that delivers: (1) access to a vast network of wire solutions via InvestorWire to efficiently and effectively reach a myriad of target markets, demographics and diverse industries; (2) article and editorial syndication to 5,000+ outlets; (3) enhanced press release enhancement to ensure maximum impact; (4) social media distribution via IBN to millions of social media followers; and (5) a full array of tailored corporate communications solutions. With broad reach and a seasoned team of contributing journalists and writers, IW is uniquely positioned to best serve private and public companies that want to reach a wide audience of investors, influencers, consumers, journalists and the general public. By cutting through the overload of information in today’s market, IW brings its clients unparalleled recognition and brand awareness. IW is where breaking news, insightful content and actionable information converge.

For more information, please visit https://www.InvestorWire.com

Please see full terms of use and disclaimers on the InvestorWire website applicable to all content provided by IW, wherever published or re-published: https://www.InvestorWire.com/Disclaimer

InvestorWire
Los Angeles, CA
www.InvestorWire.com
310.299.1717 Office
[email protected]

InvestorWire is powered by IBN

Tonix Pharmaceuticals Holding (NASDAQ: TNXP), a biopharmaceutical company with marketed products and a pipeline of development candidates, is announcing that people who are suffering from fibromyalgia pain but do not want to risk addiction to an opioid are closer to a new option for treatment. According to the announcement, the company announced positive Phase 3 study results for its non-opioid investigational drug candidate Tonmya or TNX-102 SL in late December. The results showed that Tonmya lowered the characteristic widespread pain in fibromyalgia, indicating that it could potentially be the first in a new class of painkillers to be approved for use in fibromyalgia. In addition, the experimental medicine improved sleep and fatigue in fibromyalgia. Tonix intends to submit a New Drug Application (“NDA”) with the FDA in the second half of the year and expects a decision in 2025.

Additionally, Tonix is featured in an FN Media Group News Commentary. The commentary covered Tonix’s recent news, including the announcement that the company has engaged Rho, Inc., a global contract research organization (“CRO”), to support its preparation and planned submission of its New Drug Application (“NDA”) to the U.S. Food and Drug Administration. The NDA will seek FDA approval for Tonmya(TM) (also known as TNX-102 SL, cyclobenzaprine HCl sublingual tablets) for the management of fibromyalgia. The commentary also highlighted a recent key opinion leader (“KOL”) webinar held to discuss the positive Phase 3 data of Tonmya for the management of fibromyalgia and the path to file for FDA approval in the second half of 2024.

To view the full press releases, visit https://ibn.fm/t9IVu  and https://ibn.fm/GQzjA

About Tonix Pharmaceuticals Holding Corp.

Tonix is a biopharmaceutical company focused on commercializing, developing, discovering and licensing therapeutics to treat and prevent human disease and alleviate suffering. Tonix’s development portfolio is focused on central nervous system disorders. Tonix’s priority is to submit a New Drug Application (“NDA”) to the FDA for Tonmya, which has completed two positive Phase 3 studies for the management of fibromyalgia. Tonix intends to meet with the FDA in the first half of 2024 and submit an NDA for the approval of Tonmya for the management of fibromyalgia in the second half of 2024. TNX-102 SL is being developed to treat fibromyalgia-type Long COVID, a chronic post-acute COVID-19 condition, and topline results from a proof-of-concept study were reported in the third quarter of 2023. TNX-1300 (cocaine esterase) is a biologic designed to treat cocaine intoxication and has been granted Breakthrough Therapy designation by the FDA. A Phase 2 study of TNX-1300 is expected to be initiated in the first quarter of 2024. Tonix’s rare disease development portfolio includes TNX-2900 (intranasal potentiated oxytocin) for the treatment of Prader-Willi syndrome (“PWS”). TNX-2900 has been granted Orphan Drug designation by the FDA and an investigational new drug (“IND”) application has been cleared to support a Phase 2 study in PWS patients. Tonix’s immunology development portfolio includes biologics to address organ transplant rejection, autoimmunity and cancer, including TNX-1500, which is a humanized monoclonal antibody targeting CD40-ligand (“CD40L” or “CD154”) being developed for the prevention of allograft rejection and for the treatment of autoimmune diseases. A Phase 1 study of TNX-801 was initiated in the third quarter of 2023. Tonix’s infectious disease pipeline includes TNX-801, a vaccine in development to prevent smallpox and mpox. TNX-801 also serves as the live virus vaccine platform or recombinant pox vaccine platform for other infectious diseases, including TNX-1800, in development as a vaccine to protect against COVID-19. During the fourth quarter of 2023, TNX-1800 was selected by the U.S. National Institutes of Health (“NIH”), National Institute of Allergy and Infectious Diseases (“NIAID”) Project NexGen for inclusion in Phase 1 clinical trials. The infectious disease development portfolio includes TNX-3900 and TNX-4000, which are classes of broad-spectrum small molecule oral antivirals. Tonix Medicines, the company’s commercial subsidiary, markets Zembrace(R) SymTouch(R) (sumatriptan injection) 3 mg and Tosymra(R) (sumatriptan nasal spray) 10 mg under a transition services agreement with Upsher-Smith Laboratories, LLC from whom the products were acquired on June 30, 2023. Zembrace SymTouch and Tosymra are each indicated for the treatment of acute migraine with or without aura in adults. For more information about Tonix, visit www.tonixpharma.com.

About InvestorWire

InvestorWire (“IW”) is a specialized communications platform with a focus on advanced wire-grade press release syndication for private and public companies and the investment community. It is one of 60+ brands within the Dynamic Brand Portfolio @ IBN that delivers: (1) access to a vast network of wire solutions via InvestorWire to efficiently and effectively reach a myriad of target markets, demographics and diverse industries; (2) article and editorial syndication to 5,000+ outlets; (3) enhanced press release enhancement to ensure maximum impact; (4) social media distribution via IBN to millions of social media followers; and (5) a full array of tailored corporate communications solutions. With broad reach and a seasoned team of contributing journalists and writers, IW is uniquely positioned to best serve private and public companies that want to reach a wide audience of investors, influencers, consumers, journalists and the general public. By cutting through the overload of information in today’s market, IW brings its clients unparalleled recognition and brand awareness. IW is where breaking news, insightful content and actionable information converge.

For more information, please visit https://www.InvestorWire.com

Please see full terms of use and disclaimers on the InvestorWire website applicable to all content provided by IW, wherever published or re-published: https://www.InvestorWire.com/Disclaimer

InvestorWire
Los Angeles, CA
www.InvestorWire.com
310.299.1717 Office
[email protected]

InvestorWire is powered by IBN

CEL-SCI Corporation (NYSE American: CVM), a phase 3 cancer-immunotherapy company, has closed on its previously announced public offering. The offering was comprised of 3,875,000 shares of common stock, offered at $2 per share, resulting in $7.75 million in gross proceeds before deducting underwriting discounts and offering expenses. According to the announcement, CEL-SCI anticipates using the funds for continued development of Multikine as well as for working capital and general corporate purposes. ThinkEquity acted as sole book-running manager for the offering.

To view the full press release, visit https://ibn.fm/kaEhi

About CEL-SCI Corporation

CEL-SCI believes that boosting a patient’s immune system while it is still intact should provide the greatest possible impact on survival. Multikine (leukocyte interleukin, injection) is designed to help the immune system “target” the tumor at a time when the immune system is still relatively intact and thereby thought to be better able to mount an attack on the tumor. In a phase 3 study, CEL-SCI studied patients who were newly diagnosed with locally advanced primary squamous cell carcinoma of the head and neck (oral cavity and soft-palate) with the investigational product Multikine administered first, before they received the standard of care, which involved surgery followed by either radiation or chemoradiation. The phase 3 study enrolled 928 patients. The company’s approach is unique because most other cancer immunotherapies are administered only after conventional therapies have been tried and/or failed. After analyzing data from the phase 3 study, the company has better defined the target population, which is advanced primary head and neck cancer patients with no lymph node involvement and with low PD-L1 tumor expression. In the phase 3 study, CEL-SCI observed statistically significant survival data in the final target population, showing that Multikine cut the risk of death in half at five years vs. control. The company plans to submit the proposed study protocol to the FDA in Q1 2024, with the goal to get FDA buy-in for a confirmatory clinical trial, and also to discuss potential accelerated approval pathways. Multikine received Orphan Drug designation from the FDA for neoadjuvant therapy in patients with squamous cell carcinoma (cancer) of the head and neck. For more information about the company, please visit www.CEL-SCI.com.

About InvestorWire

InvestorWire (“IW”) is a specialized communications platform with a focus on advanced wire-grade press release syndication for private and public companies and the investment community. It is one of 60+ brands within the Dynamic Brand Portfolio @ IBN that delivers: (1) access to a vast network of wire solutions via InvestorWire to efficiently and effectively reach a myriad of target markets, demographics and diverse industries; (2) article and editorial syndication to 5,000+ outlets; (3) enhanced press release enhancement to ensure maximum impact; (4) social media distribution via IBN to millions of social media followers; and (5) a full array of tailored corporate communications solutions. With broad reach and a seasoned team of contributing journalists and writers, IW is uniquely positioned to best serve private and public companies that want to reach a wide audience of investors, influencers, consumers, journalists and the general public. By cutting through the overload of information in today’s market, IW brings its clients unparalleled recognition and brand awareness. IW is where breaking news, insightful content and actionable information converge.

For more information, please visit https://www.InvestorWire.com

Please see full terms of use and disclaimers on the InvestorWire website applicable to all content provided by IW, wherever published or re-published: https://www.InvestorWire.com/Disclaimer

InvestorWire
Los Angeles, CA
www.InvestorWire.com
310.299.1717 Office
[email protected]

InvestorWire is powered by IBN

Rocket Lab USA (NASDAQ: RKLB), a global leader in launch services and space systems, has closed on its private offering. The transaction was a $355 million principal amount of 4.250% convertible senior notes due 2029; the notes are due to those reasonably believed to be qualified institutional buyers. According to the announcement, the total amount of the offering comes from both the previously announced, upsized offering of $300 million combined with the full exercise of the $55 million option to purchase additional notes, which Rocket Lab granted to initial purchasers of the notes. The company anticipates using funds from the offering to repay a portion of its borrowings under its equipment financing agreement and for working capital or other general corporate purposes. “Closing today’s transaction is another exciting step for Rocket Lab as we continue our growth trajectory, and upsizing the offering due to oversubscription is a strong show of confidence,” said Rocket Lab founder and CEO Peter Beck in the press release. “This strategic move has added additional funding to the Rocket Lab balance sheet at what we view as the most attractive cost of capital available and least dilutive path for our existing shareholders. We look forward to deploying this capital efficiently and expediently towards a mix of opportunities including potential M&A and other strategic growth and scaling investments.”

To view the full press release, visit https://ibn.fm/bCZeT

About Rocket Lab USA Inc.

Rocket Lab is a global leader in launch and space systems. Rocket Lab’s Electron launch vehicle is the second most frequently launched U.S. rocket annually and has delivered more than 176 satellites to orbit for commercial and government partners, including NASA, the U.S. Air Force, DARPA and the NRO. Rocket Lab also delivers proven suborbital hypersonic launch capability with its HASTE launch vehicle. Building on the deep heritage of Electron, Rocket Lab is developing Neutron, an advanced 13-tonne payload class, reusable launch vehicle tailored for constellation deployment and interplanetary missions. Rocket Lab is also a premier supplier of advanced satellites, flight-proven subsystems and spacecraft components. At a component level, Rocket Lab spacecraft technology spans space solar power, composite structures, flight software, star trackers, reaction wheels, separation systems and more. Rocket Lab satellite technology and components have been integrated into more than 1,700 satellite missions globally. For more information about the company, please visit www.RocketLabUSA.com.

About InvestorWire

InvestorWire (“IW”) is a specialized communications platform with a focus on advanced wire-grade press release syndication for private and public companies and the investment community. It is one of 60+ brands within the Dynamic Brand Portfolio @ IBN that delivers: (1) access to a vast network of wire solutions via InvestorWire to efficiently and effectively reach a myriad of target markets, demographics and diverse industries; (2) article and editorial syndication to 5,000+ outlets; (3) enhanced press release enhancement to ensure maximum impact; (4) social media distribution via IBN to millions of social media followers; and (5) a full array of tailored corporate communications solutions. With broad reach and a seasoned team of contributing journalists and writers, IW is uniquely positioned to best serve private and public companies that want to reach a wide audience of investors, influencers, consumers, journalists and the general public. By cutting through the overload of information in today’s market, IW brings its clients unparalleled recognition and brand awareness. IW is where breaking news, insightful content and actionable information converge.

For more information, please visit https://www.InvestorWire.com

Please see full terms of use and disclaimers on the InvestorWire website applicable to all content provided by IW, wherever published or re-published: https://www.InvestorWire.com/Disclaimer

InvestorWire
Los Angeles, CA
www.InvestorWire.com
310.299.1717 Office
[email protected]

DealFlow Events, renowned host and organizer of hundreds of investment themed conferences over the past two decades, today announced the Activist Investor Conference 2024. The leading forum for discussing governance-related issues relevant to investing professionals, the event is slated to take place on March 21, 2024, at Convene in New York City. First launched in 2010, DealFlow’s Activist Investor Conference 2024 provides unparalleled opportunities for professional education, networking and forging new business relationships. The event keeps focus on the industry’s most innovative and transformative ideas that enable investors to deepen their knowledge of governance issues and improve the fortunes of the companies in which they have invested. The conference will address several key themes of governance-related issues through engaging presentations and lively panel discussions.

To view the full press release, visit https://ibn.fm/xm7Fp

About DealFlow Events

DealFlow Events is widely recognized as a symbol of quality. For over two decades, DealFlow has created events that feature exclusive networking, education and business development opportunities. DealFlow Events has produced over 200 conferences, seminars and webcasts on a variety of financial topics. These events are the signature programs in their respective markets, offering high-quality content and professional networking opportunities. For more information, visit www.DealFlowEvents.com.

About InvestorWire

InvestorWire (“IW”) is a specialized communications platform with a focus on advanced wire-grade press release syndication for private and public companies and the investment community. It is one of 60+ brands within the Dynamic Brand Portfolio @ IBN that delivers: (1) access to a vast network of wire solutions via InvestorWire to efficiently and effectively reach a myriad of target markets, demographics and diverse industries; (2) article and editorial syndication to 5,000+ outlets; (3) enhanced press release enhancement to ensure maximum impact; (4) social media distribution via IBN to millions of social media followers; and (5) a full array of tailored corporate communications solutions. With broad reach and a seasoned team of contributing journalists and writers, IW is uniquely positioned to best serve private and public companies that want to reach a wide audience of investors, influencers, consumers, journalists and the general public. By cutting through the overload of information in today’s market, IW brings its clients unparalleled recognition and brand awareness. IW is where breaking news, insightful content and actionable information converge.

For more information, please visit https://www.InvestorWire.com

Please see full terms of use and disclaimers on the InvestorWire website applicable to all content provided by IW, wherever published or re-published: https://www.InvestorWire.com/Disclaimer

InvestorWire
Los Angeles, CA
www.InvestorWire.com
310.299.1717 Office
[email protected]

InvestorWire is powered by IBN

Knightscope (NASDAQ: KSCP), a leading developer of autonomous security robots (“ASRs”) and blue light emergency communication systems, has finalized three new contracts for its K1 Hemisphere. The contracts are with a commercial real estate company in California, a residential property in Illinois and a healthcare company in Minnesota.

Calling the K1 Hemisphere “a perfect entry point into deploying Knightscope’s combination of robotics and artificial intelligence (‘AI’) technologies,” the company noted that the Hemisphere is ideally suited to elevate the security and safety profile of any property.

“It can easily be mounted to a variety of surfaces or objects and has three cameras that provide up to 210 degrees of eye-level, high-definition video, a strobe light, automatic license plate recognition, facial recognition (optional), automated broadcast announcements and intercom capability running on a wired or fully encrypted wireless network,” the company stated in the press release. “Two Hemispheres can also be placed back-to-back for a 360-degree view.”

To view the full press release, visit https://ibn.fm/yfbST

About Knightscope, Inc.

Knightscope is an advanced public safety technology company that builds fully autonomous security robots and blue light emergency communications systems that help protect the places people live, work, study and visit. Knightscope’s long-term ambition is to make the United States of America the safest country in the world. For more information about the company, please visit www.Knightscope.com.

NOTE TO INVESTORS: The latest news and updates relating to KSCP are available in the company’s newsroom at https://ibn.fm/KSCP

About InvestorWire

InvestorWire (“IW”) is a specialized communications platform with a focus on advanced wire-grade press release syndication for private and public companies and the investment community. It is one of 60+ brands within the Dynamic Brand Portfolio @ IBN that delivers: (1) access to a vast network of wire solutions via InvestorWire to efficiently and effectively reach a myriad of target markets, demographics and diverse industries; (2) article and editorial syndication to 5,000+ outlets; (3) enhanced press release enhancement to ensure maximum impact; (4) social media distribution via IBN to millions of social media followers; and (5) a full array of tailored corporate communications solutions. With broad reach and a seasoned team of contributing journalists and writers, IW is uniquely positioned to best serve private and public companies that want to reach a wide audience of investors, influencers, consumers, journalists and the general public. By cutting through the overload of information in today’s market, IW brings its clients unparalleled recognition and brand awareness. IW is where breaking news, insightful content and actionable information converge.

For more information, please visit https://www.InvestorWire.com

Please see full terms of use and disclaimers on the InvestorWire website applicable to all content provided by IW, wherever published or re-published: https://www.InvestorWire.com/Disclaimer

InvestorWire
Los Angeles, CA
www.InvestorWire.com
310.299.1717 Office
[email protected]

InvestorWire is powered by IBN

Silo Pharma (NASDAQ: SILO) is a developmental stage biopharmaceutical company focused on developing novel formulations and drug delivery systems for traditional therapeutics and psychedelic treatments. The company today provided a positive update on SP-26, its novel time-released, dose-controlled formulation of ketamine initially targeted for fibromyalgia. According to the announcement, a pre-clinical research study is underway involving analytical testing services and small batch proof-of-concept extrusion trials to determine drug release and stability. In recent testing, SP-26 polymer implants were blended with ketamine hydrochloride (“ketamine HCL”) in two loadings, 20% and 40%, and the structural stability and integrity of both the loaded implants were maintained, with no leakage, degradation or discoloration. “Implantable drug delivery systems like SP-26 may provide sustained drug delivery for prolonged periods of time, which is critical for the treatment of chronic pain conditions,” said Eric Weisblum, CEO of Silo. “We believe the initial testing provided sufficient validation of the delivery system for SP-26 and accordingly, our focus has shifted to testing of the ketamine formulation to measure drug dissolution and time-release action.”

To view the full press release, visit https://ibn.fm/61w4w

About Silo Pharma Inc.

Silo Pharma is a developmental-stage biopharmaceutical company developing novel therapeutics that address underserved conditions including stress-induced psychiatric disorders, chronic pain conditions and central nervous system (“CNS”) diseases. Silo focuses on developing traditional therapies and psychedelic treatments in novel formulations and drug delivery systems. The company’s lead program, SPC-15, is an intranasal treatment targeting PTSD and stress-induced anxiety disorders. SP-26 is a time-release ketamine-loaded implant for fibromyalgia and chronic pain relief. Silo’s two preclinical programs are SPC-14, an intranasal compound for the treatment of Alzheimer’s disease, and SPU-16, a CNS-homing peptide targeting multiple sclerosis (“MS”). Silo’s research and development programs are conducted through collaborations with Columbia University and the University of Maryland, Baltimore. For more information about the company, visit www.SiloPharma.com.

NOTE TO INVESTORS: The latest news and updates relating to SILO are available in the company’s newsroom at https://ibn.fm/SILO

About InvestorWire

InvestorWire (“IW”) is a specialized communications platform with a focus on advanced wire-grade press release syndication for private and public companies and the investment community. It is one of 60+ brands within the Dynamic Brand Portfolio @ IBN that delivers: (1) access to a vast network of wire solutions via InvestorWire to efficiently and effectively reach a myriad of target markets, demographics and diverse industries; (2) article and editorial syndication to 5,000+ outlets; (3) enhanced press release enhancement to ensure maximum impact; (4) social media distribution via IBN to millions of social media followers; and (5) a full array of tailored corporate communications solutions. With broad reach and a seasoned team of contributing journalists and writers, IW is uniquely positioned to best serve private and public companies that want to reach a wide audience of investors, influencers, consumers, journalists and the general public. By cutting through the overload of information in today’s market, IW brings its clients unparalleled recognition and brand awareness. IW is where breaking news, insightful content and actionable information converge.

For more information, please visit https://www.InvestorWire.com

Please see full terms of use and disclaimers on the InvestorWire website applicable to all content provided by IW, wherever published or re-published: https://www.InvestorWire.com/Disclaimer

InvestorWire
Los Angeles, CA
www.InvestorWire.com
310.299.1717 Office
[email protected]

InvestorWire is powered by IBN

Safety Shot (NASDAQ: SHOT) today announced that Matthew Espinosa joins Safety Shot as a brand ambassador to share his love and enthusiasm for the first patented wellness beverage on Earth that helps people feel better faster by reducing blood alcohol content, boosting clarity and overall mood. Having amassed more than 16 million followers across social media, Matthew is a multiplatform entertainer who has been catering to fans for the last 12 years. “Matthew’s highly entertaining and comedic content appeals to a generation of people that we believe will enjoy and benefit from Safety Shot as much as Matthew has,” said Safety Shot’s CEO Brian John. “We are super pleased to have him come on board as a brand ambassador and look forward to lots of media collaborations in which even more people will be exposed to our highly anticipated, in-demand wellness beverage.”

To view the full press release, visit https://ibn.fm/kf0gv

About Safety Shot Inc.

Safety Shot, a wellness and functional beverage company, is set to launch Safety Shot, the first patented wellness beverage on Earth that helps people feel better faster by reducing blood alcohol content, boosting clarity and overall mood. Safety Shot is available for retail purchase online at www.DrinkSafetyShot.com and www.Amazon.com. The company plans to launch business-to-business sales of Safety Shot to distributors, retailers, restaurants, and bars in the first quarter of 2024. Safety Shot plans to spin off legacy assets from its Jupiter Wellness business to unlock value for shareholders.

About InvestorWire

InvestorWire (“IW”) is a specialized communications platform with a focus on advanced wire-grade press release syndication for private and public companies and the investment community. It is one of 60+ brands within the Dynamic Brand Portfolio @ IBN that delivers: (1) access to a vast network of wire solutions via InvestorWire to efficiently and effectively reach a myriad of target markets, demographics and diverse industries; (2) article and editorial syndication to 5,000+ outlets; (3) enhanced press release enhancement to ensure maximum impact; (4) social media distribution via IBN to millions of social media followers; and (5) a full array of tailored corporate communications solutions. With broad reach and a seasoned team of contributing journalists and writers, IW is uniquely positioned to best serve private and public companies that want to reach a wide audience of investors, influencers, consumers, journalists and the general public. By cutting through the overload of information in today’s market, IW brings its clients unparalleled recognition and brand awareness. IW is where breaking news, insightful content and actionable information converge.

For more information, please visit https://www.InvestorWire.com

Please see full terms of use and disclaimers on the InvestorWire website applicable to all content provided by IW, wherever published or re-published: https://www.InvestorWire.com/Disclaimer

InvestorWire
Los Angeles, CA
www.InvestorWire.com
310.299.1717 Office
[email protected]

InvestorWire is powered by IBN

DoubleDown Interactive (NASDAQ: DDI), a leading developer and publisher of digital games on mobile and web-based platforms, is reporting unaudited financial results for the fourth quarter and year ended December 31, 2023; that report includes contributions from European iGaming operator, SuprNation, which DoubleDown acquired in October 2023. Highlights of the report included $83.1 million revenue in the fourth quarter of 2023 compared to $76.2 million in the fourth quarter of 2022; a decrease in operating expenses, which totaled  $47.5 million in the quarter compared to $321.4 million in the same quarter in 2022; Adjusted EBITDA reached $36.2 million for Q4 2023, up from $24.7 million for Q4 2022; net income came in at $25.5 million for the quarter compared to a loss of $(194.4) million in the same quarter of 2022; average revenue per daily active user (“ARPDAU”) for DDI’s social casino/free-to-play games increased to $1.24 for the quarter, up from $0.98 in Q4 2022 and $1.06 in Q3 2023; and average monthly revenue per payer for the social casino/free-to-play games increased to $279 for the quarter of 2023.

“Our fourth-quarter results, which include a 3% year-over-year increase in core social casino revenue to $78.8 million and a 46% increase in Adjusted EBITDA to $36.2 million, highlight our best-in-class ability to monetize our loyal players combined with our disciplined approach to user acquisition and R&D spend which drives consistent profitability and strong free cash flow,” said DoubleDown CEO In Keuk Kim in the press release. “We continue to deliver strong engagement metrics for our flagship social casino game DoubleDown Casino, as ARPDAU and average monthly revenue per payer rose 26% and 23%, respectively, compared to the 2022 fourth quarter. As a result, cash flows from operating activities were approximately $30 million in the fourth quarter. . . . We place a primary focus on being capital efficient as reflected in our strong Adjusted EBITDA margins and free cash-flow generation. At 2023 year-end, cash and cash equivalents and short-term investments net of current borrowing were approximately $235 million, which is equivalent to approximately $4.75 per ADS. Our strong net cash position and consistent ability to generate attractive free cash flow provides the company with significant flexibility to evaluate further opportunities to deploy capital that would continue to expand our business in gaming categories with attractive addressable markets and where our operating discipline would ultimately deliver additional free cash flow and create new value for our shareholders.”

To view the full press release, visit https://ibn.fm/tz4cc

About DoubleDown Interactive Co. Ltd.

DoubleDown Interactive is a leading developer and publisher of digital games on mobile and web-based platforms. The company is the creator of multiformat interactive entertainment experiences for casual players, bringing authentic Vegas entertainment to players around the world through an online social casino experience. DDI’s flagship social casino title, DoubleDown Casino, has been a fan-favorite game on leading social and mobile platforms for years, entertaining millions of players worldwide with a lineup of classic and modern games. Following its acquisition of SuprNation in October 2023, the company also operates three real-money iGaming sites in Western Europe. For more information about this company, please visit www.DoubleDownInteractive.com.

About InvestorWire

InvestorWire (“IW”) is a specialized communications platform with a focus on advanced wire-grade press release syndication for private and public companies and the investment community. It is one of 60+ brands within the Dynamic Brand Portfolio @ IBN that delivers: (1) access to a vast network of wire solutions via InvestorWire to efficiently and effectively reach a myriad of target markets, demographics and diverse industries; (2) article and editorial syndication to 5,000+ outlets; (3) enhanced press release enhancement to ensure maximum impact; (4) social media distribution via IBN to millions of social media followers; and (5) a full array of tailored corporate communications solutions. With broad reach and a seasoned team of contributing journalists and writers, IW is uniquely positioned to best serve private and public companies that want to reach a wide audience of investors, influencers, consumers, journalists and the general public. By cutting through the overload of information in today’s market, IW brings its clients unparalleled recognition and brand awareness. IW is where breaking news, insightful content and actionable information converge.

For more information, please visit https://www.InvestorWire.com

Please see full terms of use and disclaimers on the InvestorWire website applicable to all content provided by IW, wherever published or re-published: https://www.InvestorWire.com/Disclaimer

InvestorWire
Los Angeles, CA
www.InvestorWire.com
310.299.1717 Office
[email protected]

InvestorWire is powered by IBN

Cybin (NYSE American: CYBN) (Cboe CA: CYBN), a clinical-stage biopharmaceutical company committed to revolutionizing mental health care by developing new and innovative next-generation psychedelic treatment options, today announced unaudited financial results for its third quarter ended Dec. 31, 2023, and recent business highlights. “During the past three months, we have continued to make exciting progress with positive topline data from our CYB003 and DMT programs,” said Cybin CEO Doug Drysdale. “The data collected from our clinical trials forms the foundation of our next set of value-creating milestones, as we advance our key programs this year. For CYB003, the three-month Phase 2 efficacy data is expected in Q1 and will provide insights into the durability of treatment effect in MDD. Promising outcomes, such as a 79% remission from depression at 6 weeks in our Phase 2 CYB003 trial, and important safety and dosing findings in our Phase 1 dDMT studies, validate our path forward. Plans are underway to initiate a Phase 3 multisite trial of CYB003 for MDD, and with FDA clearance, we are progressing to a Phase 2a study of CYB004 for the treatment of GAD. We are proud of the rapid progress we have made and look forward to the important work ahead of us. We are encouraged by the positive findings across our clinical-stage programs to date and believe we are well on our way to providing more effective and patient-friendly treatment alternatives for a multitude of mental health disorders.”

To view the full press release, visit https://ibn.fm/XKTPw

About Cybin Inc.

Cybin is a clinical-stage biopharmaceutical company on a mission to create safe and effective psychedelic-based therapeutics to address the large unmet need for new and innovative treatment options for people who suffer from mental health conditions. Cybin’s goal of revolutionizing mental health care is supported by a network of world-class partners and internationally recognized scientists aimed at progressing proprietary drug discovery platforms, innovative drug delivery systems, and novel formulation approaches and treatment regimens. The company is currently developing CYB003, a proprietary deuterated psilocybin analog for the treatment of major depressive disorder and CYB004, a proprietary dDMT molecule for generalized anxiety disorder and has a research pipeline of investigational psychedelic-based compounds. Headquartered in Canada and founded in 2019, Cybin is operational in Canada, the United States, the United Kingdom, the Netherlands and Ireland. For company updates and to learn more about Cybin, visit www.Cybin.com.

NOTE TO INVESTORS: The latest news and updates relating to CYBN are available in the company’s newsroom at https://ibn.fm/CYBN

About InvestorWire

InvestorWire (“IW”) is a specialized communications platform with a focus on advanced wire-grade press release syndication for private and public companies and the investment community. It is one of 60+ brands within the Dynamic Brand Portfolio @ IBN that delivers: (1) access to a vast network of wire solutions via InvestorWire to efficiently and effectively reach a myriad of target markets, demographics and diverse industries; (2) article and editorial syndication to 5,000+ outlets; (3) enhanced press release enhancement to ensure maximum impact; (4) social media distribution via IBN to millions of social media followers; and (5) a full array of tailored corporate communications solutions. With broad reach and a seasoned team of contributing journalists and writers, IW is uniquely positioned to best serve private and public companies that want to reach a wide audience of investors, influencers, consumers, journalists and the general public. By cutting through the overload of information in today’s market, IW brings its clients unparalleled recognition and brand awareness. IW is where breaking news, insightful content and actionable information converge.

For more information, please visit https://www.InvestorWire.com

Please see full terms of use and disclaimers on the InvestorWire website applicable to all content provided by IW, wherever published or re-published: https://www.InvestorWire.com/Disclaimer

InvestorWire
Los Angeles, CA
www.InvestorWire.com
310.299.1717 Office
[email protected]

InvestorWire is powered by IBN

Vistagen Therapeutics (NASDAQ: VTGN), a late clinical-stage biopharmaceutical company pioneering neuroscience to deliver first-in-class therapies for psychiatric and neurological disorders, is reporting its Q3 2024 financial numbers as well as providing an update on the company. Notable numbers from the report include research and development expenses reaching $4.5 million and $6.9 million for the three months ended Dec. 31, 2023 and 2022, respectively; general and administrative expenses for the 2023 quarter totaled $3.8 million, up from $3.1 million in 2022; and net loss reached $6.3 million for 2023, down from $9.8 million 2022. The company also reported cash and cash equivalents of some $126.6 million, with 27,029,731 shares of common stock issued and 3,577,240 prefunded warrants outstanding as of Feb. 12, 2024. The report noted that VTGN’s fasedienol PALISADE phase 3 programs for the acute treatment of social anxiety disorder (“SAD”) remains on track and the company is planning on starting a PALISADE-3 trial and PALISADE-4 trial in 2024.

“Momentum from clinical and corporate milestones achieved through the end of last quarter have significantly advanced our efforts to develop and commercialize fasedienol as a potential first-in-class acute treatment for adults with social anxiety disorder,” said Vistagen Therapeutics CEO Shawn Singh in the press release. “Building on the positive results of our PALISADE-2 phase 3 trial in SAD, we remain on track to initiate our PALISADE-3 phase 3 trial in SAD during the first half of this year. In parallel, we continue to make significant progress toward phase 2B development of two additional clinical-stage neuroscience assets in our pipeline, itruvone for major depressive disorder and hormone-free PH80 for women’s health indications, including vasomotor symptoms (hot flashes) due to menopause.”

To view the full press release, visit https://ibn.fm/1wRLt

About Vistagen Therapeutics Inc.

Vistagen is a late clinical-stage biopharmaceutical company pioneering neuroscience to deliver first-in-class therapies for psychiatric and neurological disorders. Five of Vistagen’s six clinical-stage product candidates belong to a new class of drugs known as pherines, which have the potential to rapidly deliver meaningful efficacy with a differentiated safety profile. Pherines are investigational neuroactive nasal sprays with innovative proposed mechanisms of action that activate chemosensory neurons in the nasal passages to impact fundamental neural circuits in the brain without the need for systemic absorption or binding to receptors in the brain. Vistagen’s sixth clinical-stage product candidate, AV-101, is an investigational oral drug candidate with the potential to inhibit but not block NMDA receptor activity. Vistagen is passionate about transforming what is possible in the treatment of anxiety, depression and other neuroscience disorders For more information about the company, please visit www.Vistagen.com.

NOTE TO INVESTORS: The latest news and updates relating to VTGN are available in the company’s newsroom at https://ibn.fm/VTGN

About InvestorWire

InvestorWire (“IW”) is a specialized communications platform with a focus on advanced wire-grade press release syndication for private and public companies and the investment community. It is one of 60+ brands within the Dynamic Brand Portfolio @ IBN that delivers: (1) access to a vast network of wire solutions via InvestorWire to efficiently and effectively reach a myriad of target markets, demographics and diverse industries; (2) article and editorial syndication to 5,000+ outlets; (3) enhanced press release enhancement to ensure maximum impact; (4) social media distribution via IBN to millions of social media followers; and (5) a full array of tailored corporate communications solutions. With broad reach and a seasoned team of contributing journalists and writers, IW is uniquely positioned to best serve private and public companies that want to reach a wide audience of investors, influencers, consumers, journalists and the general public. By cutting through the overload of information in today’s market, IW brings its clients unparalleled recognition and brand awareness. IW is where breaking news, insightful content and actionable information converge.

For more information, please visit https://www.InvestorWire.com

Please see full terms of use and disclaimers on the InvestorWire website applicable to all content provided by IW, wherever published or re-published: https://www.InvestorWire.com/Disclaimer

InvestorWire
Los Angeles, CA
www.InvestorWire.com
310.299.1717 Office
[email protected]

InvestorWire is powered by IBN

Tonix Pharmaceuticals Holding (NASDAQ: TNXP), a biopharmaceutical company with marketed products and a pipeline of development candidates, recently held a key opinion leader (“KOL”) webinar hosted by Alliance Global Partners (“AGP”). The webinar featured two thought leaders in the field of fibromyalgia, Dr. Daniel Clauw and Dr. Lesley Arnold. The thought leaders discussed the positive data from a Phase 3 study of Tonmya(TM) (also known as TNX-102 SL, cyclobenzaprine HCI sublingual tablets) for the management of fibromyalgia and the path to file an NDA for FDA approval in H2 2024. According to the announcement, clinical results show that Tonmya(TM) has broad-spectrum activity, addressing the three core fibromyalgia symptoms: pain, fatigue, and sleep disturbance. In addition, Tonmya(TM) has a favorable tolerability profile that is well-suited for chronic treatment.

“We believe that these positive results show that fibromyalgia can be successfully treated by Tonmya(TM) and may provide the opportunity for Tonix to have the first FDA-approved drug for fibromyalgia in more than a decade,” commented Seth Lederman, M.D., President and CEO of Tonix. “We are now an important step closer to bringing a new, first-line treatment to fibromyalgia patients that offers broad symptom relief and favorable tolerability for chronic use and adherence.”

To view the webinar, visit https://ibn.fm/bYe54

To view the full press release, visit https://ibn.fm/LMhXU

About Tonix Pharmaceuticals Holding Corp.

Tonix is a biopharmaceutical company focused on commercializing, developing, discovering and licensing therapeutics to treat and prevent human disease and alleviate suffering. Tonix’s development portfolio is focused on central nervous system disorders. Tonix’s priority is to submit a New Drug Application (“NDA”) to the FDA for Tonmya, which has completed two positive Phase 3 studies for the management of fibromyalgia. Tonix intends to meet with the FDA in the first half of 2024 and submit an NDA for the approval of Tonmya for the management of fibromyalgia in the second half of 2024. TNX-102 SL is being developed to treat fibromyalgia-type Long COVID, a chronic post-acute COVID-19 condition, and topline results from a proof-of-concept study were reported in the third quarter of 2023. TNX-1300 (cocaine esterase) is a biologic designed to treat cocaine intoxication and has been granted Breakthrough Therapy designation by the FDA. A Phase 2 study of TNX-1300 is expected to be initiated in the first quarter of 2024. Tonix’s rare disease development portfolio includes TNX-2900 (intranasal potentiated oxytocin) for the treatment of Prader-Willi syndrome (“PWS”). TNX-2900 has been granted Orphan Drug designation by the FDA and an investigational new drug (“IND”) application has been cleared to support a Phase 2 study in PWS patients. Tonix’s immunology development portfolio includes biologics to address organ transplant rejection, autoimmunity and cancer, including TNX-1500, which is a humanized monoclonal antibody targeting CD40-ligand (“CD40L” or “CD154”) being developed for the prevention of allograft rejection and for the treatment of autoimmune diseases. A Phase 1 study of TNX-801 was initiated in the third quarter of 2023. Tonix’s infectious disease pipeline includes TNX-801, a vaccine in development to prevent smallpox and mpox. TNX-801 also serves as the live virus vaccine platform or recombinant pox vaccine platform for other infectious diseases, including TNX-1800, in development as a vaccine to protect against COVID-19. During the fourth quarter of 2023, TNX-1800 was selected by the U.S. National Institutes of Health (“NIH”), National Institute of Allergy and Infectious Diseases (“NIAID”) Project NexGen for inclusion in Phase 1 clinical trials. The infectious disease development portfolio includes TNX-3900 and TNX-4000, which are classes of broad-spectrum small molecule oral antivirals. Tonix Medicines, the company’s commercial subsidiary, markets Zembrace(R) SymTouch(R) (sumatriptan injection) 3 mg and Tosymra(R) (sumatriptan nasal spray) 10 mg under a transition services agreement with Upsher-Smith Laboratories, LLC from whom the products were acquired on June 30, 2023. Zembrace SymTouch and Tosymra are each indicated for the treatment of acute migraine with or without aura in adults. For more information about Tonix, visit www.tonixpharma.com.

About InvestorWire

InvestorWire (“IW”) is a specialized communications platform with a focus on advanced wire-grade press release syndication for private and public companies and the investment community. It is one of 60+ brands within the Dynamic Brand Portfolio @ IBN that delivers: (1) access to a vast network of wire solutions via InvestorWire to efficiently and effectively reach a myriad of target markets, demographics and diverse industries; (2) article and editorial syndication to 5,000+ outlets; (3) enhanced press release enhancement to ensure maximum impact; (4) social media distribution via IBN to millions of social media followers; and (5) a full array of tailored corporate communications solutions. With broad reach and a seasoned team of contributing journalists and writers, IW is uniquely positioned to best serve private and public companies that want to reach a wide audience of investors, influencers, consumers, journalists and the general public. By cutting through the overload of information in today’s market, IW brings its clients unparalleled recognition and brand awareness. IW is where breaking news, insightful content and actionable information converge.

For more information, please visit https://www.InvestorWire.com

Please see full terms of use and disclaimers on the InvestorWire website applicable to all content provided by IW, wherever published or re-published: https://www.InvestorWire.com/Disclaimer

InvestorWire
Los Angeles, CA
www.InvestorWire.com
310.299.1717 Office
[email protected]

InvestorWire is powered by IBN

DealFlow Events, host and organizer of hundreds of investment themed conferences over the past two decades, today announced the 2nd Annual Venture Debt Conference 2024. As the world’s largest forum dedicated to non-dilutive financing strategies for emerging growth companies, the event is slated to take place on March 6, 2024, at the historic Edison Ballroom in New York City. The full-day forum will focus on the growing role of venture debt and the varied forms of financing that minimize ownership dilution, offering unique networking opportunities and in-depth strategy discussions for VC-backed and emerging growth companies. Attendees will glean insights into the most cutting-edge products and services in the alternative financing space, such as term loans, revenue-based, receivables and equipment financing. The Venture Debt Conference 2024 will feature product information and education while also shedding light on current market dynamics, the changing nature of lending and evolving client needs.

To view the full press release, visit https://ibn.fm/g30QG

About DealFlow Events

DealFlow Events is widely recognized as a symbol of quality. For over two decades, DealFlow has created events that feature exclusive networking, education and business development opportunities, DealFlow Events has produced over 200 conferences, seminars and webcasts on a variety of financial topics. These events are the signature programs in their respective markets, offering high-quality content and professional networking opportunities. For more information, visit www.DealFlowEvents.com.

About InvestorWire

InvestorWire (“IW”) is a specialized communications platform with a focus on advanced wire-grade press release syndication for private and public companies and the investment community. It is one of 60+ brands within the Dynamic Brand Portfolio @ IBN that delivers: (1) access to a vast network of wire solutions via InvestorWire to efficiently and effectively reach a myriad of target markets, demographics and diverse industries; (2) article and editorial syndication to 5,000+ outlets; (3) enhanced press release enhancement to ensure maximum impact; (4) social media distribution via IBN to millions of social media followers; and (5) a full array of tailored corporate communications solutions. With broad reach and a seasoned team of contributing journalists and writers, IW is uniquely positioned to best serve private and public companies that want to reach a wide audience of investors, influencers, consumers, journalists and the general public. By cutting through the overload of information in today’s market, IW brings its clients unparalleled recognition and brand awareness. IW is where breaking news, insightful content and actionable information converge.

For more information, please visit https://www.InvestorWire.com

Please see full terms of use and disclaimers on the InvestorWire website applicable to all content provided by IW, wherever published or re-published: https://www.InvestorWire.com/Disclaimer

InvestorWire
Los Angeles, CA
www.InvestorWire.com
310.299.1717 Office
[email protected]

InvestorWire is powered by IBN

Optec International (OTC: OPTI) is the focus of a judgment filed by California-based RB Capital Partners Inc., a private investment fund. A recent announcement noted that RB Capital was clarifying the judgment and releasing a shareholder update. According to the announcement, RB Capital observed that it was the largest investor and legitimate shareholder of OPTEC and was “forced to bring a shareholder derivative action against the company to secure our judgment, oust the failing [CEO] Roger Pawson and to try to preserve the assets of the company.” RB Capital filed the lawsuit, noting that Pawson used the company for self-dealing and mismanaged the operations of the corporation at the expense of the shareholders. The judgment was secured in November 2023; the judgment amount was $11.5 million interests and costs, which totaled $14,681,270.50 against Pawson and Optec jointly and severally.

“The court’s judgment also prohibits Pawson from serving as a director and/or CEO of Optec; prohibits Pawson from issuing any class of stock of Optec or transferring any assets of Optec to himself or any third party; prohibits Pawson from using Optec’s assets for his personal gain and to return all ill-gotten funds back to Optec, and finally, the court authorized RB Capital Partners Inc, upon application to the court, to appoint a receiver to control Optec and its assets,” said RB Capital Partners in the press release. “To date we have not sought the appointment of a receiver as we weigh the benefits of doing so, and RB Capital Partners Inc., nor any of its members, are an officer or director of Optec International Inc.”

To view the full press release, visit https://ibn.fm/cu4WL

About RB Capital Partners Inc.

RB Capital Partners is a private investment fund headquartered and incorporated in California. The main investment focus of RB Capital is on small and microcap publicly traded companies trading on the OTC Markets, NASDAQ & New York Stock Exchange. RB Capital predominantly makes debt investments and is known for paying off harmful or convertible debt, giving companies a real chance of success. RB Capital Partners does not manage any outside money nor does it have any investors. It is run and funded solely by Brett Rosen and Deborah Rosen, who each have a 50% ownership stake in the company.

About InvestorWire

InvestorWire (“IW”) is a specialized communications platform with a focus on advanced wire-grade press release syndication for private and public companies and the investment community. It is one of 60+ brands within the Dynamic Brand Portfolio @ IBN that delivers: (1) access to a vast network of wire solutions via InvestorWire to efficiently and effectively reach a myriad of target markets, demographics and diverse industries; (2) article and editorial syndication to 5,000+ outlets; (3) enhanced press release enhancement to ensure maximum impact; (4) social media distribution via IBN to millions of social media followers; and (5) a full array of tailored corporate communications solutions. With broad reach and a seasoned team of contributing journalists and writers, IW is uniquely positioned to best serve private and public companies that want to reach a wide audience of investors, influencers, consumers, journalists and the general public. By cutting through the overload of information in today’s market, IW brings its clients unparalleled recognition and brand awareness. IW is where breaking news, insightful content and actionable information converge.

For more information, please visit https://www.InvestorWire.com

Please see full terms of use and disclaimers on the InvestorWire website applicable to all content provided by IW, wherever published or re-published: https://www.InvestorWire.com/Disclaimer

InvestorWire
Los Angeles, CA
www.InvestorWire.com
310.299.1717 Office
[email protected]

InvestorWire is powered by IBN

Lelantos Holdings (OTC: LNTO), a company with a focus on sustainable energy, is taking the first step in its acquisition of Eco Management Systems, a full-service commercial and residential solar contractor. According to the announcement, Lelantos executed a memorandum of understanding with Eco to acquire 50% of the company and is now finalizing formal binding agreements. Lelantos reports that acquiring Eco will allow the company to expand its operations as well as add a residential solar program to its offerings. The company is planning on finalizing the acquisition after the successful completion of key milestones that have been identified. Eco is an experienced and highly reputable EPC that has been installing solar for homes and businesses since 2017. Licensed in Arizona, California, Illinois and Texas, Eco has goals that directly align with Lelantos objectives within the industry. Lelantos also announced that Sean Land will be joining the company’s board of directors. A key figure in the residential, commercial and industrial solar space for the past three years, Land has built a 300-plus residential dealer network, and sourced and managed a residential installation network in 42 states. “This acquisition [of Eco] provides us a pivotal component to realize the goal of vertical integration within the renewable energy space,” said Lelantos Holdings COO Joshua Weaver in the press release. “Eco’s reputation as a high-quality and well-respected EPC stands by itself, and I am excited for the value that this relationship brings to Lelantos as a whole.”

To view the full press release, visit https://ibn.fm/fpaTf

About Lelantos Holdings Inc.

Lelantos Holdings was founded in the spirit of “solution hunting” and features an innovative business structure that is purpose built to acquire or joint venture with established entities in strategic market sectors. With a focus on sustainable energy, Lelantos has a mission of being at the forefront of innovation in a dynamic industry and the goal of operating as a vertically integrated entity to reduce overhead and increase service offerings. Although Lelantos is a new entity, the company’s overall vision has been collectively developed by a seasoned management team over the past decade to culminate its current operations, foster innovation and advance technological developments. For more information about the company, please visit www.Lelantos.Energy.

About InvestorWire

InvestorWire (“IW”) is a specialized communications platform with a focus on advanced wire-grade press release syndication for private and public companies and the investment community. It is one of 60+ brands within the Dynamic Brand Portfolio @ IBN that delivers: (1) access to a vast network of wire solutions via InvestorWire to efficiently and effectively reach a myriad of target markets, demographics and diverse industries; (2) article and editorial syndication to 5,000+ outlets; (3) enhanced press release enhancement to ensure maximum impact; (4) social media distribution via IBN to millions of social media followers; and (5) a full array of tailored corporate communications solutions. With broad reach and a seasoned team of contributing journalists and writers, IW is uniquely positioned to best serve private and public companies that want to reach a wide audience of investors, influencers, consumers, journalists and the general public. By cutting through the overload of information in today’s market, IW brings its clients unparalleled recognition and brand awareness. IW is where breaking news, insightful content and actionable information converge.

For more information, please visit https://www.InvestorWire.com

Please see full terms of use and disclaimers on the InvestorWire website applicable to all content provided by IW, wherever published or re-published: https://www.InvestorWire.com/Disclaimer

InvestorWire
Los Angeles, CA
www.InvestorWire.com
310.299.1717 Office
[email protected]

InvestorWire is powered by IBN

Amesite (NASDAQ: AMST) is a leading artificial intelligence software company offering a cloud-based learning platform for business and education markets. The company today announced it is offering additional customizations empowering instructors to select from five different types of resources (including news, magazines, academic journals, market reports and press releases) to bring into their programs. The technology enables continuous and contextual updates to program materials by scouring over 250 million articles across nearly 14,000 academic sources. “We are excited to elevate the educational experience with our Article Automation feature, integrating diverse resources like news, magazines and academic journals directly into our programs,” said Amesite CEO Dr. Ann Marie Sastry. “It’s critical that our content generation remains at the forefront, enabling our customers to deliver cutting-edge programs that operate efficiently.”

To view the full press release, visit https://ibn.fm/esbdc

About Amesite Inc.

Amesite is an ed-tech, software-as-a-service (“SaaS”) company with the most advanced artificial intelligence-driven online learning platform in the industry, providing both content creation and a best-in-class infrastructure for the multibillion-dollar online learning markets in business and education. For more information, visit https://amesite.com.

NOTE TO INVESTORS: The latest news and updates relating to AMST are available in the company’s newsroom at https://ibn.fm/AMST

About InvestorWire

InvestorWire (“IW”) is a specialized communications platform with a focus on advanced wire-grade press release syndication for private and public companies and the investment community. It is one of 60+ brands within the Dynamic Brand Portfolio @ IBN that delivers: (1) access to a vast network of wire solutions via InvestorWire to efficiently and effectively reach a myriad of target markets, demographics and diverse industries; (2) article and editorial syndication to 5,000+ outlets; (3) enhanced press release enhancement to ensure maximum impact; (4) social media distribution via IBN to millions of social media followers; and (5) a full array of tailored corporate communications solutions. With broad reach and a seasoned team of contributing journalists and writers, IW is uniquely positioned to best serve private and public companies that want to reach a wide audience of investors, influencers, consumers, journalists and the general public. By cutting through the overload of information in today’s market, IW brings its clients unparalleled recognition and brand awareness. IW is where breaking news, insightful content and actionable information converge.

For more information, please visit https://www.InvestorWire.com

Please see full terms of use and disclaimers on the InvestorWire website applicable to all content provided by IW, wherever published or re-published: https://www.InvestorWire.com/Disclaimer

InvestorWire
Los Angeles, CA
www.InvestorWire.com
310.299.1717 Office
[email protected]

InvestorWire is powered by IBN

Battery Mineral Resources (TSX.V: BMR) (OTCQB: BTRMF), a battery minerals company providing shareholders exposure to the global megatrend of electrification, and its Chilean subsidiary, Minera BMR SpA, have announced key agreements with Javelin Global Commodities. According to the announcement, the company entered into a marketing agreement, a master purchase and sale agreement, and a copper concentrate prepayment and advance payment terms arrangement with Javelin. The agreements outline plans for Javelin to market the copper concentrate, gold, silver and other metals produced at the Punitaqui Plant located at the Punitaqui Mining Complex based on a $5 million copper concentrate prepayment along with an advance payment term arrangement totaling up to $20 million. “The consummation of these agreements with Javelin marks a very critical step in terms of placing the Punitaqui Mine into operational readiness and first concentrate production,” said Battery Mineral Resources CEO Martin Kostuik in the press release. “We welcome Javelin as a partner and look forward to leveraging their marketing prowess to maximize the value that the sale of copper concentrates will bring to BMR shareholders.”

BMR also announced the execution of an offtake agreement with Anglo American Sur. S.A., a division of Anglo-American PLC. According to the announcement, Anglo’s Chagres smelter in Chile has agreed to sell up to 240,000 dry metric tonnes of copper slags that will be processed into copper concentrates at BMR’s Punitaqui copper flotation plant. In addition, Anglo agreed to purchase all the copper concentrate produced from the copper slag supply. BMR plans to start the processing process in the next three months, subject to completing plant maintenance and upgrade activities. “We are extremely pleased to announce this agreement, which comes at a perfect time for BMR,” said Kostuik in the press release. “The agreement provides the company low-cost copper bearing material to be processed at our Punitaqui flotation plant while Battery begins commissioning of the plant. It allows BMR to generate cash flow from copper sales while the Cinabrio, San Andres and Dalmacia mines will be ramping up to reach full production.”

To view the full press releases, visit https://ibn.fm/QhE4W and https://ibn.fm/8bLB8

About Battery Mineral Resources Corp.

Battery Mineral Resources is a battery minerals company providing shareholders exposure to the global megatrend of electrification while being focused on growth through cash flow, exploration and acquisitions in favorable mining jurisdictions. Battery Mineral’s mission is the discovery, acquisition and development of battery metals (namely cobalt, lithium, graphite and copper) in North America, South America and South Korea, and to become a premier and responsible supplier of battery minerals to the electrification marketplace. BMR is currently pursuing a near-term resumption of operations of the Punitaqui Mining Complex, a past copper-gold producer in the Coquimbo region of Chile. BMR is the largest mineral claim holder in the historic Gowganda Cobalt-Silver Camp in Ontario, Canada, and continues to pursue a focused program to build on the recently announced, 1-million-pound-plus high-grade cobalt resource at McAra. In addition, Battery Mineral owns 100% of ESI Energy Services Inc., a profitable mainline pipeline and renewable energy equipment rental and sales company with operations in Alberta, Canada, and the state of Arizona. For more information about the company, visit www.BMRCorp.com.

NOTE TO INVESTORS: The latest news and updates relating to BTRMF are available in the company’s newsroom at https://ibn.fm/BTRMF

About InvestorWire

InvestorWire (“IW”) is a specialized communications platform with a focus on advanced wire-grade press release syndication for private and public companies and the investment community. It is one of 60+ brands within the Dynamic Brand Portfolio @ IBN that delivers: (1) access to a vast network of wire solutions via InvestorWire to efficiently and effectively reach a myriad of target markets, demographics and diverse industries; (2) article and editorial syndication to 5,000+ outlets; (3) enhanced press release enhancement to ensure maximum impact; (4) social media distribution via IBN to millions of social media followers; and (5) a full array of tailored corporate communications solutions. With broad reach and a seasoned team of contributing journalists and writers, IW is uniquely positioned to best serve private and public companies that want to reach a wide audience of investors, influencers, consumers, journalists and the general public. By cutting through the overload of information in today’s market, IW brings its clients unparalleled recognition and brand awareness. IW is where breaking news, insightful content and actionable information converge.

For more information, please visit https://www.InvestorWire.com

Please see full terms of use and disclaimers on the InvestorWire website applicable to all content provided by IW, wherever published or re-published: https://www.InvestorWire.com/Disclaimer

InvestorWire
Los Angeles, CA
www.InvestorWire.com
310.299.1717 Office
[email protected]

InvestorWire is powered by IBN

Vivos Therapeutics (NASDAQ: VVOS), a leading medical device and technology company specializing in the development and commercialization of highly effective proprietary treatments for sleep-related breathing disorders, including all severities of obstructive sleep apnea (“OSA”) in adult patients, was spotlighted in a recent Proactive interview. During the interview, Vivos Therapeutics CEO Kirk Huntsman talked with Proactive host Steve Darling about favorable market developments that have created new opportunities for Vivos to increase its pool of potential users of Vivos’ oral appliance therapies. Specifically, Huntsman noted the FDA granted a clearance for the first time ever to an appliance designed to treat moderate and severe OSA in adults with positive airway pressure and/or myofunctional therapy. He also noted other factors contributing to the positive market conditions for Vivos, including the recent discontinuation of many Philips Respironics devices and the recalls of continuous positive airway pressure (“CPAP”) devices. Huntsman observed that these factors have created a significant opportunity for Vivos to expand its user base and offer effective treatment options to those in need.

To view the full interview, https://ibn.fm/Ij7kH

To view the full press release, visit https://ibn.fm/q08yF

About Vivos Therapeutics Inc.

Vivos Therapeutics is a medical technology company focused on developing and commercializing innovative diagnostic and treatment methods for patients suffering from breathing and sleep issues arising from certain dentofacial abnormalities such as obstructive sleep apnea (“OSA”) as well as snoring in adults. The Vivos Method represents the first clinically effective, nonsurgical, noninvasive, nonpharmaceutical and cost-effective solution for treating mild to severe OSA. It has proven effective in the treatment of an estimated 40,000 patients worldwide by more than 1,850 trained dentists. The Vivos Method includes treatment regimens that employ the proprietary Vivos Complete Airway Repositioning and/or Expansion (CARE) appliance therapy and other modalities that alter the size, shape and position of the soft tissues that comprise a patient’s upper airway and/or palate. The Vivos Method opens airway space and may significantly reduce symptoms and conditions associated with mild-to-severe OSA, such as lowering Apnea Hypopnea Index scores. Vivos also markets and distributes SleepImage diagnostic technology under its VivoScore program for home sleep testing in adults and children. The Vivos Integrated Practice (“VIP”) program offers dentists training and other value-added services in connection with using the Vivos Method. For more information about this company, visit www.VivosLife.com.

NOTE TO INVESTORS: The latest news and updates relating to VVOS are available in the company’s newsroom at http://ibn.fm/VVOS

About InvestorWire

InvestorWire (“IW”) is a specialized communications platform with a focus on advanced wire-grade press release syndication for private and public companies and the investment community. It is one of 60+ brands within the Dynamic Brand Portfolio @ IBN that delivers: (1) access to a vast network of wire solutions via InvestorWire to efficiently and effectively reach a myriad of target markets, demographics and diverse industries; (2) article and editorial syndication to 5,000+ outlets; (3) enhanced press release enhancement to ensure maximum impact; (4) social media distribution via IBN to millions of social media followers; and (5) a full array of tailored corporate communications solutions. With broad reach and a seasoned team of contributing journalists and writers, IW is uniquely positioned to best serve private and public companies that want to reach a wide audience of investors, influencers, consumers, journalists and the general public. By cutting through the overload of information in today’s market, IW brings its clients unparalleled recognition and brand awareness. IW is where breaking news, insightful content and actionable information converge.

For more information, please visit https://www.InvestorWire.com

Please see full terms of use and disclaimers on the InvestorWire website applicable to all content provided by IW, wherever published or re-published: https://www.InvestorWire.com/Disclaimer

InvestorWire
Los Angeles, CA
www.InvestorWire.com
310.299.1717 Office
[email protected]

InvestorWire is powered by IBN

Save Foods (NASDAQ: SVFD), a pioneer in sustainable solutions for agriculture, announced that its board of directors has authorized the company to begin preparing a distribution plan of Save Foods’ holdings in Plantify Foods Inc. (TSX.V: PTFY.CA); the company anticipates the distribution will launch later this year. According to the announcement, Save Foods believes this strategic decision will add value to its stockholders at no additional cost. The company noted that currently, SVFD holds more than 85 million common shares of Plantify Foods, which represents 23.1% of the total number of issued and outstanding common shares of the company. The company noted that the distribution is subject to obtaining any requisite legal opinion and regulatory approvals.

To view the full press release, visit https://ibn.fm/BuIlE

About Save Foods Inc.

Save Foods is an innovative agrifood tech company that through its three operational arms delivers integrated solutions for improved safety, quality and sustainability every step of the way from field to fork. Save Foods Ltd., Save Foods’ majority-owned Israeli subsidiary, focuses on post-harvest treatments in fruit and vegetables to control and prevent pathogen contamination, significantly reduce the use of hazardous chemicals and prolong fresh produce’s shelf life. Nitrousink Ltd., another majority-owned Israeli subsidiary, contributes to tackling greenhouse gas emissions, offering a pioneering solution to mitigate nitrous oxide emissions, a potent greenhouse gas with 265 times the global warming impact of carbon dioxide. Nitrousink aims to promote agricultural practices that are both environmentally friendly and economically viable. Plantify Foods, Save Foods’ minority-owned Canadian subsidiary, offers a wide range of clean-label healthy food options that are nutritious, gluten free and nonallergenic; that use whole natural ingredients; and that are easy to prepare. For more information about the company, visit www.SaveFoods.co.

NOTE TO INVESTORS: The latest news and updates relating to SVFD are available in the company’s newsroom at https://ibn.fm/SVFD

About InvestorWire

InvestorWire (“IW”) is a specialized communications platform with a focus on advanced wire-grade press release syndication for private and public companies and the investment community. It is one of 60+ brands within the Dynamic Brand Portfolio @ IBN that delivers: (1) access to a vast network of wire solutions via InvestorWire to efficiently and effectively reach a myriad of target markets, demographics and diverse industries; (2) article and editorial syndication to 5,000+ outlets; (3) enhanced press release enhancement to ensure maximum impact; (4) social media distribution via IBN to millions of social media followers; and (5) a full array of tailored corporate communications solutions. With broad reach and a seasoned team of contributing journalists and writers, IW is uniquely positioned to best serve private and public companies that want to reach a wide audience of investors, influencers, consumers, journalists and the general public. By cutting through the overload of information in today’s market, IW brings its clients unparalleled recognition and brand awareness. IW is where breaking news, insightful content and actionable information converge.

For more information, please visit https://www.InvestorWire.com

Please see full terms of use and disclaimers on the InvestorWire website applicable to all content provided by IW, wherever published or re-published: https://www.InvestorWire.com/Disclaimer

InvestorWire
Los Angeles, CA
www.InvestorWire.com
310.299.1717 Office
[email protected]

InvestorWire is powered by IBN

McEwen Mining (NYSE: MUX) (TSX: MUX), a gold and silver producer with operations in Nevada, Canada, Mexico and Argentina, is releasing full-year and Q4 2023 production results. According to the report, the results “represent a significant improvement year-over-year and compared to prior quarters.” The report noted that consolidated production in Q4 2023 reached 49,850 gold equivalent ounces (“GEOs”) with full-year production totaling 154,600 GEOs. The results are consistent with the company’s latest forecast and fall within the guidance range the company anticipated for the year. The company noted that Gold Bar production increased during the last quarter and December, with McEwen reporting new records for both the quarter and the month. The company also released its 2024 production and cost guidance, outlining projection to produce in the range of 130,000 to 145,000 GEOs attributable to MUX from all operations.

“The reduction compared to 2024 is primarily driven by lower output from our Fox operation and from San José, which is operated by our partner Hochschild Mining,” said the company in the press release. “We are currently evaluating potential areas for enhancing production and profitability, and we will update our guidance accordingly once any further improvements are implemented. At Fox in 2024, we will be starting the development of underground ramp access to the stock orebodies, particularly Stock West, which will become the primary source of feed following the completion of mining the Froome deposit in 2026. This capital investment is partially funded by the $16.1 million flow-through financing completed in December 2023.

At Gold Bar in 2024, the first half of the year is expected to deliver higher production relative to the second half, due to a scheduled waste stripping phase in the Pick pit, in preparation for the 2025 mining program. The mining sequence continues to be optimized.”

To view the full press release, visit https://ibn.fm/7ENfL

About McEwen Mining Inc.

McEwen Mining is a gold and silver producer with operations in Nevada, Canada, Mexico and Argentina. In addition, the company owns approximately 47.7% of McEwen Copper, which owns the large, advanced-stage Los Azules copper project in Argentina. The company’s goal is to improve the productivity and life of its assets with the objective of increasing its share price and providing a yield. Rob McEwen, chair and chief owner, has personally provided the company with $220 million and takes an annual salary of $1. To learn more about the company, visit www.McEwenMining.com.

NOTE TO INVESTORS: The latest news and updates relating to MUX are available in the company’s newsroom at https://ibn.fm/MUX

About InvestorWire

InvestorWire (“IW”) is a specialized communications platform with a focus on advanced wire-grade press release syndication for private and public companies and the investment community. It is one of 60+ brands within the Dynamic Brand Portfolio @ IBN that delivers: (1) access to a vast network of wire solutions via InvestorWire to efficiently and effectively reach a myriad of target markets, demographics and diverse industries; (2) article and editorial syndication to 5,000+ outlets; (3) enhanced press release enhancement to ensure maximum impact; (4) social media distribution via IBN to millions of social media followers; and (5) a full array of tailored corporate communications solutions. With broad reach and a seasoned team of contributing journalists and writers, IW is uniquely positioned to best serve private and public companies that want to reach a wide audience of investors, influencers, consumers, journalists and the general public. By cutting through the overload of information in today’s market, IW brings its clients unparalleled recognition and brand awareness. IW is where breaking news, insightful content and actionable information converge.

For more information, please visit https://www.InvestorWire.com

Please see full terms of use and disclaimers on the InvestorWire website applicable to all content provided by IW, wherever published or re-published: https://www.InvestorWire.com/Disclaimer

InvestorWire
Los Angeles, CA
www.InvestorWire.com
310.299.1717 Office
[email protected]

InvestorWire is powered by IBN

Tonix Pharmaceuticals Holding (NASDAQ: TNXP), a biopharmaceutical company with marketed products and a pipeline of development candidates, has engaged Rho, Inc., a global contract research organization (“CRO”). Under the terms of the engagement, Rho will support Tonix in preparing its New Drug Application (“NDA”) for planned submission to the U.S. Food and Drug Administration (“FDA”) for the clearance of Tonmya(TM), a patented sublingual tablet formulation of cyclobenzaprine hydrochloride, for the management of fibromyalgia.

“We are excited by our most recent positive Phase 3 study results of Tonmya and look forward to Rho’s support in preparing our NDA,” said Seth Lederman, M.D., President and CEO of Tonix. “We intend to meet with the FDA in the first half of this year and to submit our NDA in the second half of the year. We believe we have completed all development work required for the NDA, including CMC requirements and the completion of two positive Phase 3 studies.”

To view the full press release, visit https://ibn.fm/ojYvC

About Tonix Pharmaceuticals Holding Corp.

Tonix is a biopharmaceutical company focused on commercializing, developing, discovering and licensing therapeutics to treat and prevent human disease and alleviate suffering. Tonix’s development portfolio is focused on central nervous system disorders. Tonix’s priority is to submit a New Drug Application (“NDA”) to the FDA for Tonmya, which has completed two positive Phase 3 studies for the management of fibromyalgia. Tonix intends to meet with the FDA in the first half of 2024 and submit an NDA for the approval of Tonmya for the management of fibromyalgia in the second half of 2024. TNX-102 SL is being developed to treat fibromyalgia-type Long COVID, a chronic post-acute COVID-19 condition, and topline results from a proof-of-concept study were reported in the third quarter of 2023. TNX-1300 (cocaine esterase) is a biologic designed to treat cocaine intoxication and has been granted Breakthrough Therapy designation by the FDA. A Phase 2 study of TNX-1300 is expected to be initiated in the first quarter of 2024. Tonix’s rare disease development portfolio includes TNX-2900 (intranasal potentiated oxytocin) for the treatment of Prader-Willi syndrome (“PWS”). TNX-2900 has been granted Orphan Drug designation by the FDA and an investigational new drug (“IND”) application has been cleared to support a Phase 2 study in PWS patients. Tonix’s immunology development portfolio includes biologics to address organ transplant rejection, autoimmunity and cancer, including TNX-1500, which is a humanized monoclonal antibody targeting CD40-ligand (“CD40L” or “CD154”) being developed for the prevention of allograft rejection and for the treatment of autoimmune diseases. A Phase 1 study of TNX-801 was initiated in the third quarter of 2023. Tonix’s infectious disease pipeline includes TNX-801, a vaccine in development to prevent smallpox and mpox. TNX-801 also serves as the live virus vaccine platform or recombinant pox vaccine platform for other infectious diseases, including TNX-1800, in development as a vaccine to protect against COVID-19. During the fourth quarter of 2023, TNX-1800 was selected by the U.S. National Institutes of Health (“NIH”), National Institute of Allergy and Infectious Diseases (“NIAID”) Project NexGen for inclusion in Phase 1 clinical trials. The infectious disease development portfolio includes TNX-3900 and TNX-4000, which are classes of broad-spectrum small molecule oral antivirals. Tonix Medicines, the company’s commercial subsidiary, markets Zembrace(R) SymTouch(R) (sumatriptan injection) 3 mg and Tosymra(R) (sumatriptan nasal spray) 10 mg under a transition services agreement with Upsher-Smith Laboratories, LLC from whom the products were acquired on June 30, 2023. Zembrace SymTouch and Tosymra are each indicated for the treatment of acute migraine with or without aura in adults. For more information about Tonix, visit www.tonixpharma.com.

About InvestorWire

InvestorWire (“IW”) is a specialized communications platform with a focus on advanced wire-grade press release syndication for private and public companies and the investment community. It is one of 60+ brands within the Dynamic Brand Portfolio @ IBN that delivers: (1) access to a vast network of wire solutions via InvestorWire to efficiently and effectively reach a myriad of target markets, demographics and diverse industries; (2) article and editorial syndication to 5,000+ outlets; (3) enhanced press release enhancement to ensure maximum impact; (4) social media distribution via IBN to millions of social media followers; and (5) a full array of tailored corporate communications solutions. With broad reach and a seasoned team of contributing journalists and writers, IW is uniquely positioned to best serve private and public companies that want to reach a wide audience of investors, influencers, consumers, journalists and the general public. By cutting through the overload of information in today’s market, IW brings its clients unparalleled recognition and brand awareness. IW is where breaking news, insightful content and actionable information converge.

For more information, please visit https://www.InvestorWire.com

Please see full terms of use and disclaimers on the InvestorWire website applicable to all content provided by IW, wherever published or re-published: https://www.InvestorWire.com/Disclaimer

InvestorWire
Los Angeles, CA
www.InvestorWire.com
310.299.1717 Office
[email protected]

InvestorWire is powered by IBN

SenesTech (NASDAQ: SNES), the leader in fertility control to manage animal pest populations, has been accepted as a vendor for all Ace Hardware stores, which form a network comprising over 4,500 locations. According to the announcement, all Ace Hardware stores will be able to order directly from SenesTech, and the company will participate in Ace Hardware’s vendor events, including the Ace semi-yearly markets. “We are excited to be working with Ace Hardware. They represent leaders in the retail market for do-it-yourselfers and the consumer market, for which our Evolve(TM) soft bait is uniquely positioned,” said SenesTech’s President and CEO Joel Fruendt. “This is the first major move we will make into the retail market. We have expanded our packaging to include stand-up pouches, which are the perfect solution for the retail space. We are also in discussions with various rep agency firms that specialize in representing brands to major retailers and industrial/agricultural suppliers, to represent our line, as this will accelerate our penetration into this market segment.”

To view the full press release, visit https://ibn.fm/QpfQL

About SenesTech Inc.

SenesTech is committed to improving the health of the world by humanely managing animal pest populations through fertility control. The company is an expert in fertility control to manage animal pest populations. It invented ContraPest(R), the only U.S. EPA-registered contraceptive for male and female rats, and Evolve(TM), an EPA-designated minimum risk contraceptive currently offered for rats. ContraPest and Evolve fit seamlessly into all integrated pest management programs, significantly improving the overall goal of effective pest management. SenesTech strives for clean cities, efficient businesses and happy households – with a product designed to be humane, effective and sustainable. For more information about the company, visit www.SenesTech.com.

NOTE TO INVESTORS: The latest news and updates relating to SNES are available in the company’s newsroom at https://ibn.fm/SNES

About InvestorWire

InvestorWire (“IW”) is a specialized communications platform with a focus on advanced wire-grade press release syndication for private and public companies and the investment community. It is one of 60+ brands within the Dynamic Brand Portfolio @ IBN that delivers: (1) access to a vast network of wire solutions via InvestorWire to efficiently and effectively reach a myriad of target markets, demographics and diverse industries; (2) article and editorial syndication to 5,000+ outlets; (3) enhanced press release enhancement to ensure maximum impact; (4) social media distribution via IBN to millions of social media followers; and (5) a full array of tailored corporate communications solutions. With broad reach and a seasoned team of contributing journalists and writers, IW is uniquely positioned to best serve private and public companies that want to reach a wide audience of investors, influencers, consumers, journalists and the general public. By cutting through the overload of information in today’s market, IW brings its clients unparalleled recognition and brand awareness. IW is where breaking news, insightful content and actionable information converge.

For more information, please visit https://www.InvestorWire.com

Please see full terms of use and disclaimers on the InvestorWire website applicable to all content provided by IW, wherever published or re-published: https://www.InvestorWire.com/Disclaimer

InvestorWire
Los Angeles, CA
www.InvestorWire.com
310.299.1717 Office
[email protected]

InvestorWire is powered by IBN

RJD Green’s (OTC: RJDG) ioSoft Systems division, a developer of software and provider of IT support for the platforms developed, today announced it has been engaged to upgrade operations software of Rail Pro Services, a regional industrial products distributor, to an industry-specific operations platform. According to the announcement, ioSoft will offer essential technologies development and support as well as network management services. “Some of the many benefits for the active small-cap company include: freeing up internal resources, cost reductions, outside business guidance for increased profitability through technology application, expedited projects, and scalability. We feel these efforts will create significant enhancements for Rail Pro,” said Vincent Valentine, ioSoft’s chief technology officer.

To view the full press release, visit https://ibn.fm/1JUYd

About RJD Green Inc.

RJD Green operates as a holding company with a focus of acquiring and managing assets and companies. RJD Green operates in three divisions: RJD Green Healthcare Services Division, ioSoft Systems, provides discrete payment technologies, services and software that can be integrated into targeted offerings for healthcare provider networks, hospitals, healthcare payers and individual providers; Earthlinc Environmental Services Division, which provides green environmental services and technologies; and Silex Holdings Division, which is focused in specialty construction and industrial services. The initial operations, Silex Interiors, fills a market niche between the Home Depot and local contractors. Silex manufactures and installs granite and other counter tops, cabinets and related products to the residential builder, commercial contractor, remodel contractor and DIY customer. For more information about the company, visit www.RJDGreen.com.

NOTE TO INVESTORS: The latest news and updates relating to RJDG are available in the company’s newsroom at https://ibn.fm/RJDG

About InvestorWire

InvestorWire (“IW”) is a specialized communications platform with a focus on advanced wire-grade press release syndication for private and public companies and the investment community. It is one of 60+ brands within the Dynamic Brand Portfolio @ IBN that delivers: (1) access to a vast network of wire solutions via InvestorWire to efficiently and effectively reach a myriad of target markets, demographics and diverse industries; (2) article and editorial syndication to 5,000+ outlets; (3) enhanced press release enhancement to ensure maximum impact; (4) social media distribution via IBN to millions of social media followers; and (5) a full array of tailored corporate communications solutions. With broad reach and a seasoned team of contributing journalists and writers, IW is uniquely positioned to best serve private and public companies that want to reach a wide audience of investors, influencers, consumers, journalists and the general public. By cutting through the overload of information in today’s market, IW brings its clients unparalleled recognition and brand awareness. IW is where breaking news, insightful content and actionable information converge.

For more information, please visit https://www.InvestorWire.com

Please see full terms of use and disclaimers on the InvestorWire website applicable to all content provided by IW, wherever published or re-published: https://www.InvestorWire.com/Disclaimer

InvestorWire
Los Angeles, CA
www.InvestorWire.com
310.299.1717 Office
[email protected]

InvestorWire is powered by IBN

Knightscope (NASDAQ: KSCP), a leading developer of autonomous security robots (“ASRs”) and blue light emergency communication systems, has announced that a Las Vegas apartment complex has renewed its K5 ASR contract for the 4th consecutive year. The company attributes the contribution of repeat business and ongoing client engagement as drivers of a predictable and reliable income stream, providing a solid foundation for sustained growth.

The announcement reads, “The success of this deployment was previously reported by the Las Vegas Review-Journal and News 3 Las Vegas where the K5 continues to serve its community, and it further highlights the company’s ability to maintain a loyal customer base, minimize acquisition expenses and deliver cost-efficiency that positively impacts Knightscope’s bottom line.”

To view the full press release, visit https://ibn.fm/PK6kv

About Knightscope, Inc.

Knightscope is an advanced public safety technology company that builds fully autonomous security robots and blue light emergency communications systems that help protect the places people live, work, study and visit. Knightscope’s long-term ambition is to make the United States of America the safest country in the world. For more information, visit the company’s website at www.knightscope.com.

NOTE TO INVESTORS: The latest news and updates relating to Knightscope are available in the company’s newsroom at https://ibn.fm/KSCP

About InvestorWire

InvestorWire (“IW”) is a specialized communications platform with a focus on advanced wire-grade press release syndication for private and public companies and the investment community. It is one of 60+ brands within the Dynamic Brand Portfolio @ IBN that delivers: (1) access to a vast network of wire solutions via InvestorWire to efficiently and effectively reach a myriad of target markets, demographics and diverse industries; (2) article and editorial syndication to 5,000+ outlets; (3) enhanced press release enhancement to ensure maximum impact; (4) social media distribution via IBN to millions of social media followers; and (5) a full array of tailored corporate communications solutions. With broad reach and a seasoned team of contributing journalists and writers, IW is uniquely positioned to best serve private and public companies that want to reach a wide audience of investors, influencers, consumers, journalists and the general public. By cutting through the overload of information in today’s market, IW brings its clients unparalleled recognition and brand awareness. IW is where breaking news, insightful content and actionable information converge.

For more information, please visit https://www.InvestorWire.com

Please see full terms of use and disclaimers on the InvestorWire website applicable to all content provided by IW, wherever published or re-published: https://www.InvestorWire.com/Disclaimer

InvestorWire
Los Angeles, CA
www.InvestorWire.com
310.299.1717 Office
[email protected]

InvestorWire is powered by IBN

Sigma Additive Solutions (NASDAQ: SASI) today announced that it will hold a virtual special meeting of stockholders to approve the company’s corporate name change to NextTrip Inc. and an amendment to its charter to increase the number of authorized shares of its common stock from 1,200,000 to 250,000,000. The meeting will be held via live webcast on Friday, Mar. 8, 2024, at 10:00 a.m. Mountain Time (12:00 p.m. Eastern Time). “Stockholder approval of the proposals at our Mar. 8th special meeting will allow our business to fully transition to and operate as NextTrip, with a complete focus on our travel operations, and providing legacy stockholders the opportunity to benefit from any growth while the travel principals primarily benefit at a future date based on meeting business milestones,” said Bill Kerby, CEO of Sigma.

To view the full press release, visit https://ibn.fm/elTPD

About Sigma Additive Solutions Inc.

Sigma Additive Solutions has historically been a provider of in-process quality assurance (“IPQA(TM)”) solutions to the additive manufacturing industry. As previously disclosed in Sigma’s filings with the SEC, Sigma completed its acquisition of NextTrip in December 2023. With the sale of assets related to its additive quality assurance now complete, Sigma’s business has transitioned to that of NextTrip.

NOTE TO INVESTORS: The latest news and updates relating to SASI are available in the company’s newsroom at http://ibn.fm/SASI

About InvestorWire

InvestorWire (“IW”) is a specialized communications platform with a focus on advanced wire-grade press release syndication for private and public companies and the investment community. It is one of 60+ brands within the Dynamic Brand Portfolio @ IBN that delivers: (1) access to a vast network of wire solutions via InvestorWire to efficiently and effectively reach a myriad of target markets, demographics and diverse industries; (2) article and editorial syndication to 5,000+ outlets; (3) enhanced press release enhancement to ensure maximum impact; (4) social media distribution via IBN to millions of social media followers; and (5) a full array of tailored corporate communications solutions. With broad reach and a seasoned team of contributing journalists and writers, IW is uniquely positioned to best serve private and public companies that want to reach a wide audience of investors, influencers, consumers, journalists and the general public. By cutting through the overload of information in today’s market, IW brings its clients unparalleled recognition and brand awareness. IW is where breaking news, insightful content and actionable information converge.

For more information, please visit https://www.InvestorWire.com

Please see full terms of use and disclaimers on the InvestorWire website applicable to all content provided by IW, wherever published or re-published: https://www.InvestorWire.com/Disclaimer

InvestorWire
Los Angeles, CA
www.InvestorWire.com
310.299.1717 Office
[email protected]

InvestorWire is powered by IBN